<?xml version="1.0" encoding="UTF-8"?>
<itemContainer xmlns="http://omeka.org/schemas/omeka-xml/v5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="https://feministsnaparchive.omeka.net/items/browse?tags=birth+control&amp;sort_field=added&amp;output=omeka-xml" accessDate="2026-10-06T20:38:26-04:00">
  <miscellaneousContainer>
    <pagination>
      <pageNumber>1</pageNumber>
      <perPage>10</perPage>
      <totalResults>7</totalResults>
    </pagination>
  </miscellaneousContainer>
  <item itemId="9" public="1" featured="0">
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="1806">
                  <text>Coverage from The McGill Tribune</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="8491">
                  <text>This collection holds articles from the McGill Tribune. We are not allowed to host copies of the articles for copyright reasons, but have decided to share the metadata fields, should one want to find them elsewhere. At the time of writing this, all issues of the McGill Tribune are available at &lt;a href="https://issuu.com/mcgill_tribune"&gt;https://issuu.com/mcgill_tribune&lt;/a&gt;.</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="53">
          <name>Volume</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="59">
              <text>6</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Issue</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="60">
              <text>4</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="58">
                <text>1986/09/30</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="61">
                <text>The Pill At McGill</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="62">
                <text>PDF</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="63">
                <text>McGill Tribune</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="13">
        <name>birth control</name>
      </tag>
      <tag tagId="7">
        <name>letter to the editor</name>
      </tag>
      <tag tagId="14">
        <name>reproductive health</name>
      </tag>
      <tag tagId="15">
        <name>reproductive justice</name>
      </tag>
      <tag tagId="12">
        <name>student health</name>
      </tag>
      <tag tagId="10">
        <name>The McGill Women's Union</name>
      </tag>
      <tag tagId="11">
        <name>Union for Gender Empowerment (UGE)</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="10" public="1" featured="0">
    <collection collectionId="3">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="1806">
                  <text>Coverage from The McGill Tribune</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="8491">
                  <text>This collection holds articles from the McGill Tribune. We are not allowed to host copies of the articles for copyright reasons, but have decided to share the metadata fields, should one want to find them elsewhere. At the time of writing this, all issues of the McGill Tribune are available at &lt;a href="https://issuu.com/mcgill_tribune"&gt;https://issuu.com/mcgill_tribune&lt;/a&gt;.</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="53">
          <name>Volume</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="65">
              <text>6</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Issue</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="66">
              <text>5</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="64">
                <text>1986/10/07</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="67">
                <text>Pill Confusion </text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="68">
                <text>Patricia E. Rachofsky </text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="69">
                <text>PDF</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="70">
                <text>McGill Tribune</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="13">
        <name>birth control</name>
      </tag>
      <tag tagId="7">
        <name>letter to the editor</name>
      </tag>
      <tag tagId="14">
        <name>reproductive health</name>
      </tag>
      <tag tagId="15">
        <name>reproductive justice</name>
      </tag>
      <tag tagId="12">
        <name>student health</name>
      </tag>
      <tag tagId="10">
        <name>The McGill Women's Union</name>
      </tag>
      <tag tagId="11">
        <name>Union for Gender Empowerment (UGE)</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="215" public="1" featured="0">
    <fileContainer>
      <file fileId="46">
        <src>https://d1y502jg6fpugt.cloudfront.net/62030/archive/files/06323569e47adc49b2ea4b32c3114955.pdf?Expires=1792022400&amp;Signature=KNDggXgkBaCOGwk1upPVgbSbyNTyLR4kmnPpbNavOaL2STYZvTuNtbO8K4ffcGmElISdSlCF6%7EilKLy5s5XTbfJhr91eAGIlhzCXebUW6w9lG-31BDJTKyy3WtdN4VRJcMCAw4DXQZ1RCO0zpb1mgCTnVAa6bkK7oVYwsrhVSRFXWF1AMCiCjLI%7EjWSVU4pcNWxR9qggPJY6GsGSVaf0wXNxvRNoxa-WG5aeiIwNcdkmUOfTiBUqJugbgfu8U1LhyZPx8bKxnQWC6bHKgfyVkK0S35q%7Eq38WBo%7EkCbT4c4F7GAwLSR13cbpauTUpK131fAietdS0DGr6h-QrwNMiRw__&amp;Key-Pair-Id=K6UGZS9ZTDSZM</src>
        <authentication>938de4f533d29424825fd19ed49b5fed</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="1796">
                    <text>birth control
handbook

�NOT FOR SALE OR RESALE

Birth Control Handbook 1st edition, October 1968
2nd edition, January 1969
2nd edition, 2nd impression, March 1969
3rd edition, (revised), September 1969
3rd edition, 2nd through 6th impression, November
1969 through May 1970
1st French edition, February 1970
4th edition (revised), August 1970
Published by the Arts and Science Undergraduate
Society of McGill University.
Copyright 1970 Donna Cherniak, Allan Feingold and
the Students’ Society of McGill University
Production by the workers of Journal Offset, Inc.,
Montréal.
introduction
The Birth Control Handbook was one of the first major
publications to seriously challenge the much posited
“Population Explosion” theory. In the introduction of the
revised edition (September 1969) we suggested: “The:
Population Explosion is only a threat to the supremacy
of white nations which today, as in the past, are raping
the ‘Third World for wealth, resources and human
potential. The Population Explosion is the natural
increase of ‘the black, ‘brown and yellow peoples of the
world and therefore brings out fear in the world’s white
minority, a minority. that has, through the ages, exploited
all other races with a ferocity and viciousness
incomparable to any other human injustice.”

Mailing address: Birth Control Handbook, McGill Students’
Society, 3480 McTavish St., Montréal 112, Québec.
Phone: (514) 392-8922
Cost: individual copies free, send 25¢ mailing and
handling charges; bulk cost: $35.00 per thousand copies do not send money until invoiced
Co-editors: Donna Cherniak and Allan Feingold
Photography: André and Danielle Giguère (address
requests for prints to editors).
Montreal Women’s Liberation Movement - phone (514)
844-5838
Reproduction of any part or the whole of the Birth Control
Handbook in any way is prohibited unless express
consent of the editors has been granted.

rica also relies on more subtle birth control methods to
control the population of non-white people. One problem
American scientists are running into is the ‘unwillingness
of many people to control their fertility to suit their white
oppressors. The obvious solution to this dilemma is the
development of non-voluntary contraceptive methods or
sterilization programs. In an article printed in Science
(Oct. 24, 1969), Carl Djerassi, president of Syntex
Research, states: “... in developing countries, the 2 year
dropout figure with IUD’s or with the steroid oral
contraceptives exceeds 50 percent... I am not convinced
that any better results can be obtained with any method
which requires a conscious act of conception control. For
the populations of these developing countries it will be
necessary to develop a procedure which produces, by a
Reaction to that statement from the establishment press single administration of a birth-control agent, indefinite
and right-wing doctors was immediate. To our critics, and (but reversible) sterility... ” Actually, such a chemical
more importantly to our supporters, we promised more
contraceptive is already being applied to non-white
of the same in this edition.
women in Third World nations. Injections of 150 mg. of a
potent synthetic progesterone produce infertility for 8 to
As most. people realize, the world is rapidly heading into 24 months, and in some susceptible women, sterility is
a crisis situation. America tenuously maintains a false
permanent. Women receiving this “contraceptive” are
affluence and attempts to impose ‘law and order” on an
told that the drug is 100%. effective for only 3 months.
increasingly dissident population. The only hope for
Scientists are using Third World women for experiments
American capitalism is to hold its great resources, its
with various mechanical and chemical sterilants. Djerassi
neo-colonies in the Third World, against the increasingly realizes that such experimental programs, supported by
frequent wars of national liberation. In Southeast Asia,
companies such as his own, might be suspect: “…it
American scientists and the military have developed the takes little imagination to predict what kind of major issue
perfect population control method: massive murder of
can develop from such a state of affairs, in which
“Oriental human beings’. After returning from Southeast preliminary trials on human beings, under the auspices
Asia, Professor Noam Chomsky explained: “It is
of technically advanced countries, are performed first in
important to understand that the massacre of the rural
developing countries’, and: “Even within the United
population of Vietnam and their forced evacuation is not States, some of the economically deprived black
an accidental byproduct of the war”. The theory behind
inhabitants of our urban ghettos attribute genocidal
American strategy, is stated by Samuel Huntington,
motives to family-planning programs in their areas. ”
chairman of Harvard’s Government Department, when
These “economically deprived black inhabitants” are
he says | that the NLF is ‘“‘a powerful force which cannot correct in suspecting genocidal motives. A new and
be dislodged from its constituency so long as the
growing group in the United States, called “Zeroconstituency continues to exist.’” Chomsky comments
population” supports forced sterilization programs ‘in
that the American answer to a people’s war is to
Third World Nations. Commenting on an Indian
eliminate the people. (Ramparts, Aug. 1970).
government proposal to sterilize all males with 3 or more
children, Paul Ehrlich, author of the. Population Bomb
Aside from bombs, napalm. and defoliants, Am
and chief spokesman for

Z-pop says: “We (the U.S. government) should have
applied pressure on the Indian government to go ahead
with the plan. We should have volunteered logistic
support... Coercion? Perhaps, but coercion In a good
cause.” James Ridgeway, editor of Hard. Times describes
Ehrlich’s proposals as ‘‘therapeutic counter-revolution’’.
The majority of people in the world. are starving. The real
cause. of, this starvation: is unequal and unscientific
distribution of wealth between the ‘“‘developed. nations’’.
and the “underdeveloped nations’’.
Ehrlich, his Z-pop-ers and all the other “neo-Malthusian
bullshitters” are supposedly blind to the grain rotting in
North American grain elevators, the farmers being paid not
to grow food, the being dumped into the ground, the pigs
being shot and’ buried. Never once do they mention that
only in respect of the laws of capitalism can food be
destroyed in a starving world. The Z-pop movement
suggests that people are starving because they dare to be
alive, if they were not alive they would not starve. The
solution that they suggest is genocide.
America realizes that Third World liberation movements
are devoted to freeing.their people from the strangulation
hold of American neo-colonialism and to an equitable
redistribution of wealth. The next ten years are critical to
liberation movements and America is using every weapon
in its fascist arsenal to combat.them. The population
control movement, supported by the Rockefeller and Ford
foundations, is a weapon of imperialism. Let us not see.
the Z-pop-ers as youth devoted to a cause, intent, on
“saving the world”; for in reality, they are the dupes of the
American monster pursuing a genocidal program.
II
The distortion of history is not new, but distortion of the
history of women is a particular phenomenon. Women are
usually considered sufficiently insignificant to omit from
historical accounts;. therefore any actions of women
considered important enough to misrepresent, demand
further investigation.
For most people, the name Margaret Sanger brings to
mind a kind of Florence Nightingale image the frail young
nurse (suffering from TB) who, after saving a woman from
a butchered abortion only to see her die from a later
attempt, devoted her life to. the dissemination of birth
control information. Books printed a bit closer to her time
express admiration of her courage more strongly, even
recording her willingness to go to jail for her cause, but the
overall impression is still far from the truth.
Margaret Sanger, anarchist and active member of the
American Socialist Party, published one of the first journals
of women’s liberation, called Woman Rebel, which
contained articles on political questions and on sex
education. This journal and her pamphlet on Family
Limitation were banned from the U.S. mails under the
Comstock Law.
Instead of facing trial for ‘‘obscenity’’, she chose to flee the
country to continue her work.
Margaret Sanger saw contraception as a prerequisite to
the liberation of women. For her, voluntary motherhood
would imply “a new morality

- a vigorous constructive, liberated morality which would
prevent the submergence of womanhood into
motherhood. It would set its face against the conversion
of women into mechanical maternity’’. This basic
freedom would in turn be the “keynote of a new social
awakening’.
The birth control movement has been so co-opted that it
not only ignores but often betrays many of the goals
which its founder had envisioned. The humiliating
treatment of non-married and young women who ask for
birth control information is unjustifiable. The
condescending attitude of male gynecologists toward
women cannot be tolerated further. The general state of
ignorance on all medical matters, but especially
contraception is perpetuated by the medical profession
to its financial advantage. Such gross irresponsibility
would be unthinkable in a profession sincerely
committed to the alleviation of human suffering, but it is
perfectly consistent with.a profession committed only to
the maintenance of its status and income.
The issue of contraception still contains radical potential
- what was true in Margaret Sanger’s day has not
changed much. The quality of medical attention any
woman receives is determined by her husband's or
father’s social class, not by her own needs. While
politicians academically debate the laws, their wives
and mistresses are breaking them.
The implications of effective contraception are important
in the redefinition of women. Woman’s sexuality must
no longer be considered secondary to man's. If bearing
children becomes an option, certainly the role of
socializing children can be seen as a matter of choice
as well. The independence to choose one’s function
within the society, rather than within the home is
understandably frightening to many women. Such fears
must be transformed into constructive action to oppose
the forces of sexism. From the understanding of one’s
own oppression as a woman comes a better
understanding of the oppression of others also
enchained in master-slave relationships.
The Birth Control Handbook is produced not as a favor
to an irresponsible medical profession nor as a favor to
men who want an easy but “safe” lay, but as a political
act. Organizations distributing the Handbook have a
responsibility to continually raise the issues of women’s
liberation whenever dealing with birth control. All women
have a responsibility ‘to themselves and to their sisters
to consider seriously how the politics of women’s
liberation relate to their own lives - relationships with
men, attitudes toward children, status at work, attitudes
towards establishment politics and institutions, and
most importantly, their relationships with other women.
Margaret Sanger is only one of many heroic women
whose devotion to the liberation of her sisters goes
unrecorded. It is time to write our own history and to
create a future adequate to our needs.
Women interested in the Women’s Liberation Movement
can contact the editors of the Handbook for information
about action in their locality.

�anatomy

Female reproductive structures
The female external genital organs, which are
given the general name, vulva, include the
following:
Mons veneris: This latin term describes the
cushion of fat over the pubic bone which, from
puberty on, is covered with pubic hair.
Labia majora: The folds of fat tissue on either
side of the vaginal opening are called the labia
majora or “major lips’. In children, the, labia
majora completely cover and protect the genital
organs; in mature women, the lips remain apart.
The skin, covered with pubic hair, becomes
moist and delicate closer to the vaginal opening.
Labia minora: The “small lips’ or labia minora are
folds of sensitive, reddish tissue between the
labia When a woman is sexually excited, these
small lips become slightly erect. ‘They join in
front forming the prepuce which covers the
clitoris.
Clitoris: The clitoris, the most sexually sensitive
of the female genitals, is located in front of
(above) the urethral opening, and is partially
covered by the prepuce. A homologue of the
penis, the clitoris responds to stimulation
becoming slightly enlarged and erect.
Urinary meatus: ‘The meatus, found between the
clitoris and the vaginal opening, is the opening of
the urethra through which urine is released from
the bladder.
Bartholin’s glands: The purpose of these two
small glands, situated in the labia minora on
either side of the vaginal opening, is not clearly
understood. They release only a drop or two of
mucus‘ when a woman is highly excited sexually.

Hymen: This elastic membrane, also called the
‘“maidenhead’’, is found at the vaginal entrance projecting
from the vaginal wall. In most women, the hymen does not
block the vaginal opening completely, allowing the
menstrual flow to pass through. Rupturing of the hymen
(loss of virginity) can be painless or quite difficult, and slight
bleeding often occurs. Some women have the hymen
broken medically before attempting sexual intercourse.

certain birth control methods. Internally the uterus is
lined with a thick spongy tissue called the
endometrium which is cast off as the menstrual flow
once every 28 days if pregnancy does not occur.
The lower part of the uterus which extends into the
vagina is called the cervix. The muscular cervix
contains the cervical canal which serves as a
passage between the uterus and vagina. The
opening of the cervical canal into the vagina, the
external os, is round before the first pregnancy, and
slit-shaped afterwards. The opening into the uterus is
called the internal os.
Fallopian tubes: The two Fallopian tubes (oviducts)
are attached high on either side of the uterus, and
extend about 4 inches toward an ovary. At ovulation,
a suction-like mechanism draws the egg toward the
tube's fringed end; then rhythmic tubal contractions
move the egg toward the uterus. Union of egg and
sperm (conception, fertilization) occurs within the
tube, which is less than 1/2 an inch in diameter.
Ovaries: The two ovaries (female gonads) lie on
either side of the uterus. At birth, 100,000 to 600, 000
immature egg cells (ova) each within a follicle are
embedded deep within the body of the ovary. After
puberty, the follicles move toward the ovarian
surface; each cycle, several follicles develop but only
one releases an egg ready for fertilization. The ovalshaped ovaries also release hormones which affect
ovulation and development of the endometrium.

The internal female reproductive parts are:
Vagina: The vagina, located between the bladder and the
rectum, is about 4 or 5 inches long. Normally its elastic
walls touch each other but they stretch considerably
during intercourse and even more during childbirth. When
a woman is excited, lubricating mucous secretions pass
directly from blood vessels in the vaginal wall into the
vagina.
Although externally the vagina is highly sensitive, the
internal end has little sensitivity. The vagina ends in
pockets about the cervix: those in front and back of the
cervix are called the anterior fornix and posterior fornix
respectively; those to the sides are called lateral fornices.

Uterus: The womb or uterus lies between the bladder and
the lower intestine. Before the first pregnancy, it is about
3 inches long and 2 inches across at the widest point,
and its thick muscular walls practically touch each other.
After each pregnancy, the uterus remains slightly
enlarged as does the cavity within it. Normally the top
triangular portion bends slightly forward, and the lower
portion points down and back toward the spine. When the
top bends too far forward or backward, the condition is
known as anteflexion or retroversion respectively. This
can cause problems during pregnancy, abortion and with

The Gynecological Examination

After puberty, a woman should have an annual
gynecological examination. ‘The doctor begins this
routine medical procedure by questioning the woman
about her medical history, and that of her immediate
family. Of special interest are: the nature of her menstrual
cycle, experiences with or plans for pregnancy, and use
of birth control. The woman is then left alone in the
examining room to undress completely, and is given a
disposable robe to wear. ‘I'he nurse records the woman's
height, weight, blood pressure and draws a sample of
blood for analysis. While the woman sits on the table, the
doctor examines her head, neck, breasts, back, lungs,
heart and abdomen. Then, the woman lies down and
rests her legs in stirrup-like supports.
A sheet placed over her lower body for the sake of
modesty still affords the doctor adequate access to the
vaginal area. For many procedures, the doctor inserts a
metal speculum into the vagina to hold the vaginal walls
apart. Cells for the Pap test, a routine procedure to detect
cervical cancer, are obtained by gently scraping the
cervix. An ‘internal’ or pelvic examination is done by
inserting two fingers of a surgically gloved hand deep into
the vagina, and, with the other hand on the lower
abdomen, feeling the reproductive organs.

�Male reproductive structures
The penis and scrotum are the only parts of the male
reproductive system which are external; the other
structures rest within the lower pelvic area.
Scrotum: The scrotum, a two-chambered sac lying
behind the penis and between the legs, carries and
protects the two testicles or testes. In sexually mature
males the skin of the scrotal sac is wrinkled and covered
with the pubic hair.. The scrotum normally hangs loosely
away from the body so that a temperature below normal
body temperature is maintained in the testicles. This
lower temperature Is necessary for the production of
sperm cells. In cold weather muscles in the scrotal wall
contract to bring the testicles closer to the warmth of the
testicles (testes): The two testicles are made up of tiny
sperm-producing tubes called seminiferous tubules, and
male hormone-producing cells called interstitial cells,
lying between the tubules. At puberty, the tubules begin
to produce millions of sperm cells continuously. Sperm
production can continue until a man is eighty or ninety
years old.
Epididymis: The seminiferous tubules lead into an oval
cushion of tissue called the epididymis which is
connected to the upper part of each testicle.
Vas deferens: The tubules making up the epididymis
carry sperm cells into a single tube called the vas
deferens (spermatic or seminal duct). The spermatic cord
which consists of the vas tube intertwined with nerve and
muscle fibers and blood vessels, can contract to pull the
testes into the safety of the body.

Ampulla (seed reservoir): Each vas deferens leads
upward from a testicle into the pelvis, passes around the
urinary bladder and enlarges just before the prostate
gland to form the ampulla. Contractions of muscles in the
walls of the vas deferens push sperm cells into the
ampulla. Each ampulla is about an inch long and less than
an inch wide.
Seminal vesicles: Attached to the bottom of each ampulla
is a gland called the seminal vesicle. These glands
secrete a thick yellowish substance necessary for the
survival of sperm cells and important in the composition of
the final seminal fluid.
Prostate gland and urethra: The two vas tubes join within
the prostate gland and enter the urethra. The urethra is a
tube which carries urine from the bladder to the opening of
the penis. The prostate gland produces a white alkaline
fluid which mixes with sperm cells and the secretions of
the seminal vesicles during ejaculation. This prostate
gland secretion makes up the majority of the final seminal
fluid, also called the ejaculate. Muscle tissue covering the
prostate gland contracts during ejaculation forcing semen
through the urethra and out the penis. The number of
sperm in each ejaculation varies greatly in different men.
An average ejaculation contains 350 million sperm cells.
Cowper’s glands:These two small glands join the urethra
as it leaves the prostate gland. Cowper's glands secrete a
few drops of colorless alkaline mucus during sexual
excitement.
Penis: The penis is a tubular organ made up of three
bodies of erectile
tissue which stiffen or ‘erect’ when filled with blood.
Physical or mental sexual stimulation causes the penis to
engorge with blood and to become erect. The adult male
penis is normally about 3 1/4 to 4 3/4 inches long;
however, when erect it is usually 6 to 7'2 inches long and
about 1 1/2 inches wide.
Since the female clitoris and not the vaginal barrel is the
center of female sexual sensitivity the length or width of
the erect penis has little effect on the amount of pleasure
a woman receives during sexual intercourse.
The skin covering the penis is loose and can move back
and forth.
At the base of the penis, this skin is covered with pubic
hair.
One body of erectile tissue expands at the top of the penis
to form the glans. At birth, the glans is covered with the
foreskin, which is routinely removed in many North
American hospitals. The removal of the foreskin of male
babies which is a Jewish and Moslem ritual is called
circumcision. Circumcision prevents the accumulation of
smegma, a waxy secretion which forms below the
foreskin. Uncircumcised men must pull back the foreskin
and wash away accumulated smegma regularly. The glans
of the penis, whether or not it is covered by the foreskin, is
highly sensitive to sexual stimulation. The urethra, which
carries urine and, during ejaculation, semen, ends at the
tip of the penis at the slit-like opening called the meatus.

hormones

and the
menstrual
cycle
The endocrine system consists of various ductless
glands and tissues, which release chemical substances
called hormones directly into the blood stream.
Because all hormones are interrelated, it is necessary
to consider them in terms of hormonal interactions and
balances, rather then individual substances. Hormones
significantly affect all body functions: in fact, the
endocrine system is considered a control mechanism
for the entire body.
The pituitary gland, located at the base of the brain, is
the most important endocrine gland. The pituitary
apparently regulates action of all other endocrine
glands. Follicle Stimulating Hormone (FSH) and
Luteinizing Hormone (LH) released by the pituitary,
affect the ovaries (female gonads) and thus are known
as pituitary gonodotropins.
The gonads of each sex are also considered endocrine
glands. The ovaries release sex hormones called
estrogen and progesterone which play a major role in
ovulation and in the cyclical development of the uterine
lining.
Puberty is the general term for all the physical and
psychological changes a girl undergoes between the
ages of 11 and 17, including the appearance of pubic
hair, breast development, and distribution of fat tissue,
especially about the thighs and hips. The first
menstruation or menarche is only one of these many
changes, stimulated by the production of pituitary
gonadotropins.
The average ‘menstrual cycle lasts approximately 28
days.’ Some women have consistently longer or shorter
cycles; others, especially young women, have cycles
which vary in length. The menstrual cycle can be
influenced by a change in climate or emotional stress.
The first day of the menstrual flow Is considered the
beginning or day 1 of the menstrual cycle.
Day 1 - day 5: menstrual phase
The cycle begins with the shedding of the developed
endometrium as the menstrual flow. Total blood loss
during menstruation is about 2 to 4 ounces; most of the
flow is fluid but occasional blood clots appear when the
flow is heavy. The ‘‘period’’ lasts 3 to 7 days, usually
heavy at first and tapering off at the end.

�tip of the follicle becomes transparent and thin. A sudden
increase in the amount of circulation LH causes the
thinnest area on the follicle’s surface to.rupture, releasing
the egg. The fringed end .of the Fallopian tube draws the
egg into the tube.
Movement of sperm through the cervical mucus is easiest
at this time, due to estrogen-induced nutrient and alkaline
levels.
Once the egg has been released, LH stimulates the
ruptured follicle to become a hormone-secreting gland
called the corpus luteum.
Day 15 - day 25: secretory phase
Immediately after ovulation, the corpus luteum (yellow
body) secretes progesterone which, along with estrogen
released by the ovaries, stimulates further development of
the endometrium. The endometrium becomes a rich bed
of blood vessels and tissues in preparation for
implantation of a fertilized egg. Estrogen and
progesterone also affect the pituitary gland: both
hormones block its production of FSH, and progesterone
alone blocks the production of
If the egg is fertilized, the placenta takes over the
production of progesterone, blocking the release of
pituitary gonadotropins, which in turn prevents the release
of another egg throughout pregnancy.

Women use either external sanitary napkins or internal
tampons to absorb the flow. A napkin (pad) is attached to
a belt which holds it in place against the vulva. Napkins
should be changed regularly since blood gives off an
unpleasant odor when exposed to air. Internal tampons
are held in the vagina by muscles at the vaginal opening.
When inserted correctly, tampons cannot be felt.
Tampons should be changed as often as the flow
necessitates. Women with the hymen intact (virgins) can
use tampons without difficulty. When the flow is
extremely heavy, two tampons can be used at once. The
second is inserted beside the first, and the strings should
be tied together. Some women prefer to use a tampon
and sanitary napkin to absorb a very heavy flow.
There is no reason whatsoever to prohibit sexual
intercourse during menstruation.
During menstruation, the hypothalamus (brain structure
which controls involuntary body functions) stimulates the
growth of several ovarian follicles each containing one
egg, on the surface of each ovary. FSH: also stimulates
the developing follicles to secrete estrogen.

Three days before Thursday, maid’s day off, they met in
their special place, the bench beside the pond in the park.
Lisa was shy but determined to be straight and honest as
was her nature.
‘‘I can’t do it with you.”
‘Aren't your parents going away?”’
‘It's not that. Last night I got the Curse.”’
She touched his hand with pride.
“Oh”

‘‘Don’t be sad. We had a long talk. I told her about us, too.
You see, I’ve got to act like a lady now. Girls have to act
older than boys.”
‘“Who’s sad?”’
She leaned back in the bench and took his hand.
‘‘But aren't you happy for me!”’ — she laughed — ‘‘that I
got the curse? I have it right now!’’
- Leonard Cohen
The Favorite Game

Day 6 - day 13: proliferatory phase
Estrogen released by the follicles causes the
endometrium to proliferate and induces changes in the
cervical mucus which permit easier. movement of sperm
into the uterus. Estrogen also suppresses the pituitary's
secretion of FSH. At about the 12th day, the pituitary
begins to secrete Luteinizing Hormone (LH). One follicle
develops more extensively than the others, protruding
from the surface of the Ovary.
Day 14: ovulation
Ovulation is the release of one ovum (egg) from’ the
protruding follicle. When the pituitary gonadotropins,
FSH and LH, are in a particular ratio, the

If fertilization does not occur, the corpus luteum starts to
degenerate about day 25. Its cells are reabsorbed and
replaced with normal ovarian tissue. As a woman gets
older, reabsorption is not complete and scar tissue from
the corpus luteum remains on the ovarian surface.
Follicles which began to develop but did not rupture are
also reabsorbed by the ovary.

�Day 26 - day 28: secretory phase (premenstrual)
Degeneration of the corpus luteum reduces the secretion
of estrogen and progesterone. This low hormonal level
causes the contraction of blood vessels leading to the
endometrium, thus reducing the flow of blood to the
tissue. The tiny veins and arteries of the endometrium
break down, releasing blood, thus marking the beginning
of the menstrual flow. The low hormonal level also
stimulates the secretion of FSH by the pituitary gland,
causing the whole cycle to begin again.
The climacteric (change of life)
The cycle described above continues, except during
pregnancy and breastfeeding until the climacteric when
the ovaries begin to fail. Menopause or the end of
menstruation, the most noticeable event of. the “‘change
of life’, occurs between the ages of 45 and 50. The
process is gradual as ovulation becomes more irregular
and infrequent. Once ovulation stops, progesterone is no
longer released. Estrogen production is greatly reduced.
Women under the care of a gynecologist usually receive
hormonal “replacement therapy’ for the rest of their lives.
Many women suffer from minor to severe depression
and irritability during the change of life. Because western
women are forced to compete as sexual objects, and are
allowed no meaningful function within society, such
problems take on an exaggerated importance. There is
no reason why the climacteric should affect a woman's
ability to function fully both mentally and physically or to
enjoy sexual intercourse.

Sexual
intercourse
Tne ability to enjoy sexual intercourse (coitus, ‘making
love’, copulation, “having relations’, “having sex’’, etc.)
develops with knowledge of the human body and with
experience in social and sexual relations with others. The
pleasure of sex without fear of pregnancy or moral
sinfulness continues to be denied, especially to women,
because of the repression of such knowledge and
experience.
Most couples engage in some form of sexual foreplay kissing, caressing, teasing, - before beginning sexual
intercourse. Almost any part of the body Is sensitive to
sexual stimulation, but especially the thighs, buttocks,
breasts, nipples, neck and ears. Both partners can enjoy
oral-genital contact.
When sexually. aroused, the man’s penis and the woman’s
clitoris become hard and erect, due to the engorgement of
the tissue with blood. The woman’s vaginal walls separate,
expand, and become moist with mucus. To begin coitus,
either partner guides the man’s erect penis into the vaginal
opening. Saliva Is always available as a lubricant if the
vagina is too dry for comfortable intromission. Together,
the man and woman move their bodies in such a way that
the clitoris and the penis are stimulated, not necessarily
simultaneously.

Female orgasm
Whether a woman comes to orgasm (the climax) through
masturbation, manipulation, or coitus, the physiologic
response is the same. Sexual sensitivity is centered in the
vulva, specifically the clitoris, and not the vaginal barrel
which contains many times fewer nerve endings.
Stimulation of the clitoris causes engorgement of blood
vessels in the genitals, and a general neuro-muscular
tension. Other body changes in this excitement phase
include: increased rate of breathing and of heart beat,
breast enlargement, erection of nipples, upward
movement of the uterus, and expansion of the vaginal
walls. Sometimes a sexual flush (temporary skin rash)
appears.
At the plateau phase of excitement, these changes are
accelerated, and, without distraction, the woman soon
reaches orgasm - the pleasurable release of tension in the
genitals and throughout the entire body. The vaginal walls
especially near the opening, contract rhythmically. The
uterus contracts pushing the cervix further into the vagina.
As the tension is released, the body begins to return to its
normal condition (resolution phase): but, if stimulation
continues before sexual tension drops below the plateau
level, the woman can ‘‘come’”’ again almost indefinitely.
Women can experience long orgasms or a rapid series of
orgasms without a return to the plateau phase.

Male orgasm
Male orgasm also involves the release of neuromuscular
tension throughout the body. In the plateau phase when
orgasm seems inevitable, the contents of the ampulla,
seminal vesicles, and prostate gland combine to form the
final seminal fluid. Muscles surrounding the urethra as it
leaves the bladder contract so that urine cannot be
released.
During orgasm, the semen is forced out the tip of the
penis through the urethra. The first muscular contractions
are strong and their rhythm is the same as the woman’s
vaginal contractions. The amount of ejaculate released
influences the strength (but not necessarily the pleasure)
of the orgasm. Other body changes are similar to those
in women including muscles spasms, sexual flush, and a
light film of perspiration.
During the resolution phase after orgasm, the body
changes disappear, at first suddenly, and then slowly
taking up to several hours. The penis loses much of its
erection, and a short time span (the refractory period)
must pass before a man can have another orgasm.
Positions
The many imaginative positions for making love fall into
one of two classifications: face to face, and intromission
from behind. In face to face positions

(to mention only a few), either partner can lie on top of
the other, both can lie on their sides, one can sit over the
other who is lying down, or both can stand or sit. When
intromission occurs from behind, the man can lie on top
of the woman, the woman can sit back on the man’s lap,
the woman can crouch while the man kneels behind her,
etc. Each position has its advantages and disadvantages
such as: freedom of movement, depth of penetration of
the penis, and stimulation of the clitoris. If a woman
wishes to become pregnant, the couple should have
intercourse face to face with the man on top.

Rupturing the hymen (loss of virginity) should be done
in a position in which both partners can easily control
their movements. The hymen should be stretched
gradually with gentle but constant penetration of the
penis. Slight bleeding and some pain is common;
however, some women feel no discomfort at all.
There is no reason for prohibiting sexual intercourse
during menstruation. The erect penis blocks the flow
during intercourse, and a disposable cloth placed on
the sheets can prevent possible staining when the man
withdraws his penis. Some women have a slightly
heavier flow after intercourse due to contractions of the
uterus during orgasm.

�conception

At the time of ovulation, mucus in the cervical
canal becomes more plentiful, thinner, and richer in
nutrients, so that sperm cells can pass easily into
the uterus.

The union of egg and sperm (fertilization) is a

highly complex process, the mysteries of which have
yet to be fully understood. The following description
of the fundamentals of conception is necessarily superficial.
Sperm
Sperm cells, produced in the seminiferous tubules of
the testes, are moved by muscular contractions through
the vas deferens for about three weeks until the mature
cells reach the ampulla. Secretions from the prostate
gland and seminal vesicles add both bulk and energy to
the sperm cells, creating the final seminal fluid.
Each sperm cell consists of a head, mid-piece, and tail.
The head contains 23 chromosomes responsible for the
hereditary characteristics from the father. The mid-piece
and tail are made up of coiled fibers which contract and
expand to move the sperm cell along.
An average of 350 million microscopic sperm cells are
released in one ejaculation. The life span of sperm
within the female genital tract is approximately 48
hours.

The egg
Follicle Stimulating Hormone (FSH) released by the
pituitary gland at the beginning of a woman’s cycle
stimulates several ovarian follicles to grow. About the 12th
day, the pituitary begins to release Luteinizing Hormone
(LH) as well. When FSH and LH are in proper balance,
one of the follicles ruptures, releasing an egg which is
soon picked up by the fringed end of the Fallopian tube.
The nucleus of the egg cell contains 23 pairs of
chromosomes; as the egg matures, 1 chromosome from
each pair is retained, and the other is discarded in a
cluster called the polar body. The nucleus and the
nourishing cytoplasm are surrounded by a thicker
membrane, the zona pellicuda. Smaller cells from the
ruptured follicle cling to its surface. Some of these cells
are brushed off by hair-like cilia within the Fallopian tube
as muscular contractions move the egg toward the uterus.
If the egg is not fertilized withIn 24 hours of ovulation, it
degenerates and passes out the body unnoticed.

Fertilization
During sexual intercourse, millions of sperm cells are
ejaculated high into the woman’s vagina, near the alkaline
environment of the cervix. Many sperm “swim” in the
wrong direction; others are killed by the acid condition of
the vagina, and still others are trapped in the folds of the
vaginal walls. Those that pass through the cervical canal
are moved toward the Fallopian tubes primarily by
muscular activity of the uterus. Some sperm enter each
Fallopian tube, only one of which holds an egg.
Fertilization occurs in the Fallopian tube. The first sperm
cells to reach the egg release a chemical which dissolves
cells adhering to the zona pellicuda. Once the egg is
exposed, one sperm cell bores through the cell
membrane to the center of the cell. A second chemical
reaction prevents any other sperm from entering the egg.
As the fertilized egg (gamete) is moved down the
Fallopian tube, the nuclei of the sperm and egg fuse
together to form one nucleus with 46 chromosomes.
These chromosomes reproduce themselves and the cell
divides in two. This division process continues until the
gamete is a cluster of tiny cells, each with 46
chromosomes. Fats and other substances of the egg cell
provide it with nourishment for 3 days as it travels down
the tube to the uterus.

For several days the egg cluster or blastocyst
floats freely in the uterine cavity. About six days
after fertilization, the blastocyst attaches itself to the

endometrium, and buries itself by chemically dissolving a bit of endometrial tissue. Blood surrounds
the cluster and nourishes it. Nidation (implantation)
is complete by the 12th day after fertilization. One
mass of cells from the blastocyst soon develops as
the growing embryo; others become nutritive structures such as the placenta.

Implantation often does not occur at all, and the
fertilized egg degenerates.

Determination of pregnancy
Changes of the uterus

As the ovarian follicles develop, estrogen is released by the ovaries. After ovulation, progesterone

is released by the corpus luteum, the scar tissue
on one ruptured follicle. Both hormones stimulate the

endometrium (uterine lining) to “‘proliferate’’, preparing the lining to nourish a fertilized egg after
implantation. If implantation does not occur the lining
is shed as the menstrual flow.

Usually, a woman first suspects that she is preg-

nant when her menstrual period is overdue. The
length of pregnancy is always calculated from the first

day of her last menstrual flow: thus, if a woman is
ten days late, and normally has her period every 28
days, she is considered 38 days or 52 weeks pregnant.

A woman whose period is late but who does not

wish to be pregnant should continue to use some kind
of contraception until pregnancy has been confirmed
by a doctor.

�The two kinds of pregnancy tests both attempt to detect
the presence, within urine, of a hormone called chorionic
gonadotropin. This hormone is released In increasing
amounts by the placenta, so that by the 6th week of
pregnancy (when the period is 2 weeks overdue), some
chorionic gonadotropin appears in the pregnant woman's
urine. In the “biological test’’, some of the woman’s urine
is injected into a laboratory animal such as the rat or
rabbit. If chorionic gonadotropin is present, it causes a
certain reaction (such as ovulation) in the animal. Such a
reaction is defined as a positive result, meaning that the
woman Is pregnant. This test takes at least six hours. In
the “chemical test’’ a test chemical is added to a sample
of urine. The presence or absence of a chemical reaction
determines if the test is negative or positive. The chemical
test takes only 2 to 20 minutes. Both tests are highly
accurate but false positives and especially false negatives
do occur. Pregnancy tests are not accurate for premenopausal women. Hospital laboratories are often more
accurate than drugstores in their tests. Hospital tests are
also much less expensive.

oral contraceptives
Few scientific achievements have had greater social
impact than the development of the oral
contraceptive. The Pill is presently used by
approximately 18.5 million women, about 8.5 million
of whom live in North America. The Pill is the closest
thing to the “ideal contraceptive” available, and its
popularity reflects a changing social and political
mood of a whole generation of women.
The oral contraceptive is 100% effective when taken
as instructed, relatively “safe”, easily reversible, and
in the control of the woman; however, use of the Pill
does present certain difficulties Taking one pill every
day is a nuisance, appreciated by few not taking oral
contraceptives. Minor annoying side effects are
common, although transient, in the first three months
of use. Most importantly, the oral contraceptive
constitutes an endocrinological insult to the female
body which in rare instances can lead to serious
disease and even death. Nevertheless, on the basis
of available scientific findings, the editors of this
publication are convinced that the benefits of oral
contraception outweigh its dangers. Accepted
human activities such as pregnancy and childbirth,
or even travel in automobiles carry much greater
risks to health and life. Many drugs used more
commonly than oral contraceptives, such as aspirin
or penicillin, are potentially more dangerous than the
‘Pill; however, relief of pain and combatting infection
are accepted as Important in our society. Until
recently, contraception, with its gifts of sexual
freedom and physical health for women, has not
been appreciated

For a positive confirmation of pregnancy, a woman should
see a gynecologist for an internal examination. Private
doctors are expensive, but family planning centers,
university health services, and hospital gynecological
clinics are more reasonable. Women under 18 can often
get cooperation at the adolescent clinic of a children’s
hospital.
Several signs of early pregnancy which a doctor or
paramedical specialist can detect during an internal
examination are: darker color of the vulva and vagina,
softness of the uterine isthmus (area between the cervix
and uterine body), softness of the cervix, and size of the
uterus.
If the doctor is not positive of the diagnosis or suspects
that the woman is not pregnant, the woman can be given
synthetic progesterone, either orally or by injection, which
raises the hormone level in the woman’s blood stream. If
the woman is not pregnant, the following drop in the
hormonal level causes withdrawal bleeding. Such pills
cannot abort a fetus: they can only bring on a late period.
These pills cost approximately $3 at reputable pharmacies.

as an important medical achievement.
In the beginning of this century, Margaret Sanger, one of
the greatest fighters for the liberation of women, wrote,
“No woman can consider herself free until she can
determine the number of children she will have”. In the
winter of 1950 Margaret Sanger convinced Dr. Pincus to
accept a grant of $2,100 from the fledgling Planned
Parenthood Federation which she had founded. Millions of
dollars of corporation money soon went to research
executed by Pincus and a colleague, John Rock:
nevertheless, credit for the initiation of the first research
project goes to one of the most noble women of this
century, Margaret Sanger.
Pincus and Rock experimented with synthetic estrogens
and progesterones, and eventually produced for the G.D.
Searle Company. Originally, Knovid contained 10 mg. of a
synthetic progesterone called norethynodrel and as much
as .22 mg. of synthetic estrogen called ethinyl estradiol. In
1956, Rock, Pincus and a third doctor, Celso Garcia.
selected 265 Puerto Rican women “from the low Income
population living in a housing development project in a
slum clearance area’’ for the first significant human trials.
Officially, Puerto Rican women were chosen because of
their “high pregnancy rate’; in fact, these poor, non-white
women were used as Guinea pigs since G.D. Searle
hesitated to test such potent medication on white
American women. Ironically, during the tests these women
received better medical attention than they had ever had.
The Puerto Rican tests revealed that Enovid prevents
pregnancy, and that women do not drop dead after
ingesting norethynodrel and ethinyl estradiol. By 1960, on
the basis of scanty scientific information, the United States
Food and Drug Administration (FDA) authorized the G.D.
Searle Co. to market Enovid.

By the end of the first Pill decade, 8 pharmaceutical
companies had entered the profitable oral contraceptive
market, and more than 20 brands of the birth control pill
were produced.
Description
There are two kinds of oral contraceptives: the
combination pill and the sequential pill. A series of the
combination oral contraceptive consists of 21 (20 in some
brands) identical pills each containing synthetic estrogen
and progesterone. A sequential oral contraceptive series
is made up of two different kinds of pills. The first 11, 14,
15 or 16 pills (depending on the brand) contain only
synthetic estrogen, and the next 10, 6, 5, or 4 pills contain
a combination of estrogen and progesterone.
Synthetic hormones stimulate the same body reactions as
do natural hormones. There are 2 kinds of synthetic
estrogen and 9 different synthetic progesterones. I'he two
estrogens, mestranol and ethinyl estradiol, have almost
identical properties; however the effects of ethinyl
estradiol are more highly localized at the reproductive
system. For example, ethinyl estradiol has less effect on
glucose tolerance than does mestranol. Although ethinyl
estradiol is probably the better estrogen, mestranol is
used more commonly. Mestranol is used in Knovid, Ortho
Novum, Norinyl (including Norquen and Noriday), CQuens, and Ovulen. Ethinyl estradiol is used in:
Norlestrin, Provest, Oracon, Ovral, and Demulen.
The quantity of estrogen in each pill is more important
than the kind. Several years ago it was discovered that
not more than .05 mg. of estrogen in each pill is
necessary to ensure 100% contraceptive effectiveness.
Also, when such ‘‘low dose estrogen pills” are used, risks
of serious complications are significantly reduced. In
December 1969 the British Committee on Safety of Drugs
officially recommended that brands of oral contraceptives
containing more than .05 mg. of estrogen should not be
used. In the words of the British Medical Journal, British
pharmaceutical companies “were quick to take the hint’,
and withdrew from

the market all combination pills containing more than 05
mg. of estrogen. American pharmaceutical companies
have produced low dose brands, but have refused -to
withdraw high dose pills from the market.
Most synthetic progesterones are produced by chemically
changing the synthetic male sexual hormone,
testosterone. Depending on the chemical process used,
the resulting progesterone is either estrogenic or antiestrogenic. With estrogenic progesterones, at least some
of the hormone is changed by the body into estrogen.
Norethynodrel, the progesterone component of Enovid, is
the only commonly used estrogenic progesterone.
Estrogenic progesterones should not be used since they
introduce unnecessary estrogen. On the other hand, antiestrogenic synthetic progesterones, like natural
progesterones, counter the effects of estrogen. The
antiestrogenic qualities of synthetic progesterones add to
the contraceptive effectiveness of the Pill.
Depending on the kind and quantity of synthetic
hormones used, a particular brand of combination pills
can be estrogenic or anti-estrogenic. All low dose
combination pills are distinctly anti-estrogenic, which
counteracts side effects and complications related to
estrogen (most side effects are estrogen-related). In
contrast, sequential pills are distinctly estrogenic; not only
do all sequential pills contain more than .05 mg. of
estrogen in each pill, but the anti-estrogenic effect of
progesterone is absent for most of the 21 pill cycle. Also,
in contrast to combination medication, sequential oral
contraceptives are not 100% effective, with reported
failure rates of 1 to 2% annually. In Britain in 1966, sales
of sequential pills made up only 3% of the total sales of
oral contraceptives. In North America, where the Eli Lilly
Company has maintained a strong promotional campaign
for C-Quens (the original sequential pill) the various
brands of sequential pills have not lost as much of their
market.: Sequential oral contraceptives should be ordered
off the market. Women taking sequential pills (C-Quens,
Oracon, Ortho Novum SQ, Ovex, Miniquen, Secrovin)
should see a gynecologist and ask for a change of
prescription.

�How the Pill works
A healthy woman who is not pregnant or breast feeding
menstruates approximately once every 28 days. Soon
after menstruation begins, the hypothalamus (part of the
brain) stimulates the pituitary gland to secrete a hormone
called Follicle Stimulating Hormone (FSH) into the blood
stream. FSH stimulates the growth of several ovarian
follicles, and the secretion of estrogen by these follicles. A
few days after the first release of FSH, the pituitary also
begins secretion of Luteinizing Hormone (LH). Around the
14th day of the menstrual cycle, a sudden increase of LH
secretion causes one follicle to rupture and release an
egg. After ovulation, the ruptured follicle changes into a
gland called the corpus luteum which begins to secrete
progesterone. As the quantity of estrogen and
progesterone increases in the blood stream, the pituitary
secretes less FSH and LH.
If the egg is fertilized, the corpus luteum as well as the
placenta secrete large quantities of progesterone
throughout pregnancy. Estrogen and progesterone block
the pituitary’s secretion of FSH and LH, and ovulation
cannot occur during the nine months of pregnancy.
Overlapping pregnancies are thus prevented.
The oral contraceptive mimics the body’s defences against
pregnancy by creating a hormonal pseudopregnancy
within a woman’s body. Each pill of a series contains
enough estrogen and progesterone to block secretion of
FSH and LH, thus preventing ovulation.
In addition, progesterone causes secondary changes
which make pregnancy unlikely even if the pituitary
“escapes” the effects of the synthetic hormones.
Progesterone causes the cervical mucus to become thick
and impenetrable, preventing sperm cells from entering
the uterus. Progesterone also disrupts the cyclic growth of
the uterine lining, making it unreceptive to a fertilized egg.
Since sequential oral contraceptives are primarily
estrogenic, secondary progesterone-dependent effects are
not produced, resulting in the 1% to 2° failure rate of
sequential pills.
Medical examination and prescription
Oral contraceptives, like all potent medication, must not be
used by certain women. Proper medical screening can
spot women for whom oral contraception would pose
unacceptable risks.
A complete medical history must be taken before
prescribing an oral contraceptive. Questions which must
be asked include:
1. Does the woman have, or has she ever had: a blood
clotting disease such as thromboembolism,
thrombophlebitis, pulmonary embolism, ‘stroke’’, retinal
thrombosis; migraine headaches; heart disease or defect;
endocrinological disease or disorder such as thyroid
dysfunction or diabetes; liver disease such as jaundice;
kidney disease; asthma; epilepsy; or any significant
psychiatric problem such as severe depression?
2. Is there any inheritable disease in the woman’s family’?
Has the woman’s mother ever had any form

of cancer, migraine headaches, high blood pressure, or
varicose veins’ If the woman has any sisters, similar
information about their medical histories can be relevant.
3. Has the woman ever been pregnant? How many times?
How many live babies, abortions or miscarriages has she
had? Has the woman had complications during pregnancy,
such as toxemia, varicose veins, or liver disease?
4. At what age did the woman have her first menstrual
flow’? What is the average length of her menstrual cycle
and of the flow itself? Does she experience cramps, fluid
retention, breast swelling and tenderness, or mood
changes before, during and/or after menstruation?
Women who have or who have had: thromboembolism,
thrombophlebitis, pulmonary embolism, a *“stroke’’, retinal
thrombosis, heart disease or defect, severe endocrine
disorder, recurrent jaundice of pregnancy, or any form of
cancer must not take oral contraceptives. The synthetic
estrogen delivered by the Pill can worsen existing
conditions of these diseases or increase a woman’s
susceptibility to a relapse.
Women who have had: mild endocrine disorder, liver
disease such as jaundice, or kidney disease can take the
oral contraceptive if: (a) an endocrine disorder is well under
control, (b) kidney or liver.
disease is completely cured.
Women who have or who have had: migraine headaches,
high blood pressure, varicose’ veins, asthma, epilepsy, any
significant psychiatric problem, or diabetes can take an oral
contraceptive, provided that they are closely supervised
medically, and that periodic tests are taken to ensure that
the Pill’s estrogen is not worsening their condition.
If the Pill causes migraine headaches to become more
severe or more frequent, the woman must stop taking the
medication. If high blood pressure or varicose veins are
adversely affected by oral contraception, the woman must
stop taking the medication. If fluid retention occurs as a
side effect to the Pill, asthma or epilepsy can be adversely
affected. For women with asthma or epilepsy, diuretics can
be prescribed, and only anti-estrogenic pills should be
used. Women with existing psychiatric problems must be
followed by a psychiatrist while taking oral contraception.
Women with minor depression before menstruation often
find their symptoms relieved while taking the Pill. Prediabetic women, or women with active diabetes should
have an annual or semi-annual glucose tolerance test, and
should use an oral contraceptive containing ethinyl
estradiol as its estrogenic component.
Once the medical history is taken, the doctor performs a
general and a gynecological physical examination. ‘he
woman’s blood pressure and weight must be recorded,
samples of blood and urine must be taken, and a careful
breast examination and a Pap test (for cervical cancer)
must be performed.
A doctor has a variety of brands to choose from when
prescribing oral contraceptives. The following brands are
the best available: Ovral, Ortho-Novum 1/50, Norinyl 1,
Norlestrin, and Demulen. All

contain .05 mg. of estrogen and 1 mg. or the equivalent of
progesterone (Ovral contains 25 mg. of a particularly
potent progesterone). If a woman suffers exceptional
symptoms of natural estrogen excess (nausea, vomiting,
fluid retention and breast tenderness) during pregnancy
or before menstruation, the doctor may suggest a pill
containing a larger quantity of progesterone. Norilestrin
2.5, and Provest contain more than 1 mg. of progesterone
but not more than .05 mg. of estrogen.
All women taking oral contraceptives should have an
annual gynecological examination, including a Pap test.

Personal use of the Pill
Most oral contraceptives are taken in a series of 21
pills. This produces a convenient “three weeks on, one
week off’ cycle of medication.
To begin taking the Pill, a woman must wait for a
menstrual flow. Counting the first day of her flow as
day 1, the woman takes the first pill of a series on day
5. One pill is taken at about the same time daily for 21
days. The woman counts 7 days after taking. the last
pill. On the 8th day, she takes the first pill of her next
series. Thus, if a woman takes the first pill of her first
series on a Tuesday, she takes her last pill of that
series on a Monday, and takes the first pill of the next
series on the Tuesday of the following week. The
‘starting day’ (i.e. the day that the first pill is taken) is
the same day of the week for every series.
Some oral contraceptives come in 28 day series. The
first 21 pills contain the synthetic hormones. The last 7
pills are placebos - pills that contain nothing other than
sugar. A woman taking a 28 pill series takes one pill
every day, beginning a new package the day after
taking the last (28th) pill.
If one pill is forgotten it should be taken as soon as it is
remembered, even if this means taking two pills on the
same day. If taking the pill is incorporated into routine
daily activities (e.g. “waking up’, “‘supper’, ‘“‘going to
bed’’) a woman Is less likely to forget a pill. If a
combination pill is forgotten for not more than 24
hours, the chances of pregnancy are close to zero. If
more than one combination pill is forgotten, or if one
sequential pill is forgotten, the forgotten pills should be
taken when remembered and another contraceptive
method should be used for the rest of the cycle.
Most birth control pills are packaged in “blister
envelopes’. Each pill is enclosed in an individual blister
of clear plastic on a small cardboard sheet. The blister
envelope is contained in a plastic container with rows
of holes in the bottom. To obtain a pill, the woman
pushes down on the plastic blister, and the pill pops
out of the hole in the bottom of the package. Most
package designs include a calendar mechanism in the
package which makes it possible to tell at a glance if
the day’s pill has already been taken.
The combination Pill provides 100‘, contraceptive
protection from the first pill of the first series.

If a woman is changing her brand of pill from a higher
dose of estrogen to a lower dose, another birth control
method should be used for the first 2 weeks of the first
low dose series.
Reversibility of contraceptive action
The oral contraceptive is easily reversible. When
pregnancy is desired, the woman finishes a pill series,
and does not start another series. Sixty to 75% of women
who stop taking the Pill to become pregnant achieve their
aim within three cycles of the last pill, and 90‘% become
pregnant within one year. The pregnancy rate is the same
in women who have never taken oral contraceptives and
who are attempting to become pregnant.
Babies born to women who have use a oral
contraceptives are not affected by the medication.
In a small, undetermined percentage of women who stop
taking the Pill, ovulation and menstruation are delayed for
a month or two, and in some reported cases, for as long
as a year. This condition of post-Pill amenorrhea (lack of
menstruation) has been named the “‘oversuppression
syndrome’. Amenorrhea following discontinuation of the
Pill is more likely to occur In women who have irregular
menstrual cycles before using oral contraception. The
probable cause of post-Pill amenorrhea is a lingering,
oversuppression of the hypothalamus by the Pill’s
synthetic progesterone. Almost all cases of
oversuppression disappear by themselves without
medication. If amenorrhea continues for more than 6
months, cortisone acetate or clomiphene citrate (brand
name: Clomid) is used to bring on ovulation and
menstruation. Clomid is highly effective if there Is enough
natural estrogen in the bloodstream. If the level of
estrogen is low, skull X-rays are taken to make sure that a
coincidental tumor does not exist, and supplementary
human gonadotropins are then given to induce ovulation.
Prolonged post-Pill amenorrhea responds quickly and
easily to treatment with Clomid, or, if necessary, human
gonadotropins. It is unlikely that the incidence of
oversuppression increases In women taking oral
contraceptives for prolonged periods. The practice of
discontinuing oral contraception every 2 years to
determine if ovulation occurs spontaneously is medically
useless and often results in unwanted pregnancy.

Side effects
Oral contraceptives are potent medication and induce
many body changes other than the suppression of
ovulation.
A side effect is any reaction or body change unrelated to
the purpose for which a drug is taken. For the sake of
consideration, side effects are listed below in three
classifications: nuisance side effects, metabolic changes,
and serious complications.
Nuisance effects
Most nuisance effects induced by oral contraception are
related to estrogen. Such effects are common during the
first 3 cycles of medication while the body is adjusting to
the new hormonal!

�Estimates of risk of death to
women in England 1966

levels, and they usually disappear by the 4th cycle. If any
side effect persists for longer than 3 cycles, or becomes
severe, the prescribing doctor should be consulted.
The majority of women taking low-dose oral
contraceptives do not experience any side effects, or are
bothered only by minor, ‘transient effects. Psychological
factors play a large part in the incidence of minor effects.
If any side effect is expected, it is almost certain to
appear.
Nausea sometimes accompanied by vomiting or
stomach cramps is the Pill’s most common side effect. If
it occurs, nausea appears within a day or two of the first
pill taken, and recurs at the beginning of the following
cycle. Such side effects can be avoided by: a. taking the
daily pill after a full meal; b. taking the pill just before
going to sleep; or c. taking the pill with a glass of milk or
a mild antacid.
Fluid retention can occur as a result of estrogens effects
on the body’s retention of salts. A general “bloated
feeling’, cramping or swelling of the legs, breast
discomfort, rapid weight gain, and generalized itching are
minor symptoms of fluid retention. Fluid retention can
adversely effect migraine headaches. If a woman
experiences severe headache, dizziness, and blurry or
double vision shortly after starting the Pill, she should
immediately consult the prescribing doctor, and stop
taking the medication.
Fluid retention is harmless except to women with
migraine headaches, epilepsy, high blood pressure,
vascular disease, or heart defect or disease. Fluid
retention can be alleviated by a low salt diet, restricted
water intake and, if necessary, a diuretic.
Chloasma is the rarest of estrogen-related nuisance
effects. Chloasma, also called the ‘‘mask

of pregnancy appears as “giant freckles’ on the face. Pill
related chloasma is more common in women who
experience chloasma during pregnancy, and in women
frequently exposed to strong sunlight.
Leukorrhea is an estrogen-related, harmless white or
clear, excessive vaginal discharge. If vaginal discharge
becomes bothersome, a gynecologist should be
consulted.
Estrogen deficiency and progesterone excess side effects
occur if a Pill is too highly anti-estrogenic for a particular
woman. Such side effects include: mood changes,
including depression and changes in sexual desire;
increased appetite and weight gain; fatigue; decrease 1n
amount and duration of menstrual flow; oily scalp and skin
(sometimes leading to acne); changes in facial or body
hair distribution; and breast enlargement. Progesterone
related side effects, although usually minor, either remain
constant or become worse with each’ successive cycle. A
doctor should therefore be consulted. Recent evidence
suggests that mood changes including depression might
also be estrogen-related.
Estrogen seems to cause a deficiency of a vitamin called
pyridoxine. Recent experiments indicate that pyridoxinereplacement therapy significantly improves cases of Pillrelated depression.
Breast enlargement is the most common progesteronerelated side effect. After an initial size increase, breast
size remains constant until the Pill is discontinued, at
which point the breasts return to normal size.
lf a woman is taking a Pill that delivers: more than 1 mg.
of progesterone daily, progesterone-related side effects
can usually be eliminated by switching to an oral
contraceptive with less progesterone (not to a Pill with
more estrogen).
Breakthrough bleeding and spotting (bleeding between
periods) are the only common progesterone deficiency
side effects. If they occur, such bleeding episodes usually
disappear by the fourth cycle. In persistent cases a pill
with a higher dose of progesterone can be prescribed.
Metabolic effects
The biochemical activities which keep all organisms alive
are collectively. called metabolism. The oral contraceptive
causes more than 50 biochemical changes within the
female body. Similar biochemical changes occur during
pregnancy, and most are not noticeable; however, in
susceptible women, pregnancy-related and Pill-related
metabolic changes can causes disease, and in rare
cases, even death.
Insulin production and glucose tolerance can be
adversely affected by estrogen produced naturally during
pregnancy or delivered by the Pill. Insulin is a hormone
necessary to the body’s digestion of sugar. A low level of
circulating insulin leads to a disease called diabetes
mellitus. The Pill does not cause diabetes, but it may
aggravate an existing condition of low glucose tolerance.
Diabetes is a hereditary disease, and a woman whose
blood relatives have diabetes should have a glucose
tolerance test before starting the Pill, and an annual test
while taking the medication.

Liver function is affected by pregnancy and by the Pill. In
susceptible women, the hormones of pregnancy can cause
“recurrent jaundice of pregnancy’. The oral contraceptive
can induce a similar disease process. In one year, about 1
woman in 10,000 Pill users experience jaundice, which is
characterized by extreme itchiness and a yellow
discoloration of the skin, fingernails and eyes. Jaundice
responds well to therapy.
Fat metabolism is altered by estrogen of pregnancy or of
the Pill. Estrogen causes an increase in the amount of fat
and fatty proteins circulating in the bloodstream. This is a
potentially dangerous effect.
especially if maintained for long periods, since an increase
in circulating fats such as cholesterol is associated with an
increased incidence of atherosclerosis, a vascular disease
in which arteries are clogged with layers of fat.
To date, increased incidence of atherosclerosis has not
been found in women taking the Pill. Further research is
necessary.
Lactation is adversely affected by the Pill. Women who
intend to breastfeed should not use oral contraception
immediately after child-birth.

Serious complications
Certain metabolic changes in women taking the Pill can
lead to serious complications, and even death. The
incidence of such complications is very low.
Thromboembolism: The various kinds of
thromboembolism are diseases in which an unnecessary
clot forms within a blood vessel, obstructing the flow of
blood and starving body tissues. Thromboembolism can
have serious and even fatal consequences. During
pregnancy, estrogen causes an increased level of blood
clotting chemicals (called ‘‘factors’’) within the blood
serum, creating a condition of hypercoagulability. Blood
loss during and after childbirth is greatly reduced by the
blood’s increased capacity to coagulate.
Hypercoagulability also increases a woman’s
susceptibility to thromboembolism. Estrogen delivered by
oral contraception causes increased susceptibility of the
same magnitude.
In 1968 three English scientists, M.P. Vessey, R. Doll and
H.W.H. Inman presented carefully collected statistics
evaluating risks of fatal and nonfatal thromboembolism to
women taking oral contraceptives. The excess death rate
from thromb

embolism was estimated to be 1.3 per 100,000 users
aged 20 to 34 and 3.4 per 100,000 users aged 35 to 44. It
was also estimated that 47 women in 100,000 users are
admitted to hospital every year for non-fatal
thromboembolic disease. Among non-users of the Pill,
only 5 in 100,000 are admitted every year. When
corrected for error, this reveals a nine times greater risk of
non-fatal thromboembolism for Pill users.
A recent paper, prepared by the same scientists, reveals
that the excess death rate is significantly reduced in
women using only low dose preparations (pills containing
not more than .05 mg. of estrogen).
An American study organized by Philip Sartwell of the
U.S. Food and Drug Administration, and presented in the
1969 FDA report on the Pill, reveals findings which are
approximately the same as the British ones. The Sartwell
study also indicates that high dose and sequential pills
provide additional risk.
These findings are not in themselves very frightening.
Many daily activities carry far greater risks of injury or
death. The risks of Pill-related thromboembolism are
analyzed by Dr. D.M. Potts, Medical Secretary of the
International Planned Parenthood Federation (London)
who writes:
‘The risk of death from thromboembolic disease can be
evaluated in two ways. Firstly, it can be reviewed against
a medical background. Nearly every effective drug has a
disease and even a death rate when used on a large
scale, and the Pill is no exception. When a woman
engages in sexual intercourse she takes a calculable risk
with her life either as a result of possible pregnancy or as
a result of procedures she adopts to prevent or interrupt
pregnancy. The chart below sets out this risk In women of
different ages.
Deaths following the use of IUDs are only beginning to be
assessed but it seems likely that they will be as frequent
as those with the Pill. When allowance is made for the
higher failure rate of IUDs, use of the Pill in both younger
and older age groups proves to be associated with a
lower death rate than any other procedure. In other words,
a woman who takes oral contraceptives has more chance
of being alive one year later than her sisters who choose
to have a baby or use some other form of contraception
(assuming a failure rate for other methods).
Secondly the Pill can can be looked at in its social
context. For many women there is no alternative .

RISK OF DEATH WITH VARIOUS CONTRACEPTIVE METHODS

�form of contraception that offers the degree of
effectiveness, acceptability and convenience which the
Pill offers. Many aspects of social behavior carry a much
greater risk. Tobacco and alcohol, ~ which society
demands for its comfort and pleasure, are associated
with a very heavy mortality and morbidity and their
consequences constitute a significant part of medical
practice. From the point of view of the health of society it
would be more justifiable to have oral contraceptives in
slot machines and restrict the sale of cigarettes to a
medical prescription.
The Pill and vascular disease: Estrogen causes blood
pressure increase in susceptible women.
There are several recorded cases of “stroke’’ in women
taking the Pill. A stroke is the rupture of a blood vessel
leading to or from the brain.
High blood pressure increases the chance of stroke.
Severe, debilitating headache is a stroke symptom. If
severe headache is experienced while taking the Pill, a
doctor should be consulted to rule out the possibility of
stroke.
Although a significant relationship has not yet been
demonstrated, it is believed that risk of stroke ls
increased, probably only slightly, in women taking the Pill.
The Pill and cancer: Massive doses of estrogen have
been used in gynecology for more than 30 years. No
increase in any form of cancer as a result of this
medication has been observed.
Estrogen of pregnancy produces cellular changes in the
cervix, which look very much like cellular changes of
early cervical cancer. After pregnancy, the cervical cells
regain their normal appearance. The Pill induces similar
cellular changes, and some scientists | believe that the
oral contraceptive increases the risk of cervical cancer.
On the other hand, the Pill might provide a protective
effect against uterine and breast cancer.
On the basis of presently existing information, no definite
conclusions can be reached as to the effects of oral
contraception on the incidence of cancer.
Oral contraception carries distinct sexual connotations,
and any consideration of the Pill’s risks is complicated by
the existing social ethic which views sexuality, and
especially female sexuality, as evil. All potent medication
carries risks of disease and death, but the thing that
marks the Pill for special consideration is the freedom of
sexual choice that it provides to women.
Some women’s liberation groups have adopted an “Off
the Pill” position, demanding that the oral contraceptive
be withdrawn. A better course of action, already taken up
by some, is to demand development of an even safer
contraceptive method, and to attack the giant
pharmaceutical corporations for their incredible profit
margins, racist experimental programs and medically
unacceptable marketing standards.
A special publication on the Pill, for distribution through
women’s liberation groups, is being prepared by the
editors of this publication.

condom
The condom, a sheath worn on the penis during sexual
intercourse, is a widely used, effective, mechanical
contraceptive. The condom is also known “prophylactic”,
“‘rubber’’, ‘“‘safe’, ‘‘French letter’’.
or simply ““contraceptive’’.
Most condoms manufactured today are made of thin,
strong latex rubber: condoms made from animal
membrane are also available. Rubber condoms are
approximately 0.0025 inches thick, 1 inch wide and 7
inches long. At the open end of the sheath the rubber is
thicker, forming an elastic ring which keeps the condom
from slipping off the penis. The condom is either plainended or tipped with a “‘teat’ meant to receive and hold
ejaculated semen. There are no “sizes” for condoms, since
all are considerably elastic.
Skin condoms, produced from sterile animal membrane,
first appeared in England during the eighteenth century.
Since the development of the latex rubber process in the
1930’s, skin condoms have been largely replaced by the
cheaper and equally effective rubber sheaths. The
principal advantage of skin condoms is that natural
membrane is a better conductor of heat than a film of
rubber, and therefore interferes less with sensation.
Skin condoms are packaged in plastic or aluminum
capsules containing water, glycerine and a preservative.
Rubber condoms are packaged in paper envelopes,
cardboard boxes or aluminum foil. Most rubber condoms
are sold dry and powdered: but at least one company
distributes lubricated rubber condoms sealed between
strips of aluminum foil.
Association of the condom with prostitution and prevention
of venereal disease has resulted in a reluctance on the
part of many men and women to use this birth control
method. In addition there exists a widespread
misconception that the condom is an unreliable
contraceptive when compared to other methods. In fact,
statistics reveal that when properly used, the condom is as
effective as the diaphragm and jelly method.
The condom method of birth control does have an
Important inherent disadvantage - it is a contraceptive
used by the male partner alone. If the male sexual partner
is reliable, and both man and woman accept this
contraceptive method, there is no problem; however, not
all men are trustworthy, and certainly not at all times. Since
it is the woman who bears the consequence of unwanted
pregnancy, women are more likely to appreciate the
importance of using some form of contraception during all
acts of sexual intercourse.

The mechanical nature of the condom also provides
potential problems. Some men and women do not like
using a ‘device’ during sexual intercourse, claiming it
disrupts spontaneity. If this is the sincere feeling of either
partner the condom should be avoided. On the other hand.
many men and women incorporate unrolling of the condom
into the enjoyable routine of sexual foreplay.
Many men claim that the condom dulls sexual pleasure.
Physiologically, this claim is highly questionable. Modern
condoms are extremely thin and. transmit sensation very
well. Men who insist that the condom interferes
significantly with sexual sensation are usually refusing to
accept responsibility for birth control.
The condom does have several important advantages: it is
harmless, very simple to use, and easily available. If the
male sexual partner is willing to take on the responsibility
of contraception seriously, the condom is the best birth
control method for occasional or unexpected sexual
intercourse.
Aside from contraception, the condom does provide some
protection against venereal diseases such as syphilis or
gonorrhea.
The condom is probably the most commonly used
mechanical contraceptive in North America. Fight hundred
million to one billion condoms are sold every year in
Canada and the U.S.
Since 1938 the United States Food and Drug
Administration (FDA) has supervised the manufacture of
condoms. FDA enforcement and automated manufacturing
and testing techniques contribute to the maintenance of
very high quality levels.
Use
The condom must be worn throughout sexual intercourse
since pregnancy can result from an early, unexpected
ejaculation. If the condom is not pre-rolled, it should be
rolled just before use. The condom should not be
completely rolled up - a half an inch should be left at the
closed end to receive ejaculated semen. If the condom
being used is already rolled when purchased (most rubber
condoms are pre-rolled), it should be unrolled half an inch.
The condom is then unrolled over the erect penis. The half
inch space left at the end of the condom (or the “‘teat’’, if
the condom has one) should be squeezed while unrolling,
so that air if not trapped In the closed end. It the man it not
circumcised. he must pull back the foreskin before
unrolling the condom. Properly unrolled, the condom
covers the whole penis, with the half inch extension (or
teat’) hanging limply at the end. Care must be taken not to
tear the condom with finger nails, rings or any rough
object.
When inserting the penis the male should avoid catching
the extension or teat on the outside of the vagina, since it
is possible to thrust a hole through the side of the sheath if
the tip becomes caught.
Occasionally there is insufficient moisture in the vagina to
allow for easy entry of the penis, especially if it is covered
by a dry rubber condom. Forcing the penis into a relatively
dry vagina can be uncomfortable and irritating for the
woman. Such problems can be avoided by the use of an
artificial lubricant

or a pre-lubricated condom. A commercial spermicidal
preparation (contraceptive foam, cream or jelly) is a good
lubricant to use, since it also provides contraceptive
protection. Other non-greasy jellies, such as surgical jelly,
can also be used. Of course, saliva is the most readily
available and cheapest lubricant of all. Vaseline or any
kind of petroleum jelly or oil should never be applied to
rubber condoms, since these materials destroy rubber.
Unless a pre-lubricated condom is’ used, the lubricant is
applied to the outside of the sheath after it has been
unrolled onto the penis.
Following male orgasm and ejaculation, there is always a
partial or significant loss of erection. As long as the upper
open end of the condom remains tight against the penis,
sexual intercourse can continue; however, if loss of
erection is significant and the condom does not fit firmly
against the penis, semen can leak out of the open end, or
the condom can slip off the penis, into the vagina. In such
cases. the male partner should hold the upper part of the
condom tight against the base of his penis, and withdraw
from the vagina.

If the condoms slips off the penis, it should be removed
from the vagina immediately, with the open end held
tightly closed.
The condom is removed by stretching the ring at the
open end and pulling down. The condom should be
checked immediately after removal. If for some reason
the condom has burst, the woman should immediately
insert an applicator-full of vaginal spermicide into her
vagina, or, if that is not available, douche with water. In
such clear-cut cases of contraceptive failure, pregnancy
can be avoided if the woman takes a large dose of the
female hormone estrogen shortly after intercourse. Such
an after-the-fact contraceptive is commonly used for
special cases - such as women who have been raped.
Although not all gynecologists are familiar with this

�use of estrogen, many emergency clinics in large city
hospitals have estrogen available for this purpose.
Estrogen in high doses is a potent drug and cannot be
administered casually.
Some doctors suggest that the condom should always be
used in combination with a vaginal contraceptive foam,
cream or jelly. This extra precaution reduces the chances
of conception should the condom break; however,
condoms bought from drug stores or pharmaceutical
companies can be assumed to be reliable.
Years ago doctors suggested that all condoms be tested
before use. Blowing the condom up like a balloon was the
most commonly suggested test. Considering present-day
quality control maintained by reliable manufacturers, such
testing by the user is likely to do more harm than good.
With modern condoms, the number of sheaths damaged
during testing is usually greater than the number of
defective condoms found.
Good quality condoms can be used several times. If the
condom is to be reused, it should be dropped into a
bedside glass of water after removal from the penis. A
soon as is convenient, the condom should be carefully
washed in warm soapy water. Rubber condoms should be
dried and powdered with cornstarch. Skin condoms can
be kept in a mild solution of household boric acid and
water. A condom that is

reused should be tested for leaks before each use.
If the condom is not to be reused it can be flushed down the toilet.
Condoms should never be kept in a wallet or pocket since the
combination of moisture and heat provided by contact. with the
body deteriorates and eventually rots the condom. Condoms are
best kept in the small cardboard containers in which they are
usually sold. Without excessive heat or moisture condoms can be
stored for up to two years.
Both rubber and skin condoms are meant to cover the entire penis.
Another kind of condom, called the “tip condom” or condom cap,
covers only the glans of the penis. ‘T'1p condoms should never be
used since they are likely to slip off after male orgasm.

Cost
Condoms should be bought only from drug stores,
pharmaceutical companies or family planning agencies.
‘Those sold in men’s washrooms, gas stations or from
peddlers are likely to be of inferior quality.
Condoms can be bought by anyone, without a
prescription.
The most common drug store price is $1.25 for 2 rubber
condoms. Lubricated rubber condoms cost about $1.50
for 3. Skin condoms can cost $1.00 or more each.
Rubber condoms bought in quantity from manufacturing
companies or family planning associations cost 25 to 35
cents for 3.

intrauterine
devices
The effectiveness of an intrauterine (within the uterus)
device to prevent conception has been known for over
2000 years. Hippocrates, the ancient Greek doctor
described a device which was inserted into a woman's
uterus through a hollow lead tube passed through the
cervix (entrance to the womb). For centuries Arabian and
Turkish camel drivers inserted small round pebbles into
the uteri of their camels before going into the desert to
prevent the camels from becoming pregnant during the
long journey.
In this century, Grafenberg, a German doctor, reported in
1930 of his use of an intrauterine contraceptive device
made of silkworm gut, wound into a ring and inserted into
the uterus. Grafenberg’s major contribution was the
development of a device with a structure such that it
remained only in the uterus and was not continuous with
the cervical canal or vagina. Similar devices used in the
beginning of the 20th century had structures which led into
the uterus from the cervical canal. Grafenberg claimed
that such structures served as ladders for the upward
movement of bacteria from the vagina into the uterus.
Devices with such “bacterial ladders” caused a great deal
of infection and discomfort for many women.
Because of complications with devices other than the
Grafenberg ring, intrauterine contraception was neglected,
until in 1959, two doctors working independently reported
considerable success with modifications of the original
Grafenberg device. Only recently have doctors begun to
devote serious attention to IUD’s (or IUCD’s). It took many
years for the medical profession to forget its prejudice
against anything lying within the uterus even though
‘reports on the Grafenberg ring made it clear that infection
was not a common complication.

Description
Today there are three basic kinds of IUDs: closed devices
such as the Hall-Stone ring, the Ota ring, the Zipper ring,
the Birnberg bow, and other modifications of Grafenberg’s
original design; more recently developed open devices
such as the Lippes loop, the Margulies coil and the Saf-tcoil: and closed-plane devices such as the Majzlin spring
and the Dalkon shield. The open devices and the closedplane IUDs are safer and easier to insert. Closed IUDs
should no longer be used.
Some different JUDs are illustrated above.
Most of the modern, safer devices, except the Majzlin
spring, are made of flexible plastic. The new synthetic
plastics are being used for various kinds of human
surgery and repair as well as for IUDs since the body
does not react to their presence. The

malleability of plastics provides an additional advantage IUDs made of such materials can be straightened out and
threaded into very thin introducers (inserters) which can
then be inserted into the uterus through the cervix with little
or no pain. The malleability of plastic also allows for great
latitude in design and may prove very useful in evolving the
“‘ideal design’’. The plastic tube molded into the IUD design
usually has a core of metal salts so that if the position of the
device must be determined exactly, an X-ray will reveal the
IUD (X-rays only show the presence of dense structures
such as bone, metal, or metal salts, but not plastic itself).
Although there is much disagreement as to which is the best
IUD available, the Lippes loop (size D, a little more than 1
inch across) is the most widely used. The Lippes loop is
preferred because of low expulsion, pregnancy and side
effect rates associated with its use. The more recently
developed Saf-tcoil and Majzlin spring are both about as
safe and as effective as the loop. Very recent research
claims that the newly introduced Dalkon shield might be the
best IUD of all, however much more research must be done
before the shield can be accurately evaluated.
Insertion of the device
The insertion of an IUD 1s usually a simple, rapid, and more
or painless procedure. After a general physical examination,
the

�woman lies back on the examining table with her legs in
stirrup-like supports so that her vaginal area is exposed,
and her thighs are apart. With a special Instrument
(speculum) the vaginal walls are gently separated and the
cervix is exposed. A cancer smear test (the Pap test routine in all gynecological examinations) is made by
scraping the cervix gently (cells picked up are later
examined under a microscope). The doctor has previously
determined whether the pelvic organs (uterus, bladder,
rectum) are normal and whether the uterus is angled
forward or backward. A sterile uterine probe (see diagram)
is then carefully passed into the uterus to ensure that the
cervical canal is not obstructed and to recheck the uterine
position. As the diagram shows, the IUD is threaded into a
sterile plastic introducer (if it has not already been
‘“loaded’’). The loaded Introducer is inserted through the
cervical canal and is advanced to the lowermost portion of
the uterus, Just beyond the entrance of the triangular slitlike cavity. Sometimes it is necessary to grasp the cervix
with an instrument to steady it before inserting either the
probe or introducer. As the cervix is grasped the woman
feels a pin- prick sensation, however pain is rarely
experienced. Pressure is put on the plunger of the
introducer and the IUD is pushed into the uterine cavity
where it regains its original shape. The introducer is
withdrawn leaving two nylon threads which are connected
to the device, protruding into the upper vagina. The
threads are trimmed so that only an inch or two remains
beyond the cervix.
An IUD can be inserted at any time during the menstrual
cycle, but it is best introduced on the first day of a
menstrual. period. This has several] advantages: the most
important is that insertion at that time can not interfere with
an early or unsuspected pregnancy since if the woman is
still menstruating, she has not yet ovulated that month and
cannot be pregnant. Also insertion of the IUD may cause a
slight amount of bleeding from the uterus, and this spotting
is not an additional problem during menstruation. In
addition the cervical canal is open wider during
menstruation than during other parts of the woman’s cycle.
As soon as the IUD is inserted, it begins to prevent
conception. If a woman is changing from birth control pills
to an IUD, she may be advised to take the pills for one
month longer, since most accidental pregnancies which
occur with the IUD, begin during the first month of use.
Also continued use of oral contraceptives reduces the
amount of menstrual bleeding or spotting which may be
increased during the first month of IUD use.
If the nylon appendage connected to the IUD is properly
trimmed, neither the male nor the female is at all aware of
the device during coitus.
Insertion of IUDs for women who have not had children
After a woman has a child, miscarriage or abortion, her
uterus remains slightly enlarged and her cervix slightly
dilated permanently. Many doctors refuse to insert an IUD
into the smaller, tighter uterus of a nulliparous woman
(never been pregnant)

because of severe pain which often occurs during and
immediately after insertion. Some research is presently
being done with various drugs meant to reduce the pain of
insertion for nulliparous women. Many if not most women
who have never been pregnant also experience some pain
from cramps for the first few days after IUD insertion. This
pain is sometimes not more severe than that experienced
from normal menstrual cramps; in some other cases it can
be accompanied by fainting or be so severe that removal]
of the device is necessary. All nulliparous women have a
greater tendency to expel the device spontaneously from
their uterus. Failure rates of the IUD are also significantly
higher for nulliparous women.
Removal
Removal of devices with nylon “tails” is simple. The doctor
pulls gently on the threads extending into the vagina, and
the device usually slips out easily. Women should not
attempt to do this themselves since occasionally the
cervical canal is obstructed or the IUD is lodged in the
uterine wall, and an unskilled tug could cause injury. For
devices without an appendage, the doctor inserts a small
blunt hook into the uterus, catches the IUD, and pulls it.
Expulsion and required removal of IUDs
The muscles of the uterus run in two different ways
(diagonally and transversely) and when the uterus contracts
it does so in a rhythmical way. These contractions cause
the IUD to be pushed out of the uterus of certain women. At
present there is no sure way of knowing which women are
likely to expel the device.
Between 10 and 12 percent of all women who receive IUDs
spontaneously expel the device in the first year of use.
Most expulsions occur in the first 3 months that the device
is in the uterus. Expulsions of the IUD usually occur, if at all,
during menstrual bleeding. Women using IUDs should
check the surface of their menstrual tampons or pads to
ensure that the device has not been passed out with
menstrual blood. If the IUD has a nylon appendage, the
woman should check for its presence after each period and
at least once a week. If the nylon thread or beads cannot
be felt, the doctor should be consulted and another method
of contraception should be used until a new device can be
inserted.
If a woman expels an IUD from her uterus she can have
another one inserted. The chances that this same woman
will expel the device again are very high - 50° of women
who receive a second IUD expel it from their uterus.
The Lippes loop, because of its design compresses easily
and is least likely to be pushed out of the uterus by a single
muscular contraction.
Beyond the of women who spontaneously expel the IUD,
another 8 to 10% of women have the device removed
because of troublesome ‘side effects which are described
below.
Side effects
Minor side effects to the IUD are common but not serious.
Usually, these side effects disappear after the first month or
two of use, however all side effects

should be reported to the doctor who inserted the IUD.
Side effects include: minor or severe pain similar to pain
from menstrual cramps; irregular bleeding during the
month (spotting); and very heavy menstrual bleeding for
the first few cycles after insertion. The extra heavy
bleeding for the first few menstrual cycles following
insertion seems to be a common experience. It should
be reported to the doctor but it is not serious.
Sometimes drugs are prescribed to lessen the bleeding.
Pelvic pain and regular or extra-heavy bleeding account
for most of the 8% to 10% of IUDs which are removed
either as a result of the doctor’s decision or the
insistence of the patient.

in the abdominal cavity, is not dangerous. Since the
body does not react to the IUD, it is usually left where it
is. If however, a closed device perforates there is a risk
that it will catch a loop of one of the intestines and
obstruct the passage of food or waste material. (This is
why closed devices are no longer used). Surgery is
always performed to retrieve a closed IUD, should it
perforate. Similar surgery must be performed if an open
device perforates only half-way, leaving a dangerous,
rigid “hook” protruding through the uterine wall.
There have not been any cases reported of cervical or
uterine cancer occurring as a result of IUD use. On the
basis of presently available information, it can be said
that IUDs do not cause cancer.
Serious complications
Should an IUD fail and a woman become pregnant with
Pelvic Inflammatory Disease PID (any infection’ of the
a device still in place, there is no danger to the baby.
pelvic organs) occurs as a complication to the IUD in 2% Usually the device is left in the uterus and is only
to 4% of women wearing a device. Usually, an incident
removed when the baby is delivered. There are no
of IUD - related PID is a relapse of some previously
reports of abnormalities in babies born to women with
existing infection, such as gonorrhea. In such cases, the IUDs in place.
insertion of an IUD is enough to weaken the natural
defences of the uterus, and bacteria which had been
How the IUD works
kept in check multiply and cause clinical signs of
Many conflicting theories have been suggested in
infection. Commonly used IUDs are sterilized before
attempts to explain the contraceptive action of the LUD.
distribution and sterile techniques are maintained by
The exact mode of action is still not. understood.
most doctors _ during insertion, to reduce the risk of
One widely accepted theory suggests that the IUD
PID. If PID occurs in a woman wearing an IUD, it can
interferes with the dynamic muscular balance of the
usually be treated without removing the device. Women cervix, uterus and Fallopian tubes. It is suggested that
who have had a pelvic infection previous to IUD
sperm transport up into the tubes and ovum transport
insertion can safely use a device but must make sure
down toward the uterus are disrupted by the IUD’s
that the infection has been totally eliminated.
effects on uterine and tubal muscles.
Once in. approximately 2,500 IUD insertions, the device Another group of explanatory theories concentrates on
does not remain in the uterus, but goes through the
cellular changes in the uterine lining, the endometrum.
uterine wall into the abdominal cavity. Such uterine
if the cyclic development of endometrial cells is
perforation is usually the result of error on the part of the disrupted, implantation of a fertilized egg is impossible.
inserting doctor or technician: however, some IUDs are
One group of theories is primarily biochemical, and
pushed through the uterine wall by contractions of the
suggests that when an IUD is present, the uterine”
uterine muscles themselves. Whatever the cause,
environment is chemically hostile to a fertilized egg.
complete perforation of an open device; with the IUD
A recently presented theory suggests that abnormally
itself floating freely
high concentrations of macrophages develop

�within the uterus when an IUD is present. Macrophages
are normal body cells which attack invading cells such
as bacteria, by phagocytosis. (A phagocyte is a cell,
such as a white blood cell. that can “swallow” another
cell, and thus destroy it). Macrophages normally do not
exist within the uterine cavity, and their presence might
destroy a fertilized egg.
IUDs do not cause early abortion nor do they prevent
pregnancy by creating a low-grade infection in the
uterus.
Effectiveness
The efficiency of the IUD is considerably less than the
oral contraceptive pill. At best, only 1.5 to 3 women out
of 100 become pregnant during the first year after
insertion of the IUD. Failure rates tend to decline with
further years of use. Many doctors report a
contraceptive failure rate of much higher than 3.0. With
some devices, up to 8 or 9 women out of 100 become
pregnant during the first year after the IUD is inserted _
IUDs are most effective for women who: have had
several children, and are older than 30 years of age.
Age is the more important factor. For example, in one
study on the Lippes loop, 5.19. of women 15-24 years
old at time of insertion became pregnant within the first
year. In the same study, only 4.1% of the women 25-29
years old, and 2.96% of women 30-34 years old
became pregnant in the same time period.
Women who must not become pregnant should not rely
on the IUD unless abortion is an acceptable and
available option.
Acceptability
Considering the 10 to 12%. of women who expel the
IUD within one year after insertion, the 8 to 10% who
must have it removed in that same period, and the 2%
to 3% (at least) who become pregnant, the IUD is an
acceptable method of contraception for only about 75%
of women in the first year. Acceptability goes down to
about 50% within years. For those women who can use
the IUD.: it is probably the best method available - it is
safe, easy to use, cheap, does not require repeated
action (like taking a pill daily) and does not interfere with
the act or enjoyment of sexual intercourse.
With the advent of statistically significant reports linking
oral contraceptives with an increased incidence of death
and disease from thromboembolic illness, some women
have strongly advocated the use of the IUD in
preference to the Pill. Failure rates for the IUD of 1% to
2%, and a naive belief that the IUD is “harmless” have
been repeated over and over again.
It is absurd to believe that the pharmaceutical and
plastic corporations producing IUDs have any more
concern for the lives of individual women, than do the
pharmaceutical corporations producing the

Pill. The IUD is neither harmless nor as effective as the
manufacturing companies claim. It is not possible at this
point to determine exactly how many women die as a
direct result of IUD use (possibly from perforation); it is
known however, that many women die during or after
normal pregnancy (about 300 per million pregnancies),
and that. some women using an IUD become pregnant.
As a result of contraceptive failure, 30,000 to 80,000
pregnancies occur every year in 1,000,000 IUD users.
Thus, in 1,000,000 women using the IUD for one year, 9
to “4 women die as a result of pregnancy, and beyond
these.deaths, an undetermined number of women die as
a result of criminal abortion.
Reversibility
The contraceptive effect of an IUD is completely
reversible. When the device is removed the woman can
have children again.
The IUD and genocide
The IUD is cheap to manufacture, easy to insert, and in
large scale terms is very effective. Not more than 8 to 9
women out of 100 will become pregnant during the first
year of use. Women who do not use any contraceptive
method usually do get pregnant within one year - 90
women in 100 will become pregnant In one year if they
do not try any method to control their fertility. Since the
growth of large populations in nations of the Third World
(Africa. Latin America, parts of Asia, etc) represents a
threat to the power and world dominance of such
countries as the United States, considerable attention is
being directed at the IUD by these “nations. Scientists,
working with grants from such organizations as the
Population Council, a private American foundation
supported by the Ford Foundation, John D. Rockefeller I,
and other private donors, are attempting to develop more
effective IUDs which can be inserted by only semi-skilled
personnel. By advocating “voluntary sterilization” and
use of the IUD, the governments of the United States,
Britain and other western powers are attempting to
control by contraception the numbers of non-white
people, just as white people from Europe eliminated
large numbers of red Indians by importing European
diseases for which the Indian had no antibody (immunity)
resistance. One important characteristic that the IUD
shares with sterilization is that the effectiveness of the
method cannot be controlled directly by the individual
woman who carries the IUD in her uterus. Both
sterilization and IUDs are used much more extensively in
countries other than the western nations. Of the 8 million
IUDs used, only 1 million are carried by U.S. women. In
contrast, of the 18.5 million pill users ‘in the world, at
least 8.5 million live in the U.S. and an additional .5 to 1
million in the United Kingdom.
Large scale use of contraceptive measures, applied to
women who may not want to control their fertility,
approaches genocide and ceases to be birth control.

diaphragm

and jelly
The diaphragm and spermicidal ‘jelly method is a relatively
popular and effective mechanical form of contraception.
The soft rubber diaphragm with a spring rim is fitted as a
mechanical barrier to the cervix, preventing sperm from
entering the cervical canal: the front end fits snugly behind
the pubic bone, the dome covers the cervix and the back
end rises into the posterior fornix, a small pocket behind
the cervix. A spermicidal preparation (cream or jelly)
smeared on the surface of the device acts as a chemical
contraceptive; it kills sperm which pass the diaphragm rim
or remain in the folds of the vaginal wall. Some doctors
question whether the device actually blocks the cervix or
merely serves as a platform for the spermicide. Even so, it
is always fitted as a barrier to the cervix.

device by hooking her finger under the front rim, and
pulling down and out.
The woman then learns to insert the device herself. A
teaspoonful of spermicidal jelly or cream is smeared on
the upper surface of the diaphragm (dome up or down,
depending on the woman’s anatomy). Spermicide must
not be placed on the rim since this increases the
possibility of displacing the diaphragm during coitus. With
one hand, the woman squeezes the diaphragm into a long
narrow Shape. With the other hand holding the vaginal lips
apart, she inserts the compressed device into the vagina
until the far rim passes the cervix. She then pushes the
front rim up behind the pubic bone and checks that the
cervix is completely covered.
Plastic or metal inserters facilitate insertion, especially for
women who have short fingers or dislike handling
themselves. The diaphragm is hook

Medical examination and prescription
Each woman must be individually fitted for the diaphragm
by a gynecologist or a family planning clinician. Nonprescription, “‘one size fits all” diaphragms should not be
trusted. A virgin (woman with hymen intact) can be fitted
for a diaphragm; however, sexual intercourse stretches the
vagina slightly, and she should be refitted shortly after her
first act of intercourse. Fitting should be checked at least
every two years and after any of the following
circumstances: childbirth, miscarriage, any operation
(surgery), and a gain or loss of more than ten pounds.
The doctor must perform an internal pelvic examination to
choose the size and type of diaphragm most suited for an
individual woman. The woman is asked to examine herself
internally so that she learns to recognize the edge of the
pubic bone and the cervix, important for proper fitting.
Then, the doctor inserts a sample diaphragm and asks the
woman to examine it in place. She should be able to
recognize the cervix through the rubber and the position of
the front rim. The woman removes the
ed to notches on a rod which the woman inserts into the
vagina. When she twists the rod, the device is released.
Most inserters have a blunt hook at one end for removal.
The rod is hooked to the front rim of the device which is
then pulled down and out
Use
The diaphragm is most easily inserted while crouching,
squatting, lying down, or standing with one foot raised.
The diaphragm may be inserted not more than two hours
before sexual intercourse. If more than two hours goes by
before coitus, an applicator full of spermicide should be
inserted into the vagina, or the device should be removed
to place more spermicide on the diaphragm’s surface. A
woman can walk around, bathe, or urinate with a
diaphragm in place but she should recheck its position
after a bowel movement.
After an act of sexual intercourse, an additional
application of cream or jelly must be inserted into the
vagina by means of an applicator before each additional
coitus.

�The diaphragm must remain in place for at least six hours
after the last act of sexual intercourse. and can be left in
place as long as 24 hours. A facial tissue or towel can be
used to absorb any fluid leakage from the vagina.
Spermicidal creams and jellies do not stain. After removal,
the device should be washed with mild soap and water,
dried, and powdered with corn starch.
Douching is unnecessary but if desired must be
postponed at least six hours after intercourse.
Occasionally the woman should examine the diaphragm
for holes and cracks, especially near “the rim. Filling the
device with water and checking for leaks, or holding the
device to the light are two goodd tests.
The diaphragm can be used during menstruation:
however, conception is highly unlikely at that time. If
positioned correctly the diaphragm cannot be felt by either
sexual partner during coitus. Djaphragms made of plastic
are available in case of an allergic reaction to rubber. Also,
the brand of spermicide should be changed if either
partner ‘is allergic to the kind being used.
The diaphragm is ineffective if left in a dresser drawer or
purse, however, human frailty is not ‘the only reason for its
potential failure. The device can ship out of position for a
number of reasons.
improper fit, cream on the rim, expansion of the vaginal
walls during sexual stimulation, and frequent insertions of
the penis. The diaphragm is. much more easily displaced
in coital positions where the woman is above the man.

The contraceptive foams are packaged under pressure in
aerosol cans or vials while the creams and jellies come in
tubes. A special applicator is sold with the can or tube of
spermicide.
Two brands of vaginal foam are marketed in North
America, and their brand names, “‘Delfen’”’ and “Emko’,
have become synonymous with “contraceptive foam’’.
Since vaginal foams are both easier to use and more
effective, there is no reason why creams or jellies should
be used at all.
All vaginal spermicides have a high failure rate and
should not be used by women who must not become
pregnant. The vaginal spermicide contraceptive method is
not as effective as the diaphragm and jelly or the condom.

As can be seen in the diagram, withdrawing the applicator
half an inch from the end of the vagina positions the open
end of the applicator close to the cervix. When the plunger
is pushed, the foam flows out of the applicator next to the
cervix.
Applicators which come with creams or jellies can be
screwed onto the mouth of the tube. The applicator is
filled by squeezing the tube. Otherwise, creams and jellies
are used in the same way as foams.
Foams, creams or jellies must be inserted not more than
one hour before sexual intercourse. If more than one hour
elapses between the insertion of a vaginal spermicide and
sexual intercourse, another applicator-full of spermicide
must be inserted.
If the woman gets up from bed or goes to the toilet

Cost
The cost of fitting a diaphragm by a private doctor is about
$15 to $25, and considerably less at a hospital or family
planning clinic. The device itself, which is obtainable only
by prescription costs about $4. A tube which contains
about 20 applications costs approximately $3.

vaginal
spermicides
The insertion of a sperm-killing chemical into the vagina before
sexual intercourse is an ancient contraceptive practice. More
than 3.500 years ago an unKnown Egyptian writer suggested a
mixture of honey and acacia tips (a vegetable gum) as a
vaginal spermicide. Through the ages different preparations of
harmless substances have been used as vaginal
contraceptives.
Today, several simple-to-use vaginal contraceptives are
available. These contraceptive preparations are made up of two
components: a spermicidal (sperm-killing) chemical and a
harmless, bulky base. The spermicide kills sperm cells
deposited in the vagina and the base mechanically blocks the
cervix.

so that even if some sperm cells are not killed they cannot
enter the cervical canal.
In Canada and the United States only three forms of
vaginal spermicides are readily available: foams. creams
and Jellies. Spermicidal foaming tablets and spermicidal
suppositories are also marketed but are more difficult to
obtain, especially in Canada, Neither foaming tablets nor
spermicidal suppositories are as effective as the least
effective of the foams, creams or Jellies, and therefore
should not be used.
The spermicidal foams are more effective in preventing
pregnancy than either the creams or jellies. Once inserted
into the vagina, the foam spreads quickly and evenly over
the cervix, and forms an effective barrier. The creams, and
especially the Jellies, often fail to spread properly over the
cervix and are therefore more likely to fail as
contraceptives
Messiness”” is another problem more often associated
with the creams and jellies than with the foams. Many
women complain of leakage or dripping from the vagina
during or after sexual intercourse while using cream or
jelly.

On the other hand, vaginal spermicides have
several advantages. The preparations are
harmless, can be obtained from almost any drug
store without prescription, do not involve a “device’
such as a diaphragm or condom and are easy to
use properly.
Use
To use the contraceptive foam, a woman first
shakes the can or vial and then fills the applicator
by pushing the open end of the applicator tube
down onto the nozzle of the container. As the foam
rises in the tube of the applicator the plunger is
pushed up. When the plunger has risen to the top of
the tube, the applicator is full. The woman lies down
and gently pushes the applicator into her vagina as
far as it will go. The woman then pulls the applicator
back (out) half an inch and pushes down on the
plunger.

�after Insertion of a vaginal spermicide but before sexual
intercourse, another applicator-full of spermicide must be
inserted.

rhythm

Leaking from the vagina before, during or after sexual
intercourse can be controlled by pressing a facial tissue or
clean towel against the vaginal opening. Vaginal
spermicides do not permanently stain clothing or sheets.
If a douche is desired, it must be delayed for at least 6
hours. Not all sperm cells deposited during sexual
Intercourse come into contact with the spermicide
immediately, and many sperm can live on In the vagina for
several hours after the ejaculation. Douching cannot
remove all the sperm cells from the vagina, but it does
dilute and remove most or the spermicidal preparation. In
any case. douching is not necessary after use of a vaginal
spermicide, since the natural cleansing processes of the
vagina are sufficient. (Except for certain medical purposes,
douching is never necessary).
After sexual intercourse, the ‘woman can get up or go to
the toilet without affecting the contraceptive action of the
spermicide.
After use, the plastic applicator should be dropped into a
bed-side glass of water and should be washed eventually
in warm soapy water. If the spermicide dries within the
applicator, it hardens and sticks to the sides. If this
happens, the applicator can be soaked: until the
spermicide softens. Since the applicator is made of soft
plastic, it cannot be boiled.

The rhythm method (periodic continence, safe period,
Ogino method) is simply the abstinence from sexual
intercourse each cycle on those days when a woman is
most likely to become pregnant. Used alone, it is not an
effective birth control method, but it is helpful in
determining the possibility of pregnancy in case of failure
of another method.
Women who must not become pregnant should not rely on
this method. Also, it should not be used by women who
have irregular cycles, especially for any of the following
reasons: age (under 22 or approaching menopause),
recent miscarriage or childbirth, breastfeeding, or
emotional problems. The rhythm method should be
attempted only under the guidance of a doctor or family
planning advisor.
To be successful, the rhythm method must be accepted by
both the woman and her regular sexual partner, if she has
one. Otherwise resulting frustration can threaten the
relationship, or a sexual encounter may be imposed on the
woman when she should abstain. Women whose sexual
experiences are sporadic should not depend on the rhythm
method, since the fertile period and a particular
unexpected opportunity may frequently coincide.
Use
To calculate the fertile period when pregnancy is most
likely, a woman must consider several factors: approximate
time of ovulation, life span of sperm cells, and life span of
the egg. Ovulation occurs at the middle of the cycle,
usually about 14 days before the onset of the next
menstrual flow. Therefore conception is least likely at the
beginning and end of a woman’s cycle, and most likely at
mid-cycle. Sperm can survive in a woman’s body for about
48 hours after ejaculation; the egg lives only about 24
hours after ovulation. Therefore. a woman using the
rhythm method must not have sexual intercourse from 2
days before the earliest chance of ovulation until one day
after the latest possible chance. This fertile or ‘‘unsafe’
period can be calculated in several ways.

Side effects
Some men and women are allergic to one or several brands of
vaginal spermicides. If allergic irritation occurs a doctor should
be consulted and the brand of spermicide changed.
Vaginal spermicides cannot cause cancer or any other diseases.

The calendar method
This method of calculation assumes that ovulation
occurs approximately 12 to 16 days before a
woman’s next menstrual flow. Also, intercourse
must be prohibited 2 days before this 5 day span
and 1 day afterwards to account for sperm and
egg survival. For a woman with a regular
menstrual cycle, the total period of abstinence
(theoretical fertile period) is always 8 days long.
Most women are not always regular; the length of
the cycle varies one or several days in either di

Should a vaginal contraceptive fail, the baby is in no way
affected by the spermicide.

Basal Body Temperature during the menstrual cycle

Cost

In Canadian and U.S. drug stores contraceptive foam

“kits” (including applicator) are sold for $4.00 to

$4.50. Refills of the foam alone sell for about 50 or
60 cents less than the complete kit. A can or vial of
contraceptive foam contains about 20 applications of
the preparation.

Vaginal creams and jellies are less expensive selling for about $2.50 for a complete kit. There are

about 25 applications in a tube of cream or jelly.
Contraceptive foams, creams and jellies can be
obtained at lower prices from discount drug stores,
hospital pharmacies and family planning centers.

If, then, there are serious motives to space out
births, which derive from the physical or
psychological conditions of husband and wife, or
from external conditions, the Church teaches that it
is then licit to take into account the natural rhythms
immanent in the generative functions, for the use of
marriage in the infecund periods only, and in this
way to regulate birth without offending the moral
principles which have been recalled earlier.
— From Encyclical Letter of Pope Paul VI Humanae
Vitae.

�rection. In order to use the rhythm method without error, a
woman must first keep a record of her menstrual cycle for 8
months, using some other birth control method at this time.
Marking the first day of the menstrual flow as day 1, a
woman records the length of each cycle. After doing so for 8
cycles, she calculates the unsafe period for the 9th cycle as
follows: subtract 19 from the length of the shortest cycle to
find the first unsafe day: and subtract 11 from the longest
cycle for the last unsafe day. A woman must not have
intercourse from the first to the last unsafe day. The chart
above calculates the fertile period for cycles of varying
lengths.
A woman must continue to record the length of each cycle
and base her calculations on the most recent 8 cycles. Thus,
the unsafe period for the 10th cycle is based on the shortest
and longest cycles between the 2nd and 9th cycles; for the
11th, it is based on those between the 3rd and 10th cycles:
and so on.
The temperature method
A woman’s body temperature is higher during the second
part of her menstrual cycle. Progesterone, released by the
corpus luteum after ovulation, causes a rise in body
temperature. Also, a temperature drop occurs about 48
hours before ovulation, although this drop is not always as
noticeable as the following rise. Thus temperature change
as an indicator of ovulation can be used to determine the
unsafe period.
Since body temperature also varies with daily activity, a
woman takes her temperature before getting out of bed or
beginning any activity each morning. This is known as the
basal body temperature (BBT). Special thermometers with
fine gradations are available for this purpose.
To familiarize herself with her typical cycle, a woman records
her basal body temperature daily as shown in the chart for at
least six months beforehand. She notes any other factors,
such as a cold or restless night, which might affect the
morning’s temperature. She continues recording the BBT as
long as she uses this method.
The absolute fertile period is calculated from day of the cycle
(onset of menstruation is day 1) until 3 days after the rise in
basal body temperature. This is the unsafe period when
sexual intercourse is prohibited, according to the
temperature method.
Calendar-temperature method
The absolute fertile period calculated by the temperature
method can be quite long, depending on a woman's cycle.
The combination of the calendar and temperature methods
often shortens this unsafe period. Also, if the basal body
temperature is affected by other factors such as illness, a
woman can rely on the calendar method for that cycle if she
has kept an accurate menstrual history. In the combined
method, the first unsafe day is calculated from the shortest
cycle (using the chart provided): and the last unsafe day is
the third day after a noticeable rise in the basal body
temperature.

coitus
interruptus
Coitus interruptus, also known as “withdrawal’” or “being
careful” is the oldest method of birth control still commonly
used today. Withdrawal is mentioned in Genesis, the first
book of the Old Testament, written about 3,000 years ago.
Coitus interruptus is difficult to use properly and has a very
high failure rate. Women who must not become pregnant
should not rely on their partner’s use of this contraceptive
technique.
Use
“Coitus interruptus” means interrupted sexual intercourse a good description of this contraceptive technique. When
coitus interruptus is used sexual intercourse continues until
just before the male orgasm. When the male feels his
ejaculation coming on, he withdraws his penis from his
partner’s vagina and external genitalia before ejaculating.
It is important that the male withdraws his penis completely
and ejaculates away from his partner’s vagina. Sperm cells
can move on their own, and if deposited anywhere
between the labia majora (external vaginal lips) they may
be able to continue up the vagina and into the uterus.
Contrary to common belief, more than just one particular
woman has become pregnant while still virginal. The
hymen need not be broken before pregnancy can occur.
Sexual intercourse can be resumed after the male’s
ejaculation, if the male can maintain an erection. The tip of
the penis should be carefully wiped, and if the man is not
circumcised, the foreskin should be withdrawn and the
penis wiped again.
As a contraceptive technique, coitus interruptus has
several inherent defects. Most importantly, it is the male
partner alone who determines the contraceptive
effectiveness of the method. Not all men are trustworthy,
and few can be depended upon at all times. The
assurance, “I’ll be careful’ means nothing to a woman who
knows that her partner will not physically suffer the
consequences should a ‘“‘mistake’ occur.
Not all men are physically able to use coitus interruptus
successfully. Effective coitus interruptus involving
withdrawal before ejaculation, requires the man to be
aware of when ejaculation will occur: however complete
ejaculation in a single emission (one powerful gush) is the
ejaculatory pattern in not more than 50‘. of men. The other
half of the male population usually expels semen
sporadically or in a slow stream. Whether such men are
aware of the

exact moment when semen first begins to escape, or
whether they feel only the last portion of the ejaculation
is not known.
Aside from ejaculatory pattern, men differ as to timing of
ejaculation. About 50% of all men ejaculate within 2 to 5
minutes after the beginning of sexual intercourse, while
the other 50% can continue coitus for 5 to 20 minutes
before reaching orgasm. Men who ejaculate within 5
minutes of the beginning of coitus have more difficulty
withdrawing from the vagina properly.
Both men and women face still another physiological
obstacle when attempting to use withdrawal. As orgasm
approaches, men and women experience mild to
extensive loss of consciousness during which coltal
movements lose their voluntary character. This condition
can last several seconds, and a conscious action such
as withdrawing the penis can be impossible. If
intercourse continues uninterrupted for too long, one or
both of the sexual partners may, slip into this -semiconscious stage, and forget about withdrawal.
Side effects
For many years some doctors, especially those who
opposed birth control in general, warned. of possible ill
effects of coitus interruptus. Modern medical and
statistical research has revealed that coitus interruptus is
physically harmless.
Psychologically, on the other hand, withdrawal can lead
to problems, especially for women. In Western societies
most women take longer to reach orgasm during sexual
intercourse than their male partners.
Therefore, coitus interruptus often involves interruption
before a woman can reach orgasm. If the male partner
can maintain an erection after ejaculation, sexual
intercourse can be resumed; however. not all men can or
want to continue coitus. Withdrawal thus often means
frustration for the woman unless masturbation or clitoral
manipulation brings the woman to orgasm.
Aside from the simple factor of timing, the woman may
fear, often justifiably, that the male will not withdraw his
penis before ejaculating. Concentrating on the possibility
of an unwanted pregnancy is not conducive to sexual
enjoyment and orgasm.
Men can also experience psychological or sexual
problems related to coitus interruptus. If the man
sincerely wants to protect his sexual partner from
pregnancy he may find himself in a constant state of fear
throughout the sexual act, afraid that withdrawal at the
right time will not be possible.
For all the problems associated with coitus interruptus,
this contraceptive technique is not without its
advantages. Withdrawal costs nothing and is always
available. The consistent use of coitus interruptus does
reduce the frequency of pregnancy. Even so, given the
existence of cheap, easily available mechanical,
chemical and hormonal contraceptives, coitus interruptus
should no longer be considered a valuable birth control
alternative.

other
methods
So-called contraceptive methods which are, for all practical
purposes, ineffective need not be considered extensively by
this handbook. These methods include: immediate postcoital douching, total self-restriction of female orgasm known
as “holding back’, prolonged nursing, and coitus reservatus.
There are serious drawbacks to use of the douche as a
contraceptive method. If there is to be any possibility of
effectiveness for conception control, the douche must be
used immediately after intercourse — an unpleasant
interruption for the woman, More significantly, at that time,
the pressure of the douche might easily force concentrated
sperm into the cervical orifice; sperm could very well
continue and effect fertilization.
On the other hand, if the pressure of the douche is
inadequate to distend the vagina, sperm remain untouched
in the vaginal crevices. For these reasons the douche
should not be considered a contraceptive method, and must
not be used for conception. It should be noted that too
frequent douching is harmful since it destroys protective
bacteria in the vagina.
The strong coal tar “feminine hygiene’’ disinfectants should
never be used. If not mixed properly, they will burn the
tissues.
It is a relatively common belief that if the female partner
“holds back” and does not permit herself to achieve orgasm
during coitus, pregnancy is impossible. This belief is based
on the misconception that women, like men.
ejaculate in orgasm a substance that is necessary for
fertilization. While it is true that there is a release of fluids
when a woman reaches sexual climax, these fluids simply
facilitate the swimming movement of sperm. In the partial
absence of these secretions (absence is never complete),
sperm can still reach the Fallopian tubes and fertilize an
egg. There have been many pregnancies in women who
nave never had orgasm.
There is no truth to the belief that as long as a woman is
nursing a baby she cannot conceive.
Because of hormonal balances, during early months of
breast feeding ovulation may be delayed, but this protection
does not last long, nor is it reliable.
The practice of coitus reservatus is similar to coitus
interruptus (withdrawal). The essential difference is that
whereas in coitus interruptus the male partner does not
allow himself to achieve orgasm and ejaculate within the
woman’s body, in coitus there is no ejaculation. The male
does not withdraw, but remains in sexual contact during the
female partner’s orgasm and gradually his erection
subsides. Such control for an hour or longer, it has been
reported, requires training; further it is highly probable that
some sperm will escape through the erected penis even
though the male partner does not ejaculate. The control that
is necessary for utilization of coitus reservatus a sa
contraceptive method cannot be maintained by many men.
the same psychological and physiological arguments against
coitus interruptus are directed against coitus reservatus.

�effectiveness

new methods
The Pill is only an interim solution to the problem of
hormonal contraception. Although the oral contraceptive
appears safe for the vast majority of users, it does
constitute an endocrinological insult which can lead to side
effects, disease, and, in rare cases, even death. Several
experimental contraceptive devices and drugs, some of
which are described below, may eventually replace the
Pill.

The pregnancy rate for any period of time during
which a particular birth control method is used is

an expression of the failure rate of that method.
The Pearl formula is a standardization of contraceptive failure rate.

The above formula assumes that ovulation occurs 13
times a year, thus providing 13 chances for conception.
Thirteen is multiplied by 100 to provide an easily definable
“per cent’ figure - thus 1300.
“One hundred woman years” standardizes the pregnancy
rate in terms of the number of times conception is possible
during a year’s period of exposure. The formula assumes
regular heterosexual contacts, no intervening pregnancies
or periods of breast feeding, and ovulation during each
menstrual cycle. Thus, if 60 women use one contraceptive
method for 10 months, and five conceptions occur, the
formula would reveal a failure rate of:

I3X 5 /600 = almost 11%

Two different failure rates are often provided for each
contraceptive method, ‘‘theoretical failure rates’’ and
“clinical failure rates’. The theoretical failure rate reveals the
effectiveness of a method if it is used absolutely
consistently and according to instructions. The clinical
failure rate states the effectiveness of a method used under
average conditions by average people. The theoretical rate
can be accurately determined for only two contraceptive
methods - the Pill and the IUD. With the Pill, it is possible to
objectively determine if a woman has taken one pill every
day for 21 days in a cycle; and with the IUD it is similarly
possible to objectively determine if the device is in place in
the uterus. Since all other contraceptive techniques are not
totally divorced from the sexual act, it is not possible to
make objective observations as to the consistency or
accuracy of personal use.
In the chart, theoretical failure rates and clinical failure
rates are presented only for the oral contraceptive and the
IUD. For all other methods, only clinical rates are provided.
Listings are approximations, and are subject to great
variation. A listing should be read:
“... pregnancies in 100 women using the.......
method for 1 year’’.
When considering the meaning of effectiveness statistics it
should be remembered that the most important variable is
‘‘individual failure’. Oral contraceptives can be 100%
effective: however this is meaningless if a woman forgets to
take 1 or more pills. Similarly, the condom theoretically
provides

100% protection against conception. The chart above
reveals, however, that an average failure rate for the
condom is 10 to 15 per year. In terms of effectiveness,
the main difference between the oral contraceptive and
the condom is that the former provides many fewer
opportunities for individual failure than does the latter.
When choosing a contraceptive method, personal
beliefs, preferences and hang-ups must be considered,
since they affect “individual failure’. If a woman is afraid
of the oral contraceptive, it is likely that she will “forget”
a pill every so often. If a man believes that a condom
dulls sexual sensation, or if he really does not care
whether or not his partner becomes pregnant, he may
occasionally “forget” to wear the sheath.

The continuous progesterone pill (‘‘mini-pill’’) Kistrogen is
responsible for most side effects associated with the Pill.
Experiments are being performed with an oral
contraceptive which contains only .05mg of a potent
synthetic progesterone in the daily pill. One pill of a
progesterone oral contraceptive series is taken every day,
in contrast to the 3 weeks on, 1 week off regimen of the
estrogen-progesterone pill. The “minipill’’ eliminates side
effects and endocrine changes caused by estrogen.
Unfortunately it is associated with another set of side
effects resulting from the absence of estrogen. Estrogen
as a component of the combination Pill regulates the
user’s cycle, and helps prevent ovulation. When
progesterone is used alone as an oral contraceptive,
menstrual cycles are disrupted, and ovulation still occurs.
Chlormadinone acetate (CA) is the most commonly used
progesterone in minipill preparations. CA is highly antiestrogenic, and causes localized changes in the genital
tract making conception unlikely. When a woman is taking
a continuous progesterone contraceptive, mucus in the
cervical canal becomes thick and impenetrable to sperm.
Progesterone also disrupts the cyclical development of
endometrial cells, making the whole endometrium
unreceptive to a fertilized egg. Even so, pregnancies do
occur In women taking the progesterone-only pill. Although
scientists working for pharmaceutical companies claim
otherwise, the minipill’s failure rate is at least 5 to 6 a year.
To be effective, the minipill must be taken at the same time
every single day without fail. To forget even one pill can
expose a woman to pregnancy.
The minipill is unacceptable to many women because of
its high failure rate and high incidence of extremely
irregular menstruation. If these problems can be
eliminated, the minipill might replace the estrogenprogesterone preparations.
Several chlormadinone acetate preparations have already
been on the market in England and Canada.
These pills were withdrawn in England because long term
tests revealed the development of breast nodules (tumors)
in female dogs given CA for several years. The
significance of these findings is questionable, since dogs
metabolize sex hormones differently than do humans or
monkeys. Breast nodules have not been observed in
monkeys treated with CA, nor are the breast nodules
discovered in bitches clearly cancerous. Further
experiments will probably result in the return of CA
products to the general market.

The “morning after” pill
An effective “after the fact’ oral contraceptive has
been available for several years. If a woman takes a
large dose of natural estrogen called stilbestrol within
24 hours of an unprotected act of sexual intercourse,
implantation of the fertilized egg (if there is one) is
disrupted. Stilbestrol is given to victims of rape, but
can be obtained in simple cases of unplanned and
unprotected intercourse, or in clear cases of
contraceptive failure (e.g. ruptured condom).
The “‘morning after’ pill as it now exists, usually
causes severe vomiting and nausea. Also, use of
large doses of estrogen is presently being avoided.
Progesterone injections
Injections of 150 mg. of a potent, long acting
progesterone have been used as a contraceptive
technique for several years. Unlike the progesterone
only pill, the injection method is usually 100%
effective. The synthetic progesterone used probably
causes an over-suppression of the hypothalamus,
blocking the secretion of LH. It can take 12 to 21
months after a progesterone injection for the
hypothalamic suppression to wear off, although 100°.
protection against conception is only provided for 3
months. Many scientists believe that in some cases
hypothalamic suppression induced by progesterone
injection may never wear off, leaving a woman sterile.
Progesterone injections have not been widely used in
Canada and the U.S. The majority of experiments
have been performed on nori-white, poor women,
living in Third World nations. Since the possibility of
permanent infertility is rarely explained to such
women, experiments with progesterone injections
often constitute non-voluntary chemical sterilization
programs.
The progesterone injection technique is associated
with a high incidence of extremely irregular
menstruation. If this side effect, and the possibility of
sterilization can be eliminated, the injection technique
would be a good contraceptive.
Silastic implantations
Another progesterone-only contraceptive technique
being experimented with widely on Third World
women involves the implantation, under the skin, of a
tiny plastic “pillow” filled with progesterone. Silastic,
used in making the pillow, releases progesterone at a
slow continuous rate. To implant the plastic capsule,
which is about as big as a pencil tip, a small area of
skin on the inside of a woman’s arm is locally
anesthesized. A large bore needle carrying the
capsule is then injected leaving the capsule under the
skin. The capsule can be removed In a similar way.
Side effects associated with this method are similar to
those complicating use of progesterone injections.
Silastic intravaginal-ring
This is a highly promising method. A silastic

�ring, of about the same diameter as a diaphragm, and
filled with a synthetic progesterone, is inserted into the
vagina on the first day of menstruation. When properly
placed, the ring cannot be felt by the woman or her sexual
partner. The ring is left in the vagina for 21 days and the
progesterone which is absorbed into the blood stream
through the vaginal walls, has a localized effect on the
genital tract. After 21 days, the woman removes the ring,
and menstrual-like bleeding begins a few days later.
Preliminary reports on this method indicate low side effect
levels and regular menstruation.
The once-a-month pill
A more convenient form of the combination oral
contraceptive is under investigation. A form of ethinyl!
estradiol (estrogen), which is picked up from the digestive
system and stored in fat cells, is used in combination with
a long acting synthetic progesterone. Effectiveness of this
pill appears to be high and side effect levels low; however,
the hormonal. balance of this pill is estrogenic. Antiestrogenic oral contraceptives are associated with a lower
incidence of metabolic changes and serious
complications, and so the future of this method is
questionable.

Pill for men
Experiments with several non-hormonal drugs used to
prevent sperm production have not yet been very fruitful.
Vaccinations
When the body is “invaded” by a toxic chemical or
disease organism (e.g. bacteria) white blood cells and
specialized blood serum chemicals attack the invader. In
the course of the subsequent biological battle, the
body’s defences become specialized ‘against the
particular invading chemical or organism. This
specialization process, called the development of
immunity, is highly complex and hardly understood. If
the same chemical or organism attacks again,
specialized “‘antibodies” carried by the blood serum,
destroy the
invader without exhibiting disease symptoms.
It may be possible to immunize (“vaccinate’’) a woman
against a particular man’s sperm. Sperm cells are
actually invading bodies; however, they are not normally
attacked within the female body since they do not, under
normal circumstances, induce immunization. If a woman
could be immunized against sperm, antibodies would
attack and destroy sperm cells when they enter the
Fallopian tubes.
Not all antibodies are maintained for the whole life of the
organism. For example, smallpox antibodies “wear out”
in a few years, and booster shots are needed to
redevelop immunity. Vaccination against sperm need not
be permanent, and various techniques could be used to
determine when re-lmmunization is necessary. If the
vaccination method can be perfected, it would be
preferable to hormonal contraception.

sterilization
Sterilization, a surgical procedure for the permanent prevention of conception, is usually advised
in the following situations: when another pregnancy
could endanger a woman’s life or health: when the
parents have already produced a child with an inherited nervous or physical disease, such as hemophi-

lia; where physical, mental or emotional factors
prevent the couple from caring for the child pro-

perly; when a couple considers their family complete and wishes absolute protection from further pre-

gnancy. Hospital policy varies on this question,
however age of the woman is usually a decisive
factor.

female sterilization
There are four possible surgical methods to sterilize
a woman. An oophorectomy, the removal of the
ovaries, is never done because of the importance of
the chemical hormones they produce.
Hysterectomy, or removal of the uterus is of course a
complete barrier to pregnancy but is advised only if
the uterus itself is diseased. The ovaries themselves
are generally left in place in the younger woman.
Many doctors disapprove of hysterectomy as a
sterilizing procedure on two grounds: it involves
major abdominal surgery with all the implications
therein, and the early loss of the uterus can have bad
psychological effects.
In general, unless diseased, the complete removal of
the Fallopian tubes, called a salpingectomy, has
been given up in favor of a more simple technique,
commonly known as “tying the tubes’’.
The most common method of sterilization, tubal
ligation, which involves tying off the Fallopian tubes,
effectively prevents the egg from reaching the uterus,
and the sperm from travelling into the tube. Through
a small incision on the abdominal wall the tubes are
brought into view, are cut and the ends tied.
The operation may be performed within twelve hours
after normal delivery, when the uterus is enlarged
and therefore the tubes are easily reached. After
caesarean section the operation is done immediately
after repairing the uterine incision.
In both cases the procedure hardly lengthens the
hospital stay. When a woman has not been pregnant
for several months, an interval sterilization may be
performed abdominally, as discussed above, or by
making an incision in the vagina through which either
a tubal ligation or hysterectomy can be done.
Tubal ligation is a highly successful operation with a
failure rate of about one in 250 (somewhat higher
when done after caesarean section). Less than 50%
of the attempts at reversibility have been successful.
Until improved methods allow for greater reversibility,
the operation must be considered permanent.

Male Sterilization
Sterilization may be performed on the male in two ways.
Castration, removal of both testicles, is never done on
normal individuals because it produces impotence and
eliminates sexual desire, as well as affects secondary
masculine traits. It is considered only in the case of
serious diseases such as cancer or tuberculosis.
The most common method of male sterilization, an
operation known as a vasectomy, has no effects on a
man's sexual desire or virility, except perhaps to
enhance it by relieving him from fears of having another
child. The operation involves severing the vas deferens
thereby preventing the passage of sperm from the
testicles to the penis. Since the contribution of the testes
accounts for only: about 1/10 of the volume of the total
ejaculate, the actual quantity of seminal fluid is not
appreciably diminished.
A small incision is made in the upper and lateral region
of the scrotum, directly over the spermatic cord. The
cord itself is cut and the vas deferens is separated from
the blood vessels and nerves. Two ligatures are put a
small distance apart around the vas deferens and the
portion between them is cut out. The incision is closed
with sutures and a temporary dressing applied. The
entire operation done either in a hospital or doctor’s
office takes approximately 20 minutes. Men are
sometimes advised tO wear a suspensory for a few
days to hold the testicles up so that traction on the
wound is not painful.
Male sterilization cannot be depended on for
contraception for the first three weeks after vasectomy,
during which time sperm produced before the operation
may still be present in the semen. After this time a
semen specimen is examined under a microscope to
check for the complete absence of sperm. In about 1%
of the cases the severed ends of the vas deferens grow
together and continue to transport sperm. Therefore it is
advisable to have a semen specimen examined about
every six weeks for the first six months after which such
precautions are no longer necessary.
Attempts to restore fertility after a vasectomy have been
successful in only about 50% of cases. Reversible
methods are being sought such as use of a silicon
injection which hardens to form a removable plug.
Sterilization operations were performed by Nazi doctors

n Jews in World War Il. Today, the United States legal
system manages to sterilize “welfare mothers” (usually
black people) who have had illegitimate children. In Delaware a Senate committee recommended that welfare
mothers with 2 or more illegitimate children should be
sterilized. In New York, judges offer women the choice
- either be sterilized or receive no more welfare.

Like the IUD, sterilization is used more extensively
in Third World nations. Since male vasectomy is a quick,
simple operation, it is considered invaluable in the con-

trol of Third World populations. In India where vasectomies are performed in train stations, 5,500,000 have

been ‘voluntarily sterilized’’. Pakistan is initiating a
program to sterilize 50,000 men a month.

�abortion

There are only 4 safe medical abortion procedures. The first
two, dilatation and curettage (D. &amp; C), and vacuum curettage
are used until the 12th or 13th week of pregnancy; after this
time either the saline technique or hysterotomy, both of
which require a hospital stay, must be used.

Dilatation and Curettage
Before beginning a D. &amp; C. the doctor (or
paramedical specialist) conducts an internal
examination to verify the pregnancy and check the
angle of the uterus. A speculum holds the walls of
the vagina apart throughout the operation. A uterine
sound is passed through the cervical canal into the
uterus to ensure that the canal is not blocked and to
estimate the measurements of the uterus.
A local anesthetic is sufficient to block pain occurring
during the operation. The most commonly used form,
the paracervical block is also used frequently during
childbirth. The chemical (xylocaine or carbocaine) is
delivered by injection at the back of the vagina
behind the cervix. The injection itself is not painful.
Nerves leading from the cervix are numbed by the
anesthetic, and sensation from the uterus and
especially the cervix is “blocked before it reaches the
spine. Since a local anesthetic does not affect other
body functions, the woman should eat normally
before the operation to avoid fainting.
The cervical canal must be dilated (widened) to
permit the introduction of surgical instruments. This
can be done in a number of ways. In the traditional
method, the doctor passes a series of increasingly
larger polished metal rods (Hegar’s dilators) into the
cervical opening. The first is about the width of a thin
soda straw, and the last is about the width of a
finger. The cervical tissue stretches more easily in
women who have had children. A]though the
anesthetic blocks severe pain during cervical
dilation, women sometimes feel cramps similar to
menstrual cramps. Dilation of the cervical canal can
also be accomplished by an instrument with two
rounded tips which are inserted into the canal; by
applying pressure to the handle. the tips separate,
causing the tissue to stretch. This expansion
technique takes only several seconds but
occasionally it is more uncomfortable than Hegar’s
dilation.
Once the canal is dilated the doctor inserts a curette
(surgical instrument with spoon-like tip) into the
cavity of the uterus to scrape loose the embryo and
placenta. Loosened portions of embryonic material
are removed from the uterus with a long surgical
grasping instrument called an ovum forceps. The
entire operation takes about 10 to 15 minutes.
Vacuum curettage.
This modern method of abortion, also called uterine
aspiration, was first developed in China.

It is quickly replacing the D. &amp; C. as standard procedure since it
1s quicker, involves less blood loss, less risk of uterine
perforation, and requires less anesthetic.
Preparation for vacuum aspiration is exactly the same as that
for a D. &amp; C., including the internal examination, paracervical
block, and cervical dilation. Some doctors prefer to dilate the
cervix with a ‘‘vibrodilator which attaches to some vacuum
operating units. Vibration of a soft metal cone held in the
cervical canal dilates the canal almost instantly to an exact
size; however, many doctors continue to use one of the older
methods of dilation since the vibrodilator makes a loud noise
which can be upsetting to the patient.
Once the canal is dilated, the doctor inserts a hollow tube
called the vacurette into the uterus until it touches the amniotic
sac. The vacurette is connected by transparent plastic tubing to
a collection bottle. The vacuum pressure is turned on for 20 to
40 seconds, and the doctor observes the passage of fetal and
placental tissue into the collection bottle. When the uterus is
emptied, the doctor feels a slight tug on the vacurette. In order
to ensure that no placental tissue is left in the uterus, the doctor
goes over the uterine lining with a curette as in a D. &amp; C. This
is especially important In pregnancies close to the 12 week
limit, and when the uterus is positioned abnormally.

Operating unit for vacuum curettage.

�are carefully repaired. Some doctors insist on delivery
by caesarean section for all pregnancies after a
hysterotomy, since the uterine wound can rupture due
to labor contractions. Hysterotomy is quickly being
replaced by the simpler “salting out’’ method.
Prostaglandins
Prostaglandins are a group of chemically related fatty
acids found in human seminal fluid. The use of certain
prostaglandins to terminate pregnancy is still in
experimental stages. The drug is delivered
intravenously for up to 24 hours. Since prostaglandins
stimulate smooth muscle tissue, uterine contractions
begin and eventually expel the fetus and placenta.
This technique seems promising, especially after the
12th week, and may eventually replace the saline
abortion technique.
Women should not confuse this technique with offers
from unscrupulous ‘‘abortionists’” for injections to
induce abortion. At the moment no such injection or
pill exists.

Recuperation from vacuum curettage is almost
immediate. Some women want to lie down for a few
minutes, others have cramps similar to menstrual
cramps, and still others feel perfectly normal. Women
who get up from the operating table too quickly
sometimes faint.
A woman will have menstrual-like bleeding for a day to
a week after an abortion. She may se either pads or
tampons, whichever she prefers.
The first real menstrual flow begins 3 to 6 weeks after
the abortion. Since it is difficult to tell exactly when she
becomes fertile again, a woman must consider herself
subject to another pregnancy immediately, and begin to
use some form of birth control. A woman who wishes to
go on the Pill should consult a gynecologist and obtain
a prescription before the operation. She may take the
first pill of a series within 5 days after the abortion:
otherwise, she must wait until her next menstrual flow.
A woman must not douche after an abortion. The cervix
remains slightly dilated and a douche can force fluid
into the uterine cavity.
Other than the restriction on douching, there is nothing
that a woman cannot do after an abortion. Some
women wish to rest for an hour or two: others go about
their everyday business without interruption. There is
no restriction on sexual intercourse so long as proper
birth control measures are taken.
some doctors automatically prescribe anti

biotics such as penicillin after an abortion: others who do
not believe in such prophylactic treatment give antibiotics
only if a woman shows signs of infection, since it is more
difficult to cure infection which develops despite antibiotics.
Fever
and pain in the pelvic area are symptoms of infection.
Infection after a properly performed abortion is fairly simple
to cure; however, it is serious. If fever, pain, or
uncontrollable bleeding occurs after an abortion, a woman
must see a doctor or go to a hospital emergency clinic
immediately.
Intra-amniotic hypertonic saline (“salting-out"’)
This method of inducing miscarriage, used after the
fourteenth week of pregnancy, requires a hospital stay of
several days. A small area of skin a few inches below the
navel is locally anesthetized. A long needle is inserted
through the abdominal wall and into the uterine cavity.
Several ounces of amniotic fluid are withdrawn and
replaced with an equal quantity of a strong saline (salt) or
glucose (sugar) solution. This solution kills the fetus and
prevents the release of placental hormones. Within 24 to
48 hours the woman goes into labor and miscarries.
Hysterotomy (miniature caesarean section)
Hysterotomy involves major surgery with a hospital stay of
about one week. An incision is made in the abdominal wall
just above the pubic bone. A second incision is made in the
uterine wall, and the fetus and placenta are removed. Both
incisions

Availability of abortion
Archaic and oppressive laws continue to prevent all but
rich women in North America from obtaining abortions on
demand. Nevertheless, there are several radical and
liberal groups who have taken on the responsibility of
finding legal or illegal abortions for all women. Usually
these groups have three options: helping women through
the red tape and humiliation of applying to a hospital
board; finding qualified illegal abortionists; and arranging
the abortion in a state where legal process is simple.
Such groups concentrate their energies in different areas,
depending on their political perspective, and on the
particular abortion situation in their community.
Referral through the Women’s Liberation Movement is
probably the quickest and least traumatic. Radical or
community clinics and the occasional student health
service are also quite cooperative. The Clergymen’s
Council on Abortion and family planning agencies vary
greatly in each community: in some places these groups
do referrals but in others they have not gotten past talking
about it.

DANGER
There are only 4 methods of abortion which can be
Fluids inserted into uterus:
considered safe. Competent, medically trained
* Soap suds
* Alcohol
abortionists, whether they are acting legally or not,
never use methods described below. These methods * Potassium Permanganate
* Lye
involve extreme pain and can lead to permanent
* Lysol
disability, infection, or death :
* Pine Oil
Severe burning of tissues - haemorrage - shock - death

Oral Means:
* Ergot compounds - overdose is, poison - can cause Air pumped into uterus:
Collapse from gas emboli in the blood stream.
fatal kidney damage
Sudden violent death.
* Quinine Sulphate - can cause deformities in fetus
or death to mother
Injections into Uterine Wall: .
* (Estrogen - useless)
* Ergot
* (Castor oil - useless)
* Pitocin
Nothing that is swallowed can cause abortion without * Sodium Pentothal
also causing death or severe disability to the mother

Other Means:
Vacuum Cleaner - connected to uterus - not to be confused
Solids inserted into uterus
with vacuum aspiration - is fatal almost immediately extracts uterus from pelvic cavity.
* Physical exertion such as lifting heavy objects, running
* Knitting Needles
*Catheters
etc is useless.
*Coat Hangers
*Gauze (packing)
* Falling down stairs - severe injury to mother but no
*Slippery Elm Bark
*Artists Paintbrushes
abortion.
*Chopsticks *
*Curtain Rods
Butcher abortions are deadly - only doctors or other
*Ballpoint Pen
*Telephone Wire
*Pastes
specially trained personnel can safely use one of the 4
methods of abortion - all other methods can cause death
but rarely induce abortion
If you have used on yourself or have allowed to be
used,.any of the above methods of abortion go to the
Common danger of perforation of womb and blad- nearest hospital immediately.
der - death from infection or haemorrhage.

�The new Canadian abortion law has been in effect for
over a year, but the availability of abortion goes
unchanged. The law only legitimizes the few abortions
which hospitals have been permitting all along. In effect,
the law allows for abortion if a continued pregnancy would
threaten the life or health of the women.
“Life or health” is defined by a board of three doctors, all
of whom are usually male. The interpretation of the law to
justify abortions which male doctors consider. justifiable
and to prevent those of which they disapprove borders on
absurdity. For example, the law does not permit abortion
for possible fetal malformations. Nevertheless. many
doctors believe that a woman who is exposed to German
measles during the. early months of pregnancy should be
aborted, since her baby is likely to be born deformed. The
formal reason given tor such an abortion is ‘possible or
existing anxiety to the woman due to potential fetal
abnormalities” . Yet the same. doctors refuse to grant
abortions to women
who simply do not want a child be the reason social,
economic, physical, emotional. or political.

The Canadian law requires approval of a three member
hospital board on each abortion case: bu the law does not
demand that every accredited hospital establish such a
board. Also, by law the procedure must be performed in a
hospital: up to the third month this is medically’
unnecessary, and serves only to put the cost of abortion
beyond the means of many women
The doctors who send desperate women away without
granting a legal abortion seem to have no qualms about
treating these same women in the emergency clinic for the
results of self-induced or butcher abortions. Some of these
women die, others are permanently sterile, and many.
undergo experiences too brutal and horrifying to be
believed.
The situation.in the United States is not much better. In the
majority of states, abortion is legal if pregnancy threatens
the life of the. mother. Twelve states (Colorado, California,
Georgia, Maryland, New Mexico, North: Carolina,
Arkansas, Kansas. Oregon, Wisconsin, Hawaii and New
York) have liberalized their laws to a certain degree. The
first five require the approval of a hospital board. Some
always include a residency requirement whereas others
demand it only in cases of rape or incest (since crimes
have to be proven according to state law). The New York
law, passed by only one vote, is considered the most
liberal of American abortion laws.
The existence of such laws does not make it easy to
obtain an abortion in these states. Where hospital boards
exist, there is a strong conservatism maintained to prevent
the hospital from acquiring a reputation “as an “easy”
place to get an abortion. Doctors who are intimidated. by
their superiors hesitate even to bring a case to the board.
In New York, where the law does not demand
hospitalization, many county medical boards have come
out against office procedures for obvious financial
reasons. (Costs which vary from $100 to $400 for the
abortion itself are increased to $600 to $800 by hospital
char

Statistics
Statistics for illegal abortion are developed on the basis of
population, hospital records, total number of births, death
from post-abortive complications, questionnaires etc.
Some of the most carefully developed and most widely
accepted figures are listed below. Statistics for legal
abortion, such as performed in Communist countries and
in Japan are from hospital records.
General:
In the world: at least 30,000,000 abortions every year.
At least 4/5 of all abortions are performed on married
women.
Canada:
At least 100,000 illegal abortions every year.
At least 20,000 admissions to hospital for post abortive
complications - at least 1,000 of these cases result in
severe disability or death.

United States:
At least 1,000,000 illegal abortions every year.
Four out of five legal abortions are performed on private patients,
not clinic patients. Nine out of ten legal abortions are performed
on whites, not Blacks.
Where abortion is legal:
Bulgaria: between 1962 and 1964, 67,000 legal abortions without
a single death.
Czechoslovakia: between 1962 and 1964, 140,000 legal
abortions without a single death.
Hungary: between 1962 and 1964, 358,000 legal abortions with 2
deaths.
Japan: 1,500,000 legal abortions every year performed by more
than 20,000 specially licensed technicians.

ges). These boards have also recommended an earlier
cut-off point than is provided in the law after which
abortions will not be performed. Due to the shortage of
adequate medical facilities in New York, the backlog for
abortion has become critical. Many women are forced to
wait until they are more than 3 months pregnant, and
therefore must undergo the more complicated and
expensive procedures for advanced pregnancies.
None of these problems is accidental, nor can we expect
them to be solved without a radical restructuring of the
entire medical profession, indeed, of the whole society.
The number of doctors trained each year is controlled by
the American Medical Association; thus a shortage of
doctors maintains the high income of the members of the
profession. Para-medical staff who could easily be trained
to do abortions and many other routine medical
procedures would tend to demystify the godlike image of
the doctor. To date, there is no program for the training of
para-medical staff in the numbers required to meet the
needs of the people.
The prohibitive costs of all medical procedures determine
the quality and amount of medical attention a person will
receive, regardless of that person’s needs. The emphasis
on curative rather than pr

ventative medicine ensures business for the medical
profession but does little to improve the quality of life for
all people.
Abortion as a medical problem is complicated by the
chauvinism expressed and perpetuated by the medical
profession. So long as male doctors see women as
breeders with no other useful function within society,
women will continue to be denied control of their own
bodies. The fact that a husband or parent (depending on
the woman’s age and marital status) must grant
permission for abortion and many other medical
procedures is merely a reflection of the ownership of
women’s minds and bodies by men.
Poor women, especially black women, suffer the worst
humiliation at the hands of male doctors and their hospital
boards. These woman are commonly ‘offered’ abortion with the stipulation that they must accept sterilization as
well. The rationale that such measures are necessary to
alleviate the population crisis is merely a cover for racist
genocide. The children of the rich exploit and pollute the
resources of the earth, not the children of the poor.
The struggle for justice on the abortion issue will not be
complete until abortion becomes just another medical
procedure available free to all women whenever
necessary.

venereal
qisease
Syphilis
Syphilis, the most dangerous form of venereal disease, is an
acutely infectious disease, invading every system of the body.
If treated it can be cured; if not, it can be disabling and fatal.
The treponema pallidum is a spirochaete (coil-shaped
organism) which initiates the syphilitic condition. It is extremely
sensitive to drying, heat, mild antiseptics, and soap and water.
Moisture is essential to its survival and therefore it flourishes in
areas such as the mouth, genitals and anus. SYPHILIS IS
ONLY TRANSMITTED THROUGH INTIMATE SEXUAL OR
PHYSICAL CONTACT. SYPHILIS IS VERY RARELY
TRANSMITTED BY OBJECTS SUCH AS TOILETS, TOWELS,
CUPS, CUTLERY, ETC.
Symptoms
The primary stage of syphilis usually shows itself about three
weeks after exposure to infection; however a range of up to 90
days is recognized. It is characterized by a chancre or sore on
either the genital organs, the anus, or in some women on the
cervix. The treponemes penetrate microscopic breaks in the
skin. The sore develops where white blood corpuscles pack the
infected areas so tightly that by cutting off the blood supply,
they kill the local tissue. Chancres which appear in the mouth
are usually acquired by kissing a person with secondary sores.
The sore is neither painful nor itchy, and often goes unnoticed.
It may disappear after several days whether or not the disease
is treated. The early disappearance of such sores deludes
many infected individuals about the serious nature of their
condition. A person with primary syphilis, is highly infectious to
other people.
If untreated, syphilis progresses to its second stage. The
numerous symptoms of this stage often imitate those of other
common diseases, and therefore they are often misinterpreted
or unnoticed. They include: sores in the mouth; sore throat;
skin rash: enlarged glands, particularly about the genitals;
swollen joints; fever; headache; pain in bones and joints; and
patchy balding. If left untreated, secondary symptoms tend to
come and go for about four years. As in the primary stage, the
disappearance of such symptoms is no indication of cure, and
the individual is still highly infectious.
If the patient is not treated, the disease enters a latent (hidden)
state giving no visible symptoms of its presence. During the
early part of this stage the patient may suffer an infectious
relapse with the reappearance of sore and rash. However, the
latent state may last anywhere from five to fifty years. As the
disease progresses, the patient loses his infectiousness to
others as the disease “‘goes underground .

�related information

Late syphilis, the fourth stage may manifest itself in any
body system, however the cardio-vascular and nervous
systems are the most common targets. Syphilis attacks the
heart in many ways: the treponemes destroy the elastic
fibers of the wall of the aorta causing aneurysms (stretched
sacs) to develop: the valve between the left ventricle and
the aorta may be destroyed, causing the heart to enlarge in
muscle power and capacity to compensate for its
inefficiency; and inflammation of the mouths of the
coronary arteries can diminish the blood supply to the heart
muscles. Any one of these conditions may prove fatal.
Syphilis of the nervous system also takes one of many
forms: when the coverings of the brain and the blood
vessels are involved, paralysis may develop in varying
degrees, from one eye muscle to half the body. If the
substance of the brain or spinal cord is involved, a type of
paralysis of the legs called tabes dorsalis may develop with
complications such as impotence and urinary difficulties.
When the effects of syphilis are concentrated on the brain
substance, general paralysis of the insane may follow.
Symptoms may develop slowly or suddenly, and may lead
to extreme mental and physical deterioration, and death.

Blood donors are always tested for venereal disease.

Diagnosis
Diagnosis of syphilis is a very difficult process. The
treponema pallidum do not lend themselves to staining for
microscopic observation, nor can they be grown on a
biochemical media in the laboratory. At the primary stage of
syphilis, the blood tests are negative, that is, they show a
normal condition. For these reasons knowledge of the
social background (whether or not the individual has
engaged in casual sexual relations with someone who is
likely to be or possibly may be infected, and whether or not
there is a family history of the disease) is of utmost
importance to the doctor. If the primary sores are still
present, fluid from them may be examined by special
microscopic techniques, in order to establish a diagnosis.
During the second stage, blood tests designed to
determine whether a person has developed reactions
characteristic of the disease, become more effective.
However one negative blood test is not enough assurance
that the individual is not infected. A second should be taken
within a few weeks whether or not any symptoms remain.
Microscopic examination of fluid from swollen glands may
yield some information also.
During latency, only repeated positive blood tests will
confirm the disease. Infection may be masked (resulting in
a negative test) if the person is undergoing anti-biotic
treatment for some other reason. A second test is always
necessary.
In the fourth stage, both tests of blood and cerebrospinai
fluid and microscopic examination of tumor tissue are
effective.
Syphilis may be contracted congenitally (from birth). For
this reason all pregnant women are tested for syphilis. If
treated early in pregnancy, the mother can be cured and
the baby will be born normal. Otherwise, the baby may be
born dead or diseased. Much depends on the extent of the
mother’s infection.

Gonorrhea
Gonorrhea is essentially a disease of the linings of the
genito-urinary organs. The gonococcus organism spreads
immediately below the surface of these linings. It is highly
sensitive to drying, change in temperature, and weak
antiseptics. Like syphilis, GONORRHEA IS TRANSMITTED
THROUGH INTIMATE SEXUAL CONTACT. IN ADULTS IT
IS NOT TRANSMITTED BY CLOTHING, TOWELS,
TOILETS, ETC. On the other hand, the eyes of newborn
babies and the immature sexual organs of small girls are
terribly susceptible. Gonorrhea can spread through a
nursery faster than measles.

Treatment
Treatment for all stages of syphilis involves an injection of
various dosages of penicillin. Sometimes a single injection
is sufficient: however a series of two injections may be
advised. It is important that the treatment be followed by at
least two negative blood tests in order to make sure that the
treatment is complete. THE EARLY STAGES OF SYPHILIS
CAN BE COMPLETELY CURED. Even in late syphilis, the
destructive processes can be stopped, and some
improvement may be made in the individual’s condition.
Free clinics for the treatment of venereal disease are
maintained in all cities in Canada. It is important that people
cooperate with the medical staff in naming sexual contacts if
necessary. Strict confidence is usually maintained.
SYPHILIS IS A HIGHLY INFECTIOUS, DANGEROUS
DISEASE. IT IS IMPORTANT THAT ALL SEXUAL
CONTACTS OF AN INFECTIOUS INDIVIDUAL BE
REACHED FOR MEDICAL ASSISTANCE.

Female Symptoms
The incubation period (time after contact until the disease
can be detected) for gonorrhea is from two days to three
weeks. In women, the urethra and cervical canal are first
infected. Most women are unaware of these symptoms,
however some experience discomfort when urinating or
have a slight vaginal discharge. If the woman is not treated,
various complications may arise. The glands in the genital
area may become very swollen and painful. The infection
may spread up the urethra to the bladder causing cystitis, a
condition where urination becomes more frequent and
painful. Inflammation of the rectum, called proctitis, is not
uncommon.
The most serious complication however, is inflammation of
the Fallopian tubes, called salpingitis. In the acute form, the
woman may have no prior symptoms before becoming
acutely ill with low abdominal pain on one or both sides,
perhaps vomiting and fever. Subacute forms involve similar
but milder attacks over several months. Menstruation may
be erratic in length of cycle and amount of flow. If not
treated a chronic state develops in which the Fallopian
tubes become twisted with scar tissue. If both tubes are
affected, complete sterility may result.

Male Symptoms
The symptoms of gonorrhea in the male are more
annoyingly obvious. At first a burning sensation may be felt
when urinating, and then a discharge of yellow pus from
the urethra is noticed. This discharge is highly infectious,
and bacteria may be carelessly transferred to the eyes. If
untreated, the infection spreads to the bladder causing
cystitis, to the semlnal vesicles, or to the epididymis. (Refer
to male anatomy). Infection of the epididymis can be very
serious, Causing a hard tender swelling in the scrotum.
When healing takes places, the scar tissue may block the
passage of sperm from the testicles, rendering the man
sterile.
In both male and female, the gonococci may reach the
blood stream and cause a form of arthritis or inflammation
of the joints. Babies born to women with gonorrhea may
develop serious eye infections.
In past, such infection was a common cause of child
blindness. Therefore as a preventive measure, the eyes of
every new born baby are treated with silver nitrate solution
or penicillin drops. Early therapy saves the child’s eyesight.
Diagnosis
Gonorrhea can be diagnosed in three ways: microscopic
examination of discharge from potentially infected organs;
use of laboratory cultures of the bacteria taken from a
discharge; and a blood test. It is important that more than
one test be taken whether or not the first has been
negative. Blood tests for gonorrhea are almost useless:
however the more accurate blood test for syphilis is often
given at the same time in case the patient may be infected
with: both diseases at once.
Treatment
Treatment of gonorrhea usually involves one or two
injections of penicillin. The dosage of penicillin has
increased over the years as various strains of the bacteria
develop a level of resistance to the drug. An example of
this, a strain of gonorrhea called Vietnam Rose, has
developed this resistance when prostitutes near military
bases attempt to protect themselves from the disease by
taking low doses of antibiotics. These drugs may not be
strong enough to kill the bacteria, and an environment is
provided in which the bacteria can adapt to varying levels
of chemical presences. Different antibiotics are constantly
being tested and tried to keep in check this ancient
scourge of mankind.

VD is just a disease. If you need
treatment, go to a doctor. You have

the right to proper medical atten-

tion, for syphilis, gonorrhea, or
any other health problem.

bibliography
The following is a highly selected bibliography of recent
medical articles. For a complete list of scientific articles and
publications referred to by this publication, please contact the
editors. Abstracts of all medical articles included in complete
list is available to groups doing research on the Pill or IUD.
General books &amp; publications
Breen, J. L. ‘‘Venereal Disease”, Symposium of Sex Education
of the College Student, Florida 1966.
Calderone, M. S. ed., Manual of Contraceptive Practice, a The
Williams &amp; Wilkins Co., Baltimore, 1964.
Charbonneau, H. &amp; Mongeau, S., Naissance Planifiees, Les
Editions du Jour, Ottawa; 1966.
Eastman, N. &amp; Hellman, L., William’s Obstetrics, Appleton
Century Crofts, N.Y., 1966.
Green, T. H., Gynecology: Essentials of Clinical Practice,
Little, Brown &amp; Co., Boston 1965.
Greenblatt, B. R. A Doctor’s Marital Guide for Patients.
Budlong Press Co., Chicago, 1964.
Guttmacher, A., Birth Control and Love, MacMillan Co.,
revised 1969.
Guttmacher, A., Pregnancy and Birth, Signer Books, N.Y.
revised 1962.
Havemann, E. Birth Control, Time-Life Books, N.Y. 1967.
King, A. &amp; Nicol, E., Venereal Disease, Cassell, London, 1964.
Kinsey, A. C. et al. eds., Sexual Behavior in the Human
Female, Pocket Books of Simon &amp; Shuster, Inc. N.Y. 1953.
Kistner, R., The Pill, Delacorte Press, N.Y 1968.
Kleinman, R. ed., Medical Handbook, International Planned
Parenthood Fed., London 1968.
Lowe, D. Abortion and the Law, Simon and Shuster, N.Y.,
1966.
Masters, W. H., &amp; Johnson, V. E., Human Sexual Response,
Little, Brown &amp; Co., Boston 1966.
Mongeau, S., Cours de Sexologie, Editions du Jour, Ottawa
1968, vols. I-IV.
Morton, R. S., Venereal Disease, Penguin Books, Great
Britain, 1966.
Neubardt, S., A Concept of Contraception, Trident Press, N.Y.
1967.
Potts, M. ed., A Guide to the Abortion Act 1967, Alra Inc.
London 1968.
Stone, A. &amp; Himes, N., (revised by Rovinsky, J.) Planned
Parenthood, Collier Books, N.Y. 1960.
Swartz, D.P. &amp; Vande Wiele, R. L., Methods of Conception
Control, Ortho Pharmaceutical Corp., N.J. 1966.
Williams, H., The Pill in New Perspective - Pregnant or Dead?
New Perspectives Publications, San Francisco, 1969.
Wood, C.; Sex and Fertility, Thames &amp; Hudson, London, 1969
Abortion
Buckle, A., Anderson, M., &amp; Loung, K., “Vacuum Aspiration of
the Uterus in Therapeutic Abortion’, Brit. Med. J., 2:456, 1970.
Cisler, Lucinda, “Abortion Reform: The New Tokenism’’,
Ramparts, vol. 9. no. 2, Aug. 1970.
Eaton, C. J. “Uterine Aspiration for Evacuation of the Pregnant
Uterus’, JAMA 207:1887, 1969.
Embrey, M., Induction of Abortion by Prostaglandins EK] and
Brit. Med. J., 2:258, 1970.
Ingram, J. “Changing Aspects of Abortion Law’, Am. J. Obst. &amp;
Gynec., 101:35, 1970.

�Population control and genocide
Ridgeway, J., ““Anti-Personnel Bomb’’. Hard Times, no. 37. June
23, 1969.
Weissman, S., “Why the population bomb is a Rockefeller: baby’.
Ramparts, vol. 8, no. 11, May 1970.
Oral contraceptives
Abraham, G.E., et. al., “Effect of a combination of norethyhodrel
and mestranol on plasma luteinizing hormone in hormal women’’.
Am. J. Obstet. Gynec., 104:1038, 1969.
Ambrus, J.L., ““Progestational agents and blood coagulation’’,
Am.J. Obstet. Gynec., 103:994, 1969.
Atkinson, E.A., et al., “Intracranial: venous thrombosis as
complication of oral contraception’. Lancet, 1:914, 1970.
Baumblatt, M.J. and Winston, F., “Pyridoxine and the Pill”. Lancet,
1:832, 1970.
Bowman, J.A., “The effect of norethindrone-mestranol on rvical
mucous’. Am. J. Obstet. Gynec., 102:1039, 1968.
Brakman, P., et. al. “Effects of different systemic contraceptives on
blood fibrinolysis’. Am. J. Obster. Gynec. 106:187, 1970.
Carbia, E., et. al., ““Colposcopic study of the uterine cervix during
administration of ethynodiol diacetate with mestranol’ Am. J.
Obster. Gynec., 102:1023, 1968.
Coburn, J., “Off the Pill?”. Ramparts, vol. 8, no. 12, June 1970.
Connell, E.B. and Kelman, C.D., “Eye examinations in patients
taking oral contraceptives’’. Fertil. Steril. 20:67, 1969.
Daniel, G.R., “Chlormadinone contraceptive withdrawn’’. Bnt.
Med. J., 1:303, 1970.
Diczfalusy, E., “Mode of action of contraceptive drugs”. Am. J.
Obstet. Gynec., 100:136, 1968.

Dickey, R.P. and Dorr, C.H., “Oral contraceptives: selection of the
proper pill’. Obstet. Gynec., 33:273, 1969.
Diddle, A.W., et al., “Oral contraceptive medications and
vulvovaginal candidiasis’. Obstet. Gynec., 34:373, 1967.
Diddle, A.W., et. al., “Oral contraceptive medications and
headache”’. Am. J. Obstet. Gynec., 105:507, 1969.
Di Paola, G., et. al., “Estrogen therapy and glucose tolerance
test”. Am. J. Obstet. Gynec., 107-124, 1970.
Djerassi, C., “Prognosis for the development of new chemical
birth-control agents’’, Science, 166:468, 1969.
Drill, V.A., | and Calhoun, D.W., “Oral contraceptives and
thromboembolic disease’. JAMA, 206:77, 1968.
Effect of oral contraceptives on serum lipids and lipoproteins’.
Lancet, 2:256, 1969.
Faust, J.M. and Tyler, E.T., “Ophthalmologic findings in patients
using oral contraceptives”. Fertil. Steril, 17:1, 1966.
‘Further doubts about oral contraceptives”. Brit. Med. J.. 1:252,
1970.
Goolden, A.W.G., et al., “Thyroid status in pregnancy and in
women taking oral contraceptives”. Lancet, 1:12, 1967.
Grant, E.C.G., “Venous effects of oral contraceptives”. Brit. Med.
J., 4:73, 1969.
Grant, E.C.G., and Pryse-Davies, J., “Effect of oral contraceptives
on depressive mood changes and on endometrial monoamine
oxidase and phosphatases”. Brit. Med. J., 3:777, 968.
Ham, J.N. and Rose, R., “Platelet adhesiveness and liporotein
lipase activity in controls and in subjects taking oral
contraceptives ’. Am. J. Obstet. Gynec., 105:628, 1969.
lHspels, A.A., “The ‘morning-after pill” - a preliminary report’’.
IPPF Med. Bull., vol. 3, no. 3, p. 6, 1969.
Hazzard, W.R., et al., “Studies on the mechanism of increased
plasma triglyceride levels induced by oral contraceptives”. New
Eng. J. Med., 280:471, 1969.
Hobel, C.J. and Mishell Jr., D.R., “Pulmonary embolism and oral
steroidal contraceptives”. Am. J. Obstet. Gynec.. 01:994, 1968

Horne, C.H.W., et al., “Effect of combined oestrogenprogestogen oral contraceptives on serum-levels of
alpha-2macroglobulin, transferrin, albumin, and IgG”. Lancet,
1:49, 19/0.
Inman, W.H.W. and Vessey, M.P., “Investigation of deaths from
pulmonary, coronary, and cerebral thrombosis and embolism in
women of child-bearing age”. Brit. Med. J., 2:193, 1968.
Jackson, M.C.N., “The committee and the Pill”. Lancet, 3:1427,
1969.
Jeffcoate, T. et al., “Puerperal thromboembolism in relation to
the inhibition of lactation by cestrogen therapy”. Bnt. Med. J.,
4:19, 1968.
Jeffcoate, T.. RCOG statement on oral contraceptives’. Brit.
Med. J., 2:293, 1970. |
Kader, M.M.A., et al., “Clinical, biochemical, and experimental
studies on lactation. Biochemical changes induced in human
milk by gestagens’”. Am. J. Obstet. Gynec., 105:978, 1969.
Kora, S.J., “Effect of oral contraceptives on lactation’’. Fertil.
Steril., 20:419, 1969.
Kreer, M. J., et al., “Idiopathic cholestasis of pregnancy. The
response to challenge with the synthetic estrogen, ethinyl
estradiol’. New Eing. J. Med., 277:1392, 1967.
Lotvin, B.R. and Berman, E., ‘““Once-a month oral
contraceptive: quinestrol and quingestanol’’. Obstet. Gynec.,
35:933 7 1970.
MacLeod, 8.C., et. al., “The oversuppression syndrome”’. Am.
J. Obstet. Gynec., 106:359, T970.
Mardell, M. and Zilva, J.F., “Effect of oral contraceptive on the
variations in serum iron during the menstrual cycle’’. Lancet,
2:1323, 1967.
Melamed, M.R., et al., “Prevalence reates of uterine cervical
carcinoma in situ for women using the diaphragm or
contraceptive oral steroids’. Brit. Med. J., 3:195, 1969.
“Metabolic effects of oral contraceptives”. Lancet, 2:783. 1969.
Mishell dr., D.R., et al., “The effect of an oral contraceptive on
thyroid function’’. Fertil. Steril., 20:335, 1969.
Oakley, C. and Somerville, J., “Oral contraceptives and
progressive pulmonary vascular disease’’. Lancet, 1:890, 1968.
O'Leary, J.A. and Spellacy, W.N., “Zinc and copper levels in
pregnant women and those taking oral contraceptives’. Am. J.
Obstet. Gynec., 103:131, 1969.
“Oral contraceptives and thromboembolism”. Lancet, 1:962.
“Oral contraceptives and hypertension”. Brit. Med. J.. 2:378,
1970.
“Oral contraceptives and alopecia’. Brit. Med. J., 1:593, 1968.
“Oral contraceptives and depression”. Brit. Med. J., 4:380,
1969.
Oral contraceptives and gestational diabetes’. Brit. Med. J.,
1:190, 1970.
“Oral contraceptives and thromboembolism”. Brit. Med. J.,
2:187, 1968.
“Oral contraceptives - choice of product”. Brit. Med. J.. 1:690,
1968.
Paola, G., et. al., “Oral contraceptives and carbohydrate
metabolism’’. An. J. Obstet. Gynec., 101:206, 1968.
‘Plasma proteins and oral contraceptives’’. ‘Lancet, 1:72.
Poland, B.J., “Conception control and embryonic development’.
Am. J. Obstet. Gynec., 106:365, 1970.
Poller, L., et al., “Effects of low-dose oral contraceptives on
blood coagulation’’. Brit. Med. J., 3:218, 1968.
Potts, D.M., “Thromboembolism and the pill - new data’. PPE
Med. Bull., vol 2, no. 4, p. 2, 1968.

“Progesterone oral contraception and blood coagulation”. Brit.
Med. J., 1:554, 1969.
Report on the Oral Contraceptives, Advisory Committee on
Obstetrics and Gynecology, FDA, 1966.
Roland, M.., et al., “Sequential endometrial alterations during one
cycle of treatment with synthetic progestagen-estrogen
compounds’. Fertil. Steril., 17:338, 1966.
Rose, D.P. and Braidman, .I.P., “Oral contraceptives, depression,
and aminoacid metabolism’’. Lancet, 1:117, 1970 Schrogie, J.J.,
“Oral contraceptives: a status report’. FDA Papers, vol. 4, no. 4,
1970.
Second Report on the Oral Contraceptives, Advisory Committee
on Obstetrics and Gynecology, FDA, 1969.
Shearman, R.P., “Investigation and treatment of amenorrhoea
developing after treatment with oral contraceptives . Lancet,
1:325, 1968.
Song, C.S., “Hormones and the liver’. The effect of estrogens,
progestine, and pregnancy on hepatile function’. Am. J. Obstet.
Gynec., 105:813, 1969.
Song, J., et. al., “Endometrial changes in women recelving oral
contraceptives”. Am. J. Obstet.” Gynec., 107:717, 1970.
Spellacy, W.N., ‘“‘Glucose, insulin, and growth hormone stuides in
long-term users of oral contraceptives’. Am. J. Obstet. Gynec.
106:173, 1970.
Thompson, D.W., “Oral contraceptives and cervical! atypia: A plea
for objective appraisal”. Canad. Med. Ass. J., 101: 285, 1969.
Vessey, M.P. and Doll, R., “Investigation of relation between use
of oral contraceptives and thromboembolic d1sease’’. Brit. Med.
J., 2:199, 1968.
Vessey, M.P. and Doll, R., “Investigation of relation between use
of oral contraceptives and thromboembolic dlsease. A further
report’’. Brit. Med. J., 2:651, 1969.
Vessey, M.P. and Weatherall, J.A.C., “Venous thromboembolic
disease and the use of oral contraceptives. A review of mortality
statistics in England and Wales’. Lancet, 2:94, 1968.
Vessey, M.P. et. al., ‘““Postoperative thromboembolism and the
use of oral contraceptives’. Brit. Med. J., 3:123, 1970.
Wynn, V. and Doar, J.W.H., “Some effects of oral contraceptives
on carbohydrate metabolism’. Lancet, 2:761, 1969.
Wynn, V., et al., “Fasting serum triglyceride, cholesterol, and
lipoprotein levels during oral contraceptive therapy”’. Lancet,
2:756, 1969.

Intrauterine Contraceptive Devices
Davis, H. J. , “The shield intrauterine device’. Am. J. Obstet.
Gynec., 106:455, 1970.
Engineer, A. D. et al., ““Chemical composition of the deposit
formed on the Lippes loop after prolonged use’’, Am. J. Obstet.
Gynec., 106:315, 1970.
Hall, R.E., “A four-year report on loop D”. Int. J. Fertil. 13:309,
1963.
Hall, R.E., “A reappraisal of intrauterine contraceptive devices
prompted by the delayed discovery of uterine perforations . Am.
J. Obstet. Gynec., 99:808, 1967.
Kar, A.B., et. al., “Effect of an intrauterine contraceptive device on
biochemical composition of uterine fluid’. Am J. Obstet. Gynec.,
101:966, 1968.
Kar, A.B., rt. al., “Effect of an intrauterine contraceptiv devite on
urea content of uterine fluid’. Am. J. .Obstet Gynic., 104:607,
1969.
Mateos-Candano, M., et. al., “Comparative study on the use of
the IUD in different socio-economic groups’. Am. J Obstet.
Gynec., 99:291, 1967.
Mishell, Jr., D.R. et. al., ‘““The intrauterine device: a bacterialogic
study of the endometrial cavity’. Am. J. Obstet Gynec., 96:119,
1966.

Morgenstern, L.L., et. al., “Observations on spermatozoa ‘n the
human uterus and oviducts in the chronic presence of intrauterine
devices’: Am. J. Obstet. Gynec., 96:114, 1966.
Ping Yen Wei, “Occurence of ectopic pregnancy In women with
IUDs and consideration of the contraceptive mechanism of the
JUD’’. Am. J. Obstet. Gynec., 102:776, 1968.
Sagiroglu, N. and Sagiroglu, E., “Biologic mode of action of the
Lippes loop in intrauterine contraception’. Am. J. Obstet. Gynec.,
106:506, 1970.
Scott, R.B., “Critical illnesses and deaths associated with
intrauterine devices’. Obstet. Gynec., 31:322, 1968.
Serr, D.M., et al., “Electrical activity of the human uterus in the
presence of intrauterine contraceptive device’. Obstet. Gynec.
35:216, 1970.
Statham, R. and Morton, R.S., “Gonorrhoea and the intrauterine
device’. Brit. Med. J., 4:623, 1968.
Tietze, C., ““Contraception with intrauterine devices’. Am. J.
Obstet. Gynec., 96:1043, 1966.
Tietze C., and Lewit, 8S., (eds), Intra-Uterine Contraceptive
Devices, Int. Congress Series no. 54, Excerpta Medica, 1962.
Willson, Jr., et. al., “The effect of an intrauterine contraceptive
device on the histologic pattern of the endometrium’’. Am. J.
Obstet. Gynec., 93:803, 1965.
Wynn, R.M., “Fine structural effects of intrauterine contraceptives
on the human endometrium’. Fertil. Steril, 19:867, 1968.

��</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="4">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="1807">
                  <text>Other publications</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="7">
          <name>Original Format</name>
          <description>The type of object, such as painting, sculpture, paper, photo, and additional data</description>
          <elementTextContainer>
            <elementText elementTextId="1803">
              <text>Paper</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="1797">
                <text>Birth Control Handbook: 4th edition (revised)</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="1798">
                <text>The Birth Control Handbook was first published in 1968 as an initiative of the Students’ Society of McGill University to disseminate information about birth control, sexual education, and reproductive justice. At the time, publishing and distributing such information was illegal under Canadian anti-obscenity law. This is the 4th edition (revised), published in August 1970 after the 1969 Omnibus Bill was passed, legalizing birth control and decriminalizing abortion. </text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="1799">
                <text>Donna Cherniak, Allan Feingold, and the Students’ Society of McGill University (SSMU)</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="1800">
                <text>The Arts and Science Undergraduate Society of McGill University</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="1801">
                <text>1970</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="1802">
                <text>PDF</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="13">
        <name>birth control</name>
      </tag>
      <tag tagId="14">
        <name>reproductive health</name>
      </tag>
      <tag tagId="15">
        <name>reproductive justice</name>
      </tag>
      <tag tagId="25">
        <name>sexual health</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="229" public="1" featured="0">
    <fileContainer>
      <file fileId="60">
        <src>https://d1y502jg6fpugt.cloudfront.net/62030/archive/files/52ac03182fc29c26fa820bda1eaa4224.pdf?Expires=1792022400&amp;Signature=av2PulJYOhkhmXRayUI64PreOZCbRkCBY-HIhlIgOUIQVVe9y3BC87PCVQDxpmjEESb8hPmb925AHgBShmROOHWyL2hjhiwOgkNquQkNc%7E7L8Yutd%7ELRtoUbthHJE8mo989qYqUKH35svdhKx2c7kcgv5DrbHyuCl5A3id0aovMuZKLcmnjx9mwVrBmLM3ayvzgL0C8K0wmZWjTcM2O03EgtgR946LEfA6S4YPoGJ52kRzFs6WSeSzAZ1QBXO29Tr0NMQIPvQ3bhizPsUh2FqyNwx-RyZsvInnf16%7EP65%7EmaEUrIfAm7pduqDnY521Q8NeICSWmeOSRUn1P2lpWuGg__&amp;Key-Pair-Id=K6UGZS9ZTDSZM</src>
        <authentication>5b0f1ce848034deb394a0e8b5631bd76</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="1921">
                    <text>February 10, 2020
mcgilldaily.com | The McGill Daily

features

11

Accessing Emergency
Contraception
An International Student’s Experience
Anonymous
content warning: mention of
OCD and skin-picking disorder

I

n the span of 36 hours, I found
out that my anti-anxiety
medication had interfered with
my hormonal birth control, that
there was a possibility that I could
be pregnant, and that I immediately
needed to get a copper intrauterine
device (IUD) inserted in my uterus
in order to prevent pregnancy.
To say that I was overwhelmed
would be an understatement –
nothing could have prepared me
for the leaps and hurdles I would
encounter while trying to get a
copper IUD inserted in the next 36
hours with McGill international
student health insurance offered
with International Student Services
(ISS). I write this guide hoping
that no one else finds themselves
in a similar situation without any
knowledge of what to expect.

(The $20 probiotics that I decided
to buy were not prescribed by a
doctor, and therefore not under the
purview of Blue Cross.) A portion of
this is reimbursable with Medavie
Blue Cross international student
insurance, but I had to pay the full
amount up front. For many, I know
this is not possible, and the fact that
our health insurance is shit (more on
that later) is unacceptable.
How it started.
Those who have been medicated
for a mental illness understand the
absolute shit show that is tapering
off medications. Antidepressants,
which I’d been on since the fall of
2019, never fully worked for me.
Yes, they reduced the chance of me
having an anxiety attack, but they
never addressed the all-consuming
compulsions that have characterized
my OCD since I was in middle
school (or my skin-peeled thumbs
– another common characteristic of
the illness). So, when my psychiatrist

Nothing could have prepared me
for the leaps and hurdles I would
encounter while trying to get a
copper IUD inserted in the next 36
hours with McGill international
student health insurance offered with
International Student Services (ISS).
I was, and am, immensely
privileged in that I had the funds
necessary to pursue this route, as
well as a good support network
around me. Between the doctor
consultation, the IUD itself,
antibiotics, probiotics, and the
gynecologist visit: it cost $435, $300
of which had to be provided in cash.

in the United States prescribed me
a mood stabilizer that she thought
would improve my condition –
without the side effects I dealt with
on antidepressants – I was hopeful.
I followed her instructions,
lowering my dosage of the
antidepressant
fluvoxamine.
I
began taking the mood stabilizer

IUD Receipt

oxcarbazepine late Friday night.
I took it again Saturday night. On
Sunday morning, when I decided to
search up the medication online, just
for the heck of it, my heart fucking
flipped – oxcarbazepine was known
to interfere with hormonal birth
control pills.
For many reasons, the burden
of preventing pregnancy usually
falls on the person with a uterus in
sexual relationships where semen
is also involved. Yes, people with
penises can wear condoms, but they
aren’t completely foolproof. And
while clinical trials for hormonal
contraceptives made for people
with penises are ongoing, they are
not yet available to the public. So,
many people with uteruses take on
the responsibility of using a form of
hormonal birth control, all of which
come with numerous side effects.
The pill can cause depression,
migraines, and increase your risk of
blood clotting (while the pill was in
its early stages of development, the
dosage of estrogen within the pills
was much too high, and 11 people
taking it died from blood clots). The
implant can cause users to experience
long-term bleeding; the shot can also
cause long-term bleeding, as well
as depression and nausea; and the
IUD, though extremely effective, is
fucking painful to insert.
The best type of birth control
for me had been the pill – I hadn’t
experienced the worst of its side
effects, and I was good at taking it
on time every day. In the past, I had
thought about getting a hormonal
IUD but decided against it, as I was
scared and uncomfortable at the
thought of the insertion procedure.
But once I found out that there was
a possibility I could be pregnant, my
comfort was the least of my worries.
I was willing to sacrifice anything
to ensure I wasn’t pregnant, and
honestly, I’ve always been pretty
open about the fact that I would
definitely get an abortion if I found
out I was.
Making a next-day appointment.
I spent that Sunday talking to
pharmacists, first at the Jean Coutu
on Parc Ave. at 8 a.m. to make sure
there definitely was an interaction
(there was), then calling the CVS
back home to confirm at 9 a.m., and
finally at the Jean Coutu on Saint
Catherine Street West around 10
a.m. where I tried to buy Plan B.
The
pharmacist
there
recommended I didn’t buy an
emergency contraceptive pill, and
I think they were right to do so. I

Phone records
had had sex twice in the past seven
days, once on the Monday prior, and
once that Wednesday. Although I
had been absolutely protected by
the pill at that time, it was unclear
if it would still protect me, given the
fact I’d taken interfering medication
twice in the past 48 hours, and that
condoms are not always effective.
To be completely sure I had not
conceived, they recommended that I
get the copper IUD.
Some may not know that the
copper IUD is the most effective
method of emergency contraception
out there, lowering one’s chances
of getting pregnant by 99.9 per
cent if inserted within five days
of unprotected sex. While oral
emergency contraceptives may be
preferable due to their non-invasive
nature, they only work well up to
three or five days after unprotected
sex, depending on whether you take
the pill with levonorgestrel, also
known as “Plan B,” “the morning
after pill,” etc., or the one with
ulipristal acetate, also known as
“ella,” respectively. Meanwhile, a
copper IUD can prevent pregnancy
up to seven days after unprotected
sex (though Planned Parenthood’s
website says up to five days).

However, a barrier against getting
the copper IUD is that it’s more
expensive than oral emergency
contraceptives, which cost around
$20-$30 (at least in Quebec) when
your insurance doesn’t cover them.
And it’s important to note that
emergency oral contraceptives are
not covered under ISS, while IUDs

A barrier
against getting
the copper IUD
is that it’s more
expensive than
oral emergency
contraceptives,
which cost
around $20-$30
[...] when your
insurance doesn’t
cover them.

�12

features

February 10, 2020
mcgilldaily.com | The McGill Daily

are – albeit only up to $50. Once
I get reimbursed from Blue Cross,
I will have, in effect, paid $35 for
the IUD, as it cost $85 upfront,
which is still more expensive
than Plan B, but only by $5-$15.
The copper IUD can then be used
as contraception for up to five
years, which can save you money
in the long run – Blue Cross only
covered 80 per cent of my roughly
$25 monthly pack of pills.
I was undoubtedly scared of
getting an IUD. But the idea of
being pregnant was scarier.
Trying to find a place that could
insert it on Monday, the next day,
I made calls to at least 10 different
clinics. I was on hold with 811,
trying to talk to an Englishspeaking nurse, for more than 45
minutes. I spent almost an hour
and a half in total on the phone,
trying to find a clinic that could
schedule me in for a same-day
appointment.

Initial Costs:
octor consultation
IUD insertion: $100
IUD: $85
nti iotics
ro iotic
otal cost
u ront

not an option – I had had sex the
Monday night prior. Although the
first place I called was full, I asked
for a recommendation for another
clinic offering same-day insertion,

[Clinique Médicale MaisonneuveRosemont] – as well as many other
clinics shown online through the
Quebec government’s website – do
not display a great deal of information
regarding their services online, and
callin the to con r what the
offer is o ten necessar
When I finally did get off hold
and talk to a nurse at 811, they
were actually pretty helpful. I
was given a list of clinics nearby
that offered same- or next-day
copper IUD insertion, and I called
one asking for an appointment on
Monday morning. Tuesday was

and I was able to schedule an
appointment at Clinique Médicale
Maisonneuve-Rosemont
for
Monday morning at 9 a.m. I could
finally breathe.
Clinique Médicale MaisonneuveRosemont is an interesting place.
Located in a building with multiple

Doctor’s Appointment Receipt

medical offices and a Familiprix,
the clinic takes requests for sameday and next-day appointments
both online and via phone. Since
I did not have a RAMQ (Quebec
health insurance card), I could not
register for a walk-in appointment
online, but I was able to book an
appointment by calling the front
desk at 514-257-7000.
This clinic – as well as many
other clinics shown online
through the Quebec government’s
website – do not display a great
deal of information regarding
their services online, and calling
them to confirm what they offer
is often necessary. The clinics
shown online via the Quebec
government’s website are in
French, and Google Translate is, of
course, not always the best. I made
do with Google and my (limited)
French, but if there is someone
you trust who knows French well,
ask them for help. It will make the
whole process so much easier.
Other clinics I was recommended
in Montreal include Clinique
angus (they take calls for walkin appointments the next day
beginning at 5 p.m., but if you’re
an international student like me,
call their regular number at 514807-2333); Clinique en route - gare
centrale (the nurse informed me that
they would take calls for walk-ins
beginning at 7 a.m. on Monday, 514954-1444); and Clinique médicale
des 2 tours (which you can call for
a walk-in appointment the next day
beginning at 6 p.m., 514-954-4444).
The insertion procedure.
I woke up early Monday morning,
nerves racing in anticipation of
the procedure (It was probably
also a result of not having taken
any medication for my anxiety
the night before). Unmedicated
and scared, my boyfriend drove
me 25 minutes from the McGill
area to the clinic, located near the
Olympic stadium. We parked, he
held my hand, and we found the
clinic inside the medical complex.
Like the receptionist had said,
it was located at the end of the
hallway, on the right – bureau 60.

Reimbursements:
octor consultation
IUD insertion:$100
IUD: $50
nti iotics
Probotic: $0
Cost post-reimbursement:

I brought with me everything I
could possibly think of needing –
Advil, a water bottle, my passport
and IDs, a printed out copy of my
insurance card, my debit card,
and $200. Because of the type of
insurance I had, the receptionist
told me on the phone earlier that
I’d need to pay upfront in cash,
and get reimbursed by Blue Cross
later. I stumbled in at the front
desk, speaking a mix of English
and (extremely) limited French.
Sitting with my boyfriend in
the clinic, we waited about 10
minutes until a nurse called us in.

I made calls to at
least
different
clinics was on
hold with 811,
trying to talk to an
English-speaking
nurse, for more
than
inutes
I spent almost an
hour and a half
in total on the
hone
This was probably the most
confusing part – although the
clinic says online that they offer
services in both French and
English, some who work there do
not speak the latter. With the help
of my boyfriend (who knows more
French than I do), and another
nurse, we were fortunately able
to convey the reason I was there
and the situation I was in, and
they sent me to a different room
in the clinic where we waited for
a doctor.
After relaying the days I
had had sex and when I began
oxcarbazepine, the doctor agreed

that a copper IUD would work for
me as emergency contraception.
I was lucky, they said, because
the gynecologist that performed
insertions was in today. After
giving me a prescription for the
Mona Lisa copper IUD, a receipt
for my insurance company, and a
card displaying the location of the
gynecologist’s office – just upstairs
in the same medical complex –
they sent me along to Familiprix
to buy the contraceptive itself
(which was about $85). This
hadn’t been a part of my initial
calculations, and when I used my
Canadian debit card to pay for
it, I couldn’t purchase it – most
likely due to the daily purchase
limit on my account. (So if you’re
ever in my position, it’d be a good
idea to check your account limits
– I ended up needing to use my
American card.)
We took the elevator to the
third floor, and I explained my
situation, once again, to the
receptionist. They had to confirm
with the clinic downstairs, but
after they did, they penciled me
in for an appointment. It was a
small room, filled with families
waiting to see the doctor. About
30 minutes after I sat down, the
gynecologist called me in.
My boyfriend and I sat in the
two chairs in front of their desk.
The gynecologist unwrapped the
box and explained the different
parts of the IUD to me, telling me
that before the procedure, I would
have to be swabbed and tested
for gonorrhea and chlamydia –
apparently if you insert an IUD
and have those STIs, it’s not
good. I would also have to take
antibiotics to treat gonorrhea and
chlamydia, regardless of what the
test results were, just in case.
I felt lucky; the gynecologist
said they’d never performed
an insertion that resulted in
infection, and that they’d done
this procedure for awhile. Before
I knew it, I was lying down on the
table, my feet in stirrups, tightly
squeezing my boyfriend’s hand.
I’m not going to lie, it hurt pretty
bad. Apparently if you’ve never

�features

given birth before it hurts more,
and I certainly hadn’t. The worst
moment was when they pinched
my cervix, which is necessary
in order to insert the IUD into
my uterus. It felt like an instant,
intense period cramp, and I was
in pain. I’d told myself I’d try not
to scream during the procedure,
but it fucking hurt at that point.

Because of
the type of
insurance I had,
the receptionist
told me on the
phone earlier that
I’d need to pay
[$200] upfront
in cash, and get
reimbursed by
Blue Cross later.
Fortunately, it’s a pretty short
procedure, all done in about two
minutes (though it felt like forever
in the moment). I lay on the bed for
a minute or two, trying to gather
my sense of self. A bit of blood had
stained the bed I was laying on. I’ve
always had low iron, and for the
whole hour after the procedure, I
felt extremely nauseous. I ended
up sitting outside the office on the
ground with my head between my
knees while my boyfriend paid the
appointment fee – $100 in cash.
We then went back to Familiprix
to fill a prescription – antibiotics
for gonorrhea and chlamydia
($30), and, as my boyfriend
recommended, we bought some
probiotics ($20). That turned out
to be a really good decision; the
antibiotics absolutely destroyed
my digestive system. I can’t tell you

February 10, 2020
mcgilldaily.com | The McGill Daily

13

how much I shit the following days.
I don’t want my story to make
you think everyone will have
a terrible experience getting
an IUD. People’s bodies react
in different ways; for some it’s
easier, for some it’s more difficult.
I’ve heard that some can even go
back to work right afterwards.
Needless to say, that was
not the case for me. While my
experience wasn’t completely
terrible, it was more painful than
I expected. I had to stay home for
the next two days, and the cramps
and shits got intense. I won’t go
into detail, but I’m sure you can
imagine. What helped me most
was the probiotics, taking two
Advil every eight hours, and a hot
water bottle. If you don’t have
one, take an old, clean sock and
fill it with rice. Then heat it up
in the microwave for 30 seconds;
it will feel – and work – the same
as the hot water bottle you buy at
the pharmacy.
The aftermath.
I
stopped
spotting
and
experiencing cramps roughly a
week after the procedure. I’m
supposed to take a pregnancy
test approximately two to three
weeks after the IUD insertion to
make sure I didn’t conceive. (If
you don’t want to wait until your
next scheduled period to take a
pregnancy test, you can take one
7-14 days after having sex – but it
may not be as accurate as if you
wait until the week your period
is supposed to start.) And in two
months, I have an appointment
back at the gynecologist for them
to check up on my IUD. The
cramps have subsided for the
moment, but we’ll see how my
first period with a copper IUD
goes; many people using this
form of birth control report heavy
cramps and bleeding, as well as
irregular periods.
When I tried to have my
expenses reimbursed, the Medavie
Blue Cross office on McGill

chlamydia antibiotics, they were
each reimbursed by 80 per cent.
Together, they cost approximately
$30, and Blue Cross says they will
pay $25 for it. All in all, Blue Cross
will pay $280 out of the $415 total
expenses (excluding the probiotics).
According to VP Finance Samuel
Haward, both he and the SSMU
Mental Health Commissioner have
met with the directors of ISS and
Student Services to discuss the
review of international student
health insurance and negotiate a
new plan with Blue Cross. Haward
stated that student associations have
little control over the plan, and that
it is under the purview of Senate and
Procurement Services. Fortunately,
this review may be happening
sooner rather than later – it is set to
occur in 2020-2021.
As
international
student
Antibiotics Receipt
insurance is set to be reviewed,
College Avenue informed me that alternatives – one hormonal I implore both Senate and
Services
to
they do reimbursements online intrauterine system (IUS) in Procurement
and via their mobile app now –
not in person. I used to be able
to walk to their location next to
Dormez-Vous on Sherbrooke and
get my birth control prescriptions
reimbursed there, but that
location closed in November 2019.
As it takes five to seven business
days for the claim to be processed,
I found out five days after I
submitted my claim exactly how
much I would be reimbursed.
The approximately $415 in
prescriptions and doctors visits
that I submitted to Blue Cross,
as I suspected, was not entirely
reimbursable. While the visit
to the gynecologist ($100) was Quebec costs around $325, consider the extensive barriers
completely covered, the initial meaning that an international that international students face
doctor consultation was not – I student who purchases one may under this current plan. Upfront
especially
unexpected
paid $200 in cash for it, and Blue still have to pay around $275 for costs,
Cross says they will cover $106.20 it after getting reimbursed – it ones paid in times of emergency,
of it. As I mentioned earlier, for is still a barrier, and even more disproportionately affect lowerthe copper IUD itself, they only so if one wishes to purchase the income students. If someone who
cover $50 in IUD purchases hormonal IUS. (And especially is in my position is not able to pay
(meaning I will have paid $35 for considering the fact that these these costs, there is the possibility
that they could become pregnant,
it). While $35 for a copper IUD is costs had to be paid upfront.)
As for the gonorrhea and and that is unacceptable.
not as expensive as the hormonal

I implore both Senate and
Procurement Services to consider the
extensive barriers that international
students face under this current plan.
Upfront costs, especially unexpected
ones paid in times of emergency,
dis ro ortionatel affect
lower-income students.

IUD Insertion Reciept

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="2">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="1805">
                  <text>Coverage from The McGill Daily</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="7">
          <name>Original Format</name>
          <description>The type of object, such as painting, sculpture, paper, photo, and additional data</description>
          <elementTextContainer>
            <elementText elementTextId="1928">
              <text>Paper</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Volume</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="1929">
              <text>109</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Issue</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="1930">
              <text>17</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="55">
          <name>Page Number(s)</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="1931">
              <text>11-13</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="1922">
                <text>Accessing Emergency Contraception</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="1923">
                <text>A feature article describing an international student's experiencing accessing emergency contraception and dealing with McGill's international student health insurance.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="1924">
                <text>Anonymous</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="1925">
                <text>The McGill Daily</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="1926">
                <text>2020/02/10</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="1927">
                <text>PDF</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="13">
        <name>birth control</name>
      </tag>
      <tag tagId="14">
        <name>reproductive health</name>
      </tag>
      <tag tagId="12">
        <name>student health</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="452" public="1" featured="0">
    <fileContainer>
      <file fileId="286">
        <src>https://d1y502jg6fpugt.cloudfront.net/62030/archive/files/5c55bd21a8508480cdf75c14f8086d72.pdf?Expires=1792022400&amp;Signature=OR3qDulHDFXLUCX85XR23aFQkG%7E92P77iMVbqlmEVDE8qr3ktEpp3gvBQOuRkM5qOENPnHOYvAGhAMgSo8xlvKbOS-IdwK4NH7kVLTeYABbE9tTPCeN23Evd3LnC9aF%7Eyd2dh4l-ggSsB1OmBCo1knbnLccNifmX9ILZIih3eXgqhc9Rf3p76jccD4f6ZrmsMQJk0VUuD1tLvB0euQGMMAufVlMrGU6fZ16jZrc%7EgZwLuF9t77w4qCUsW3k37Z7TjlIjghP1nLxM9UG9dLtfLcPiYLtgFtfas2pLZl%7EkkwJJehfBS921YEVMld6SixKA1PzK9cgbYnnjIaBjXuPNKg__&amp;Key-Pair-Id=K6UGZS9ZTDSZM</src>
        <authentication>4c09939b9a209edd2ad7335f6e598c96</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="4280">
                    <text>14

Features

The McGill Daily • Monday, March 17, 2008

15

“

Hormonal birth control
is no longer an option, and
never will be again in my life.
– Laura McMahon,
U3 Philosophy and English

Ming Lin / The McGill Daily

The
new

pill politics
“A

lesse made me stop wanting sex.”
This is scrawled in black Sharpie
on an advertisement for the popular
brand of birth control, in a stall of a women’s
washroom in Redpath Library. Simple and
shocking, it hints at the contradictions that
surround women’s attempts to control their
fertility. Why does a drug that allows women
to have sex without fear of pregnancy also
potentially inhibit their desire to do so?
Laura McMahon, a U3 Philosophy and
English major, has a horror story about Alesse.
She credits this pill with what she calls a “completely, all-consuming bout of depression”
which lasted for an entire year of high school.
“It never occurred to anyone – not my
mom, my boyfriend, my friends, or even my
therapist – that there was a link between my
taking the Pill and my depression,” she says.
The malaise temporarily ended McMahon’s

relationship, caused problems with her friends,
and left her feeling somehow inadequate.
Only through a combination of travel, new
circumstances, and, most significantly, using a
different form of contraception, did McMahon
manage to fight the depression and get back
on her feet.
Today, McMahon resolutely says that “[hormonal] birth control is no longer an option,
and never will be again in my life.”
Yet McMahon’s story, as well as that of the
anonymous bathroom scribe, are just two
among many. Birth control is intrinsically
linked with the “free love” movement of the
sixties, second-wave feminism, and women’s
liberation. While some women rely on chemical or hormonal forms of birth control, such
as the Pill or the patch, others rely primarily
on barrier methods, namely condoms or diaphragms.

Naomi Lightman examines the
troubling past and alarming
side effects of the contraceptive
that changed the world

Many women experience only positive benefits from hormonal forms of fertility control.
However, a growing minority of women and
men are now emphasizing the need for more
vigorous debate surrounding the Pill’s safety,
distribution, and efficacy.
Underlying this is an understandable fear
that criticism of the Pill necessarily labels one
as anti-sex, anti-feminist, or paternalistic. But
this concern only contributes to the lack of
critical analysis and discussion. Birth control
options must be located within their broader
social and political context, where misogyny,
heteronormism, and corporate interests often
outweigh the needs of individual women.

A troubling genesis
“The Pill has a really deplorable history
in terms of eugenics,” says Jocelyn Porter,

who works as a Health Animator at Head and
Hands, a not-for-profit organization in NDG
that promotes the physical and mental wellbeing of youth.
Porter emphasizes that birth control has
been tested primarily on marginalized populations, who had very little control over the
process. Significantly, most trials for contraception drugs were done in poor, “underdeveloped” nations in the global South. The Pill,
for example, was tested most extensively on
thousands of poor women in Puerto Rico in
1956 before it was approved for use in the
United States in 1960.
Norplant, a long-lasting birth control
implant (which was discontinued in the U.S.
and Canada in 2002) was tested on women in
Chile in 1972. Depo-Provera, which uses trimonthly injections of progesterone, was tested
for decades on Mexican and Thai women to

establish whether it was acceptable for use by
North Americans. Native American women,
especially those with mental disabilities, were
also used as test subjects by Depo-Provera.
“Not only were impoverished women in
developing nations used as guinea pigs, but if
we look at where it’s been given out for free or
for really cheap, it’s also tinged with racism,”
says Porter, adding that sometimes injections
of Norplant were tied to welfare benefits in
poor, primarily black areas of the U.S.
Margaret Sanger, founder of the American
Birth Control League (which eventually became
Planned Parenthood), is often considered the
original spokesperson for birth control. While
Sanger’s goal of introducing a simple, widely
accessible, and cost-effective pill form of birth
control was admirable, she was also a eugenics
proponent. This movement aimed to decrease
the fertility rate among genetically “disadvantaged” populations.
“Birth control was marketed as a way of
controlling the ‘population of the unfit,’ like
poor ethnic populations,” Porter says.
Sanger fed off white, upper-middle class
fears about a “race suicide” of the “fit,” and
uncontrollable population growth of the
“unfit.” Those who promoted the Pill and
other hormonal methods of contraception
used them to curtail specific populations.
Today, this history is not common knowledge. While it is unlikely to affect women’s
present-day fertility choices, it is important to
acknowledge the racist and classist origins of
birth control drugs.

Where are the teachers?
Many women recall going to the doctor to
discuss birth control for the first time, feeling
rushed and uncomfortable, as if taking the Pill
was really the only viable option.
“You go in there, you’re young, and you’re
usually scared because something is wrong,”
says Anna Feigenbaum, a McGill graduate
student and an instructor in Communication
Studies.
“They [doctors] think you’re stupid and
incapable of using any form of birth control
that is non-chemical, and you don’t think to
question it unless you start feeling sick.”
Feigenbaum herself recalls lasting on the
Pill for only six months until she became ill,
and says that “the whole time I was on it I was
a total nutcase.”
Optimally, women would learn in high
school – in a relatively neutral, non-judgemental manner – about the array of birth control
options and then make informed decisions
for themselves. However, according to recent
McGill Arts graduate Theresa Howard, sex
education in North American schools often
falls short.
Howard’s undergraduate thesis was entitled

“Learning About Birth Control: The Challenges
and Opportunities.” In it, she interviewed 12
McGill students about how they had learned
about birth control.
“A lot of women felt like their doctor and
teachers didn’t have enough time, or weren’t
willing to give them enough time, to sit down
and really go through the different options,”
Howard says. As a result, she found that
women often value information from their
peers over that of medical professionals or
educators.
Formal sexual health education in Canadian
schools began in the early 20th century due to
anxieties about venereal disease. In the 1960s,
curriculums adjusted to address the rising
rates of unplanned pregnancies, while in the
1980s they began to concentrate on the growing AIDS crisis.
While many Canadian schools currently
do offer comprehensive sexual health education, including instruction on different birth
control methods, studies consistently report
that these programs are deficient. One study
discovered that only 15.5 per cent of Bachelor
of Education programs at Canadian universities had mandatory sex-ed training, and 26.2
per cent had optional sex-ed courses.
Additionally, due to severe cuts to social
programs and education budgets, the quality – as well as the very survival – of sexual
health programs is threatened across Canada.
In Quebec, sex education was essentially cut
from high schools in 2005. This came at a time
when the rates of sexually transmitted infections (STIs) were – and remain – alarmingly
high among Canadian youth.
Overall, Feigenbaum says that, even among
university-aged people, there is an information gap concerning non-hormonal birth control options. This is coupled with what she
calls a “complaining discourse” surrounding
condoms, forcing a heteronormative focus on
penetrative sex.
“There are limited alternative information
sources, particularly ones that have funding
and infrastructure,” she laments. “It’s time to
expand our definitions of sex.”

Medicalizing bodies
Despite these misgivings, the Pill remains
the most widely-used method of birth control
for women under 30. Just the fact that we refer
to this hormonal contraceptive as “the Pill,”
when there are countless other tablets and
capsules, is indicative of its dominance in public discourse about contraception.
The known list of hormonal birth control’s potential side effects range from minor
to fatal, including depression, weight fluctuations, decreased libido, and a risk of blood
clots for smokers. However, as a relatively new
drug, long-term side effects of the Pill are dif-

ficult to determine. They will only begin to
be revealed as the first generation of users
develop symptoms. Troublingly, there have
been almost no long-term controlled research
trials on the Pill.
Hormonal oral contraceptives put the
entire onus of birth control on women. While
this is reassuring for many, it also completely
eliminates any male accountability. As a consequence, it becomes women’s sole responsibility to obtain, pay for, and take the Pill – as
well as to suffer its physical or emotional side
effects.
Sam Mackenzie, a researcher at Douglas
Hospital and a McGill Neuroscience graduate,
says he has “serious reservations” about hormonal forms of birth control.
Mackenzie’s concerns began during a
course on endocrinology, the study of hormones in the brain. He learned that levels
of estrogen naturally fluctuate in a woman’s
body, but that hormonal birth control eliminates these fluctuations.
“It can lead to really elevated levels of estrogen across the entire cycle,” he says, explaining that estrogen plays a role in the serotonin
level and in memory. “So if there’s a natural
cycle, it gives me pause to tinker with that....
I’m not convinced that the Pill has no effect on
the long-term health of those systems.”
However, Howard says she hesitates to use
the word “natural” in discussions on birth
control. “That word gets thrown around a lot.
People will say that something is ‘natural’ and
therefore it’s the way it’s supposed to be.”
Yet Howard also admits to having doubts
about chemically controlling women’s menstrual cycles. “I do think [hormonal birth
control] is not the right choice for everyone,”
she says.

Conflicts of interest
For those hoping for better choices in the
future, research and development (R&amp;D) on
alternative, safer oral contraceptives has been
lacking. This is likely because of cost and
potential liabilities. Many pharmaceutical companies have completely withdrawn from R&amp;D
in pregnancy prevention, focusing instead on
marketing.
As a result, most recent industry-funded
research only focuses on improving existing
methods. For example, the patch and the ring
both release the same hormones as the Pill
into the bloodstream, via the skin, or in the
case of the latter, the vaginal wall.
“It seems like they’re always coming up
with something new, but it’s always a variation
on the same thing,” says Porter. She also notes
that non-contraceptive benefits of hormonal
birth control, such as acne treatment or relief
of menstrual cramps, are also often used to
lure younger users.

Additionally, birth control pamphlets and
guides for selecting the right contraception
are often sponsored by Pill manufacturers,
who have a vested interest in women “choosing” what they sell. These guides also often
frame the Pill as “the” contraceptive.
“These supposed information pamphlets
are actually advertisements,” says Howard.
“And birth control pills are also sometimes
given free to doctors by pharmaceutical companies as a promotion. This can influence
what doctors prescribe, either because the
product has been really sold to them by the
company, or because that’s just what they happen to have on hand.”
Feigenbaum notes that sometimes doctors
who are quoted in these information sources
are also on the boards of the pharmaceutical
companies that make the product, or in some
way connected to their payroll, as a type of
conflict-of-interest.
“Of course, it won’t say that when you
open up your web page,” she says. “It’ll just
say, ‘Great new drug for you,’ with doctor recommendations. Then, it turns out – through
usually not too many clicks – that the doctor
works for the lab.”
Overall, critics argue that pharmaceutical
companies are consciously drawing attention
away from non-medical methods of contraception. “It takes attention away from barrier
methods which have the highest efficacy-tosafety ratio, and I think are really fantastic,”
says Porter.

Healthy skepticism
It’s clear that every woman ought to have
the option of using oral contraceptives and
other hormonal forms of birth control if she
so desires, and at reasonable cost.
However, the consensus seems to be that a
healthy degree of skepticism is warranted concerning safety, and there need to be unbiased
information sources readily available about
alternative methods.
McMahon argues that we can no longer pass
the Pill off “as something totally normal and
benign.” For herself, she says she has learned
over time which condoms work best for her and
afford the maximum pleasure and safety.
“I’d way rather take real, visible, and exterior precautions on principle,” she says.
However, Avital Oretsky, U0 Arts, has been
on the Pill for almost two years and has not
experienced any negative side effects, besides
initial nausea. Oretsky says she is happy with
the Pill, and plans to stay on it for the foreseeable future. However, she too admits to a
certain degree of uncertainty.
“I’m still kind of unsure about how I feel
about it,” she says, “even though all doctors
reassure you that it’s totally safe and fine for
your body.”

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="2">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="1805">
                  <text>Coverage from The McGill Daily</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="7">
          <name>Original Format</name>
          <description>The type of object, such as painting, sculpture, paper, photo, and additional data</description>
          <elementTextContainer>
            <elementText elementTextId="4288">
              <text>PDF</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Volume</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="4289">
              <text>97</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Issue</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="4290">
              <text>42</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="55">
          <name>Page Number(s)</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="4291">
              <text>14-15</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="4281">
                <text>The new pill politics</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="4282">
                <text>A feature about the history of oral contraception.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="4283">
                <text>Naomi Lightman</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="4284">
                <text>The McGill Daily</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="4285">
                <text>2008/03/17</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="4286">
                <text>PDF</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="44">
            <name>Language</name>
            <description>A language of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="4287">
                <text>English</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="13">
        <name>birth control</name>
      </tag>
      <tag tagId="59">
        <name>racism</name>
      </tag>
      <tag tagId="14">
        <name>reproductive health</name>
      </tag>
      <tag tagId="15">
        <name>reproductive justice</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="595" public="1" featured="0">
    <fileContainer>
      <file fileId="552">
        <src>https://d1y502jg6fpugt.cloudfront.net/62030/archive/files/69e9c81fe202eb88baea8d0f96cb317e.pdf?Expires=1792022400&amp;Signature=cM2bKo4nXA-7ndcdIiiRb9YCIuulDnzThSCxALo5zMhFGqZwW0hEYxwraVv%7EZ4lNKLTjfcNLKGyWTyLOVchSps9D4az-WEu7Q22jWdQ6Mcq8fBy2cS3e2TKlAGngyIm5mn9-mTwJAOrcXdCZDE-j9jygjIeh9ZpZhkf9uPX9HiqAbt9krzMQBY232yJn6w1ZSo48dE5NrPETVaeLsRo-CWZA-1Du1FfTFFQIGr5V2CsDu%7EZpIIo2yiMdE61BVjJWDJaWCOcW%7EDv5xZnx3zD8R5Z5GEyV2wIJPJZgNU3M6U%7EpqZj6C9vffE7JbTsiUD%7EHJFJlETdvtmCACuQQbVThfQ__&amp;Key-Pair-Id=K6UGZS9ZTDSZM</src>
        <authentication>8643d0d1f229a025b3847050e5cfc51d</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="7499">
                    <text>délit | 29 janvier 2008
02 xle
www.delitfrancais.com

Nouvelles

Des radicaux à McGill
La bibliothèque de McGill offre un
regard sur les périodiques radicaux des
années 1970.
campus
Louis St-Aimé
Le Délit

M

ercredi soir dernier à la
bibliothèque McLennan
avait lieu le vernissage de
l’exposition Québec Alternative, présentée conjointement par Media@
McGill et la Division des livres rares
et des collections spécialisées de la
bibliothèque de l’Université McGill.
Le matériel exposé provient directement de la collection personnelle de
Marc Raboy, professeur d’éthique,
média et communication à McGill.
«Ce n’est pas de la nostalgie. Ce n’est
pas un regard sur un moment qui est
disparu et oublié. [...] C’est de l’histoire, mais ça porte avant tout sur le
pouvoir de la communication», a-t-il
expliqué lors du discours d’ouver-

ture, auquel ont assisté plusieurs
membres de la presse radicale montréalaise. Le docteur Raboy avait fait
don de sa collection privée à la bibliothèque pour en permettre l’accès
aux chercheurs contemporains et futurs. «Il y a [des revues] qui reflètent
des moments historiques et d’autres
qui traitent des enjeux qui sont encore d’actualité», a-t-il précisé lors de
son discours.
Un point de vue essentiel; un
message optimiste
«Les médias et les médias alternatifs sont essentiels», a jugé
Jonathan Sterne, professeur associé
du Département de l’histoire de
l’art et des études en communication, au commencement de la soirée. Un propos qui trouve écho chez
Marc Raboy: «Il y a là-dedans quelque chose d’universel. [...] L’intérêt
est que cela se passe maintenant à

l’échelle globale. Le message à retenir
est que ‘vous pouvez communiquer’,
a-t-il dit au Délit. Et les résultats sont
durables». Il a cité en exemple la pièce d’exposition Birth Control Handbook
publiée par le groupe Médecine Pour
Tous il y a une quarantaine d’années, à l’époque où cette information n’était pas disponible et où les
consultations médicales n’étaient pas
gratuites: «Aujourd’hui, on ne remet
pas en question [la raison d’être de
ces publications]. Ce qui a commencé en marge de la société est progressivement devenu normal».
Dans les deux présentoirs de
verre qui abritent l’exposition étaient
aussi mis en évidence des revues périodiques, des calendriers activistes
et d’autres publications portant des
noms tels que Le temps fou, La vie en
rose et Québécoises deboutte!.
Rompre avec la tradition?
Le Délit a demandé à Allison
Flynn, membre du bureau des relations médiatiques de McGill, s’il
n’était pas inhabituel dans cette université de réputation conservatrice de

Marc Raboy discute avec des invités lors du lancement de l’exposition.
Éric Chevalier

manifester une telle reconnaissance
envers des éléments contestataires
de la société. «Tout à fait, a-t-elle répondu en riant. Mais c’est une très
bonne initiative visant à présenter
les médias d’une autre génération.
Même si on n’était pas impliqués
dans l’organisation de l’événement,
on tenait à le publiciser et à le faire
connaître aux gens». La plupart des
visiteurs interrogés mercredi soir se
sont dits satisfaits de l’exposition. Au
moins un curieux, cependant, en est
sorti déçu: «Les présentations orales
étaient intéressantes, mais l’exposi-

tion ‘est morte’. Les présentateurs
ont rappelé que les gens doivent
s’investir pour faire bouger les choses. Alors c’est plutôt paradoxal de
s’extasier sur ces revues radicales enfermées dans de vieux pupitres. C’est
bien que [les organisateurs] hiérarchisent ces publications, mais l’exposition est trop pauvre», s’est lamenté
au Délit ce visiteur qui a préféré demeurer anonyme. x
L’exposition Québec Alternative est
présentée jusqu’au 30 mars au 4e étage
de la Bibliothèque McLennan.

Une formation d’avenir

Téléphone : 418 654-2500
Sans frais : 1 877 326-5762

www.inrs.ca

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="10">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3753">
                  <text>Coverage from Le Délit</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="53">
          <name>Volume</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="5865">
              <text>97</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Issue</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="5866">
              <text>2</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="55">
          <name>Page Number(s)</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="5869">
              <text>2</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="7">
          <name>Original Format</name>
          <description>The type of object, such as painting, sculpture, paper, photo, and additional data</description>
          <elementTextContainer>
            <elementText elementTextId="5871">
              <text>PDF</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="5864">
                <text>2008-01-29</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="5867">
                <text>Des radicaux à McGill</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="5868">
                <text>Louis St-Aimé</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="5870">
                <text>PDF</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="5872">
                <text>Le Délit</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="5873">
                <text>Coverage of an exhibit in McLennan Library showcasing radical media from the 1970s.</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="13">
        <name>birth control</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="772" public="1" featured="0">
    <fileContainer>
      <file fileId="688">
        <src>https://d1y502jg6fpugt.cloudfront.net/62030/archive/files/e0e3935df9b36de84b6a95aa47d95dee.pdf?Expires=1792022400&amp;Signature=vP0cv%7EVmwfEUvTatxDwPKN-mPbthkxq3ZV5bO6Dgws5KoeavhaOdSd1MLsofQdPqBcxJWHWb%7EWor3M7RmsHZ4cJcMHm03gM6CbrnYR85hcbwQGd3h1z%7ERdtODx46fiV7bvBIzX5WiCkSS%7EvtlNZzS1UPbFV-JmEZ%7EgNdBNEW7P3nPs4HXRj9MH5D9uX8Y6NBKb0DWQ4nLxtOS6k1hxr8K1EYfJOxgO2jFcbuRp-V0rjssIscYIhlE6jAMueGEU%7E-fTaUh-je0llD04GdG-s7-MWbLi6%7Eqlqm8Yaa82QK0OORkkE2%7EprliAbgFFfDj3Qu3krxvvP4XmI5LIIc8EBN2A__&amp;Key-Pair-Id=K6UGZS9ZTDSZM</src>
        <authentication>f1069714b7443de1cb96d74943accb55</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="52">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="8456">
                    <text>ÉDITORIAL
La sexualité chez les jeunes : entre ouverture et
abstinence

Actualités

Société

Culture

Au féminin

Éditoriaux

Archives

À propos



Contribuer

La pilule : cadeau empoisonné ?
La prise du moyen de contraception n’est pas anodine et doit être remise en question.

Tweeter

Dernière édition

Édition du 5 avril 2023
Niels Ulrich | Le Délit

Moyen de contraception incontestablement populaire, la pilule contraceptive est considérée comme un symbole de
l’émancipation des femmes. Or, derrière la contraception hormonale se cache une réalité inquiétante.
Le réflexe pilule
Peu importe l’âge, la pilule contraceptive est conseillée presque automatiquement aux femmes et jeunes filles qui
cherchent un moyen de contraception. En fait, il s’agit du moyen le plus prescrit et compte parmi les médicaments les
plus consommés par les Canadiennes selon l’Enquête canadienne sur les mesures de la santé. Au moyen d’hormones
comme l’œstrogène et la progestérone, la pilule contraceptive bloque l’ovulation et le cycle menstruel pour empêcher
la nidation, soit l’implantation de l’embryon. Si adéquatement utilisée, son taux d’efficacité est évalué à 99%, tout
comme le timbre contraceptif, le stérilet hormonal, l’anneau vaginal et l’injection intramusculaire. Aussi, la pilule est
couramment prescrite pour atténuer l’acné des jeunes femmes, réduire le syndrome prémenstruel et régulariser les
règles. Bien que le·a pharmacien·ne ou le·a médecin doit informer sa patiente des effets secondaires possibles, ces
derniers sont caractérisés comme mineurs et sont justifiés par les bénéfices qu’apporte la pilule. Pourtant, rarement, si
ce n’est jamais, l’on entend parler des conséquences dangereuses et parfois même mortelles dues à la prise de ce
moyen contraceptif. Celles habituellement mentionnées sont la prise de poids, des changements d’humeur, la baisse
de libido, des ballonnements ou encore des étourdissements. En effet, la majorité des femmes ﴾70%, selon l’enquête
indépendante menée par la journaliste Sabrina Debusquat﴿ prenant la pilule contraceptive souffrent de ces
symptômes. Or, le moyen de contraception le plus populaire au Canada cache une histoire et des répercussions
alarmantes ; un silence plane quant aux effets nocifs et étonnamment fréquents que cause la pilule à la gente féminine.
Effets plus qu’indésirables
En 2015, la famille de Florence Aumont‐Légaré, 28 ans, a découvert les dangers que comporte la pilule sous de
tragiques circonstances. Quelques jours après une douleur au mollet qui semblait d’abord anodine, Florence perd
connaissance et est rapidement transportée à l’hôpital. Malheureusement, le soir même, Florence décède malgré les
soins hospitaliers. Les analyses ont démontré par la suite qu’une embolie pulmonaire était en cause. La première
question qui fut posée aux parents de Florence était si elle prenait la pilule contraceptive. La question fut évoquée par
tout·e·s les spécialistes interrogeant ses parents qui, eux, n’avaient jamais été informés du danger que courait leur fille
par la prise de la contraception orale. Le cas de Florence Aumont‐Légaré n’est pas un cas isolé, bien au contraire. Les
chiffres les plus précis proviennent de France, par le rapport de l’Agence Nationale de Sécurité du Médicament
﴾ANSM﴿, qui rapporte une moyenne de 2 529 accidents et 20 décès annuellement dus à la formation de caillots dans le
sang provoquée par l’utilisation de la pilule. Pour ce qui est du Canada, entre 2007 et 2008, Santé Canada a relaté la
mort de 23 jeunes femmes liée à la pilule anticonceptionnelle de la marque Yaz et Yasmin. Thrombose veineuse,
embolie pulmonaire ou encore accident vasculaire cérébral ﴾AVC﴿, le risque de troubles sanguins avec la prise de cette
contraception est connu depuis les années 1960 par le corps médical. Pourtant, la formation de caillots sanguins est
rarement mentionnée pour prévenir les jeunes femmes des effets possibles de la pilule et de plus, peu d’entre elles ont
été formées à reconnaître les signes d’un tel symptôme.

Playlist Culture 2021–2022

Et les effets indésirables ne s’arrêtent pas là. La contraception hormonale peut avoir une incidence sur la santé

Le Délit 2021-2022 · Le Délit Culture

mentale ; on l’associe de plus en plus à la dépression. Cette corrélation est plutôt récente puisque les rares études
menées antérieurement démentaient toute association entre l’utilisation de la pilule et le risque de dépression.
Cependant, ces études s’étaient penchées sur des femmes plutôt âgées qui prenaient la pilule depuis longtemps. Une
étude danoise a quant à elle étudié le cas d’un million de jeunes femmes dans la période suivant leur première
utilisation de la contraception hormonale. Les résultats démontraient une hausse significative, allant jusqu’à 80%, de

À découvrir

l’occurrence de dépression chez les femmes utilisant un contraceptif hormonal.

Imaginaire …

Le réflexe pilule doit disparaître pour laisser place à la discussion

Sexisme chez les scientifiques
Si la femme témoigne de symptômes désagréables durant la prise de la pilule, le·a médecin est encouragé·e, sans être
toutefois obligé·e, de rapporter ces effets à Santé Canada. Ainsi, il se forme un décalage énorme entre l’expérience
qu’ont de nombreuses femmes prenant la pilule et le discours médico‐scientifique dominant. Ce manque d’écoute et
de considération face à l’avis des femmes pourrait s’expliquer entre autres par la sous‐représentation du genre
féminin en science. Tant dans la recherche en laboratoire que dans la production scientifique, le professeur de
l’Université de Montréal Vincent Larivière dénonce depuis une dizaine d’années le manque de femmes dans la
production d’articles scientifiques. Plus précisément, moins d’un tiers des auteur·e·s des plus grandes revues
scientifiques américaines comme la Public Library of Science et l’American Geophysical Union sont des femmes et ce
phénomène se répète à l’échelle mondiale. Cette inégalité dans la hiérarchie scientifique n’est évidemment pas
récente ; rappelons‐nous qu’il n’y a pas si longtemps, les femmes n’avaient pas accès aux cours de mathématiques et
de sciences puisqu’elles étaient confinées à l’enseignement ménager. Bien que cette mentalité rétrograde ait perdu de
sa force avec le temps, elle reste tout de même ancrée dans les perceptions sociales, engendrant une tendance chez les
femmes à s’orienter vers des métiers à caractère social. Il n’est ainsi pas surprenant de constater que les études
concernant la pilule contraceptive ont été majoritairement guidées par des hommes.
L’écosystème affecté
En plus de causer préjudice à la santé des femmes, la pilule œstroprogestative apporte des effets dommageables pour
l’environnement. Les hormones libérées dans le sang sont évacuées par l’urine dans les nappes d’eau souterraines, les
rivières et les lacs. La présence de telles hormones dans l’environnement aquatique perturbe le comportement sexuel
des poissons, diminue leur fertilité et crée un phénomène de féminisation des mâles, c’est‐à‐dire la transformation des
poissons mâles en femelles. Ces perturbations affectent tout autant les mammifères et les oiseaux aquatiques comme
le canard, le goéland et l’oie.
Émancipation sexuelle illusoire
Alors que la pilule est considérée comme un emblème féministe, il suffit de se pencher sur la genèse de sa
commercialisation pour y découvrir une histoire peu glorieuse. C’est d’abord une infirmière et sage‐femme
américaine, Margaret Sanger, qui a fait la promotion de la pilule contraceptive et a cherché à convaincre les décideurs
américains de financer cette nouvelle découverte scientifique. Elle était certes féministe mais flirtait aussi avec
l’idéologie eugéniste et voyait en la contraception orale un moyen de limiter les naissances de certaines minorités
ethniques. Dans un contexte de Guerre froide, des milliardaires américains furent charmés par l’idée de contrôler le
taux de reproduction des femmes au nom de « l’amélioration du patrimoine génétique » et financèrent le projet de
Sanger. Des essais cliniques ont d’abord été menés dans les années 1950 sur des femmes américaines sans toutefois
leur mentionner l’effet contraceptif de la pilule. Dû aux effets secondaires insoutenables tels que des changements
d’humeurs et des caillots sanguins, un nombre élevé de participantes abandonnèrent l’étude, et l’équipe de recherche
se tourna vers Porto Rico où le phénomène de surpopulation commençait à inquiéter. Des Portoricaines furent
soumises de force à l’étude malgré les effets secondaires dénoncés. Les résultats furent néanmoins concluants, la
pilule contraceptive démontrait un taux d’efficacité de 100%. La quantité d’hormones fut par la suite diminuée pour
faciliter sa commercialisation aux États‐Unis.

Il faut prendre en considération le fait que la prise d’hormones n’est pas l’unique solution contraceptive.

Sans diaboliser la pilule contraceptive, il faut tout de moins prendre conscience de ses conséquences au niveau de la
santé physique et mentale ainsi qu’au niveau environnemental. Bien que sa découverte scientifique est considérée
comme un point central de l’émancipation sexuelle de la femme, il ne faut pas oublier que cet instrument de libération
fut d’abord orchestré par l’homme. Évidemment, grâce à la contraception, la femme a un plus grand contrôle de son
corps et il est impératif de ne pas obstruer cette autonomie. C’est pourquoi il faut prendre en considération le fait que
la prise d’hormones n’est pas l’unique solution contraceptive. Une méthode au taux d’efficacité similaire à celui de la
pilule est le stérilet en cuivre. Ce dispositif intra‐utérin en forme de T est introduit dans la cavité utérine, processus
médical qui ne prend qu’une dizaine de minutes. Certaines femmes optent quant à elles pour une méthode naturelle
en suivant leur cycle d’ovulation à l’aide d’un calendrier, d’un thermomètre ou d’un moniteur symptothermique. Avec
toutes ces alternatives, le réflexe pilule doit disparaître pour laisser place à la discussion. C’est aux professionnel·le·s de
la santé, médecins, infirmier·ère·s, pharmacien·ne·s, d’être à l’écoute de leurs patientes, de prendre le temps de
répondre à leurs questions et de les mettre en garde sur les conséquences qu’implique leur choix de contraception. Car
si l’on prend en considération le bien des femmes et de l’environnement, la pilule devient plus difficile à avaler.

À lire aussi : Infographie sur la contraception masculine. Où en est‐on ?

Articles en lien

Rose Chedid | Le Délit

Rose Chedid | Le Délit

Mahaut Engérant

Mon expérience positive de la

Pilule et libido : Pourquoi j’ai

Le fardeau de la contraception

pilule

dit stop

ne devrait pas reposer
uniquement sur les épaules des
femmes

À propos

Principes

Contribuer

Publicité

DPS – SPD

McGill Daily

Auteur.e.s

Archives

Contact

Privacy - Terms

Created with the free version of PDF Mage

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="10">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="3753">
                  <text>Coverage from Le Délit</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="53">
          <name>Volume</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="7839">
              <text>108</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Issue</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="7840">
              <text>15</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="55">
          <name>Page Number(s)</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="7843">
              <text>8-9</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="7">
          <name>Original Format</name>
          <description>The type of object, such as painting, sculpture, paper, photo, and additional data</description>
          <elementTextContainer>
            <elementText elementTextId="7845">
              <text>Webpage</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="7838">
                <text>2019-01-29</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="7841">
                <text>La pilule: cadeau empoisonné?</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="7842">
                <text>Juliane Chartrand</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="42">
            <name>Format</name>
            <description>The file format, physical medium, or dimensions of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="7844">
                <text>PDF</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="7846">
                <text>Le Délit</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="7847">
                <text>An article explaining the social, physical, and environmental drawbacks of hormonal birth control methods like the pill.</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="13">
        <name>birth control</name>
      </tag>
      <tag tagId="14">
        <name>reproductive health</name>
      </tag>
    </tagContainer>
  </item>
</itemContainer>
